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The value of cardiac rehabilitation (CR) after a transient ischaemic attack (TIA) or 
‘minor’ stroke is untested despite these conditions sharing similar pathology and risk 
factors to coronary heart disease.  
 
Aims 
To develop and test the feasibility of conducting a randomised controlled trial of a 
novel home-based rehabilitation programme, ‘The Healthy Brain Rehabilitation 
Manual’, with a pedometer, for patients with a first TIA or ‘minor’ stroke of 
atherosclerotic origin, utilising the core components of home-based CR. This thesis 
describes the systematic reviews of the literature, qualitative research and feasibility 
and pilot studies of the intervention, developed according to the Medical Research 
Council (MRC) guidelines for developing complex health service interventions.  
 
Method 
Systematic literature reviews informed adaptation of a home-based CR manual. This 
was further refined through 3 focus groups (TIA/minor stroke patients and carers; 
clinical academics; and health professionals). Next, a 6 week feasibility study 
randomly allocated participants to 3 arms: (1) standard/usual care; (2) manual; (3) 
manual plus a pedometer. All groups received telephone follow-up at 1 and 4 weeks 
post-enrolment. Biophysical and questionnaire assessments at baseline and 6-weeks 
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included VO2max testing. Two trained review authors independently assessed the 
manual to identify the Behaviour Change Techniques (BCTs) used. 
For the 12 week pilot trial participants were randomly allocated to: (1) standard care 
(n=12); (2) manual plus pedometer with telephone follow-up by General Practitioner 
(GP) (n=14); (3) manual plus pedometer with telephone follow-up by stroke nurse 
(n=14). The telephone follow-up was undertaken at 1, 4 and 9 weeks. Focus groups 
were undertaken to explore participants’ views on the intervention. Eligibility criteria 
for both the feasibility and pilot studies included being within 4 weeks of a first TIA or 
‘minor’ stroke.   
Results 
a) Systematic review 1 
Only 4 studies were identified which utilised lifestyle interventions within the first 90 
days following a TIA and/or ‘minor’ stroke, highlighting the dearth of evidence of 
non-pharmacological interventions in this area. The main behaviour change techniques 
(BCTs) used within the included studies were goal setting and instructions about how 
to perform given behaviours. 
 
b) Systematic review 2 
I reviewed the BCTs utilised in home-based CR and published between 2005-2015. 
Twenty different BCTs were used in the 11 included studies, with social support 
(unspecified) used in all studies and goal setting (behaviour) in 10. Of the 11 studies, 
10 reported effectiveness in reducing CVD risk factors.  
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c) Feasibility Study 
Twenty-eight patients were invited to participate, with 15 (10 men, 5 women; 9 TIA, 6 
minor stroke; mean age 69 years) consenting. Participants completed all assessment 
measures except VO2max testing, which all declined. The intervention was viewed 
positively and pedometers valued highly, particularly for goal-setting. Overall, 36 
BCTs were used in the intervention, commonest centred around goal setting, planning 
and social support. 
 
d) Pilot Study 
Of 125 eligible patients, 44(35.2%) consented to initial study contact, with 40(90.9%) 
participating and 39(97.5%) completing the study. From baseline to follow-up, there 
was a general improvement in cardiovascular risk factors in the intervention arms. 
Qualitative work with participants and stroke nurses confirmed acceptability of the 




It is feasible to conduct a trial to evaluate the effectiveness of a novel home-based CR 
programme, ‘The Healthy Brain Rehabilitation Manual’, implemented within 4 weeks 
of a first TIA/minor stroke. This intervention has been developed following the MRC 
guidelines, with clear patient and public involvement, and has demonstrated 
improvements in cardiovascular risk factors. The commonest BCTs used within the 
manual revolve around goals, planning and social support. The findings from the 
feasibility and pilot work will be used to further refine the next stage of the 
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intervention’s development, a randomised controlled trial, powered to detect 





“Not everything that can be counted counts, and not everything that counts can be 
counted... 
In the middle of difficulty lies opportunity” 
Albert Einstein 
 
 “Today’s rain is tomorrow’s whisky.” 
Traditional Scottish proverb.  
 
For Laura, Leo and Sofia.  
 
 
Annie and Catherine……always in my thoughts and heart.  
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The research contained in this thesis was performed during my 4 years as a NIHR 
Clinical Academic PhD Fellow (September 2014 – September 2018).  
I first became interested in rehabilitation and secondary cardiovascular prevention 
through my own athletic participation, my first passion being football, as well as 
through my clinical work within sport and exercise medicine and primary care.  This 
interest was further supported by a BSc (Hons) intercalated degree in the area of sports 
medicine and a MPhil research degree which assessed physical activity promotion 
within primary care as well as a Masters in Public Health, in which I conducted a 
review of the factors associated with sport participation in adults with long-term 
disability.  
Throughout my medical career I have always seen physical activity promotion and, 
more widely, secondary cardiovascular prevention as imperative, especially when the 
contribution of non-communicable diseases to the burden of chronic diseases are 
considered. In my role as General Practitioner (GP), particularly in an area of high 
deprivation, I feel it is particularly important to educate all patients with regards 
cardiovascular prevention and I particularly enjoy advising patients about how to 
become more physically active.  Health professionals in this area often neglect health 
promotion due to the time constraints placed on GPs and the perceived lack of 
knowledge.  Yet we know that certain patient groups, particularly those that have 
suffered cerebrovascular events, are at significant risk of future cardiovascular events, 
which will then have a significant impact on them personally, their families and wider 
society. An important area of research is therefore the feasibility of conducting 
secondary prevention following an initial cardiovascular event such as a transient 
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ischaemic attack (TIA) or ‘minor’ stroke. Indeed stroke, a major cause of death and 
disability may be prevented by intervention following a TIA or ‘minor stroke’ but the 
best approach to such prevention remains unknown. Through this study I therefore 
wanted to develop a home-based intervention, using core components of cardiac 
rehabilitation, with or without an added pedometer intervention, to promote secondary 
cardiovascular prevention in this patient group.  
Chapter 1 describes a review of the current literature in terms of TIAs, minor stroke 
and secondary cardiovascular prevention. In Chapters 2 and 3, systematic reviews of 
the literature are presented in terms of secondary prevention lifestyle interventions 
initiated within 90 days of a TIA/minor stroke and the behaviour change techniques 
(BCTs) used within home-based cardiac rehabilitation programmes. Chapter 4 then 
presents the initial qualitative work done on the proposed intervention, ‘The Healthy 
Brain Rehabilitation Manual’, with Chapters 5 and 6 then presenting the feasibility 
and pilot studies conducted on this intervention. Finally, Chapter 7 then provides an 
overall summary to the thesis.    
My aim is that by the end of this PhD, clinicians and health professionals will have an 
appropriately evidence-based intervention to promote secondary prevention to those 
who have just suffered a TIA and ‘minor’ stroke and that this intervention will satisfy 
the current unmet needs in this patient group as well as reducing their future risk of 
cardiovascular events. My hope would now be that I could apply for further funding to 
continue to develop this intervention and a randomised controlled trial to prove its 
effectiveness in reducing further vascular events when implemented immediately post-





















1.1 Stroke prevalence, impact and risk assessment 
 
Strokes and transient ischaemic attacks (TIAs) are highly prevalent conditions. Stroke 
killed 5.7 million people worldwide in 2005 and was estimated to cause 6.5 million 
deaths in 2015 (1), with stroke survivors often being left with considerable disability 
(2) and indeed, stroke is the leading cause of disability within the United Kingdom 
(UK) (3). At least 57,000 new strokes occur each year in England, with 32,000 stroke-
related deaths reported each year (4). Approximately a quarter of people who 
experience a stroke will leave hospital with a moderate or severe disability (4) and, 
while stroke incidence increases with age, 38.2% are reported to occur in people aged 
between 40-69 years of age (4). Indeed the average age of a first stroke is gradually 
falling (4), currently reported to be 68.2 years of age for men and 73 years of age for 
women (4).  
In 2016, 36,741 patients were living with stroke in Northern Ireland (NI) (5) and in 
2006, approximately 1,700 TIAs and 4,000 strokes occurred in NI alone (6). Many 
strokes are preceded by TIAs in the previous ninety days (7), and therefore the 
immediate period after a TIA is a crucial time to intervene to reduce the risk of stroke.  
The 90 day risk of vascular events following a TIA or ‘minor’ stroke, excluding events 
within the first week after diagnosis when the risk is highest, can be as high as 18% 
(8), a figure supported by other studies (9). The ABCD2 score (derived from a 
calculation based on the individual’s age, blood pressure, clinical signs, duration and 
diabetes - see Section 2.2 for further details) in patients with a TIA is used to identify 
the future risk of stroke (7). The presence of a new infarct, identified on brain imaging 
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and indicating that the patient has actually had a stroke rather than a TIA, places the 
patient at higher risk of a further stroke within the first 90 days (10).   
 
1.2 Stroke prevention 
 
Immediate assessment of TIA and ‘minor’ stroke patients following the initial event, 
with initiation of secondary prevention focused on pharmacological interventions, can 
reduce the 90 day risk of stroke to 2% within the research setting (11). Indeed 
Rothwell et al (11) conducted a prospective study on 1,278 patients in Oxford, United 
Kingdom (UK), with a TIA and/or stroke and followed them up for ninety days. They 
found that the 90 day risk of recurrent stroke in the patients referred to the study clinic 
reduced from 10ꞏ3% to 2ꞏ1% when assessment and treatment was initiated within, 
generally, twenty four hours of the initial event. This is particularly true for initiation 
of aspirin therapy (12). These results have however not been replicated within routine 
practice, with most patients waiting at least a week from the incident event before 
being reviewed by a specialist and secondary prevention mechanisms introduced (13), 
despite recently released guidelines advising review of TIA symptoms within 24 hours 
in a specialist neurovascular clinic (14).  
Evidence is growing regarding the contribution of change in modifiable risk factors to 
reductions in cardiovascular deaths (15) and there is a need to consider how to 
promote non-pharmacological measures within secondary prevention (16). Indeed 
Hughes et al (15) found that approximately 60% of the reduction in coronary heart 
disease, which shares a similar underlying pathological mechanism to cerebrovascular 
disease, in NI between 1987 and 2007 was due to changes in modifiable 
cardiovascular risk factors and only approximately 35% of the reduction was 
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attributable to medical or surgical treatments.    
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2. Transient Ischaemic Attack (TIA) and ‘minor’ stroke 
 
2.1 Definition of TIA and minor stroke 
 
TIA and ‘minor’ stroke are defined clinically by the patient’s history, a neurological 
examination and neuroimaging (typically a CT and/or MRI head scan), with evidence 
of infarction indicating a diagnosis of stroke and the absence of infarction indicating 
TIA (17). Typical symptoms of a TIA and stroke include the rapid onset of speech 
disturbance, unilateral weakness or sensory loss, monocular blindness, visual field 
defect or ataxia, amongst others. TIA is defined as “a transient episode of neurological 
dysfunction caused by focal brain, spinal cord or retinal ischaemia, without acute 
infarction” (10). Whilst stroke has traditionally been defined as “an acute onset of 
focal neurological symptoms which last more than twenty-four hours” (18), a more up-
to-date definition is “the acute onset of focal neurological symptoms from the brain, 
retina or spinal cord of any duration, in which imaging or autopsy show focal 
infarction or haemorrhage relevant to the symptoms” (19). ‘Minor’ stroke is defined 
by a score of 3 or less on the National Institutes of Health stroke scale at initial 
assessment as per previous authors (20)(21). 
 
2.2 Risk of stroke following a TIA - ABCD2 score 
 
The ABCD2 score in TIA patients is used to identify the future risk of stroke (7) 
although the individual risk of subsequent stroke also varies with the underlying 
mechanism(s) involved (10)(17). The ABCD2 score consists of:
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Elements of ABCD2 score Points 
Age 60 years or above 1 
Blood pressure 140/90mmHg or above 
on first evaluation 
1 
Clinical symptoms of focal weakness 
with spell 





Duration of 60 minutes or more 
or 10-59 minutes 
2, OR 
1 
And Diabetes 1 
 
The points for each feature are added together to obtain the total ABCD2 score for that 
TIA episode. The 90 day risk of stroke based on the ABCD2 score is 3.1% when the 
score is low (0-3), 9.8% with a moderate score (4-5) and 17.8% with a high score of 6-
7 (17).   
 
2.3 Stroke Risk Factors 
TIAs and strokes are most commonly caused by the embolic or thrombotic 
consequences of atherothrombotic disease (17), similar to the underlying pathological 
mechanism for cardiovascular disease (22) (23)(24). As well as sharing a similar 
underlying pathological mechanism, cerebrovascular and cardiovascular disease share 
common underlying risk factors (23)(25) and a high prevalence of asymptomatic 
coronary artery disease has been identified post-TIA (8)(24)(25)(26)(27).   
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The modifiable risk factors for all vascular diseases include smoking, excessive 
alcohol intake, physical inactivity, dietary factors, hypertension, dyslipidaemia, 
diabetes, and obesity (28) as well as low VO2max (29)(30)(31)(32). Five modifiable risk 
factors are reported to account for 82% of strokes: hypertension, smoking, obesity, 
unhealthy diet and physical inactivity (33).   
O’Donnell et al (34) conducted the INTER-STROKE study between 2007 and 2010, 
which was a population-based case-control study in 3,000 cases within twenty-two 
countries, to review stroke risk factors. Cases were those with a first stroke diagnosis 
and controls were those with no stroke diagnosis, matched for age and sex. Significant 
risk factors for all strokes (34) have been included in the below table and have been 
compared to risk factors for myocardial infarction from the INTER-HEART study (35) 
to illustrate the similarity in risks between cardio- and cerebro-vascular disease. The 
INTER-HEART (35) study is similar to INTER-STROKE (34)(36), being a case-
control study but assessing the risk factors for coronary heart disease in 12,461 cases 
across 52 countries.  
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Risk factor  Risk for all strokes 
(Odds ratio, OR, 99% 
Confidence intervals, 
CI adjusted for age, 
sex and region) 
Risk for myocardial 
infarction (Odds 
ratio, OR, 99% 
Confidence intervals, 
CI adjusted for age, 
sex and smoking) 
History of 
hypertension 
OR 2ꞏ64, 99% CI 
2ꞏ26–3ꞏ08 
OR 2.48, 99% CI 2.30-
2.68 
Current smoking  OR 2ꞏ09, 99% CI 
1ꞏ75–2ꞏ51 
OR 2.95, 99% CI 2.72-
3.20 
Waist-to-hip ratio (i.e. 
abdominal obesity, top 
2 tertiles versus the 
bottom one) 
OR 1ꞏ65, 99% CI 
1ꞏ36–1ꞏ99 
OR 1.36, 99% CI 1.24-
1.48 
Diet risk score (top 2 
tertiles versus the 
bottom tertile) 
OR 1ꞏ35, 99% CI 
1ꞏ11–1ꞏ64 
 
Vegetable and fruits 
daily  




OR 0ꞏ69, 99% CI 
0ꞏ53–0ꞏ90 
OR 0.72, 99% CI 0.65-
0.79 
Diabetes mellitus OR 1ꞏ36, 99% CI 
1ꞏ10–1ꞏ68 
OR 3.08, 99% CI 2.77-
3.42 
Alcohol intake (1-30 
drinks/month) 
OR 0.90, 99% CI 0.72-
1.11 
OR 0.79, 99% CI 0.73-
0.86 
Psychosocial stress OR 1ꞏ30, 99% CI 
1ꞏ06–1ꞏ60 
OR 2.51, 99% CI 2.15-
2.93 
Depression OR 1ꞏ35, 99% CI 
1ꞏ10–1ꞏ66 
 




apolipoproteins B to 
A1 (for stroke risk, the 
top 2 tertiles compared 
to the last whilst for 
myocardial infarction 
the 2nd quintile 
compared to the 1st) 
OR 1ꞏ89, 99% CI 
1ꞏ49–2ꞏ40 




Overall these risk factors account for approximately ninety per cent of the risk for 
stroke and this was confirmed on a more recent update of the INTERSTROKE study, 
published in 2016 (36). As can be seen from the table, these risk factors are very 
similar to that of myocardial infarction, that is, cardiovascular disease risk factors. 
Thus there are several lifestyle modifications that might contribute to a substantial 
reduction in the risk of vascular events post-TIA and there is evidence that the earlier 
these interventions can be introduced, the better the outcome (11)(37). National 
guidelines also state that TIA patients should be reviewed in a specific clinic within 
one week of the diagnosis (13), for the early introduction of prevention and 
rehabilitation.   
Despite improvements in acute stroke care, prevention remains the cornerstone of 
reducing the stroke disease burden (38). Indeed a Cochrane review has highlighted the 
importance of tackling modifiable vascular risk factors for secondary prevention in 
those diagnosed with a TIA and/or stroke (16) but the review highlighted the need for 
further clinical studies in this area, with only one completed study included in the 
review.      
 
2.4 Pharmacological Secondary Prevention of Stroke 
 
National United Kingdom (UK) guidelines for the pharmacological treatment of stroke 
have been established by the National Institute for Health and Clinical Excellence 
(NICE) (13)(39) and the Royal College of Physicians (14) and are supplemented by 
guidelines on tackling individual risk factors. Following the acute diagnosis of stroke, 
anti-platelet medication is initiated unless contra-indicated. This typically takes the 
form of a prophylactic 75mg daily dose of aspirin although other agents, for example 
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dipyridamole and clopidogrel, may be added or used instead of aspirin. Statins are 
generally initiated to lower cholesterol levels (40) and appropriate anti-hypertensive 
medications utilised for blood pressure control as per national management guidelines 
(41).     
 
2.5 Non-pharmacological/ lifestyle risk factor modification of stroke risk  
2.5.1 Physical activity 
 
The WHO (World Health Organisation) reports that: 
"Physical activity is a fundamental means of improving the physical and 
mental health of individuals." (42) 
Physical activity promotion and participation must therefore be one of the key goals 
for modern-day health systems (43). Indeed good health is a key determinant of 
development and essential for economic growth (42). Moreover, the WHO in 2010 
(44) identified physical inactivity as the fourth leading risk factor for global mortality 
and other authors (45) report that physical inactivity directly causes 5.4 million deaths 
per year, equivalent to the mortality risk of smoking and obesity combined.  
 Physical activity has been shown to reduce risk for cardiovascular disease, stroke and 
type II diabetes mellitus (43)(46)(47); it reduces blood pressure, improves the level of 
high density lipoprotein cholesterol, improves control of blood glucose in overweight 
people (47) and also reduces the risk for colon cancer and breast cancer among women 
(42)(48). High levels of moderate-intensity physical activity (60-75 minutes/day) also 
appear to eliminate the negative health and mortality effects of being sedentary (49). 
Moreover physical activity has positive effects on osteoporosis and the risk of falls 
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(50), on musculoskeletal conditions such as osteoarthritis (51) and low back pain and 
on mental and psychological health, by reducing depression, anxiety and stress 
(52)(53)(54).     
Indeed Chan et al (46) undertook a cross-sectional study of sedentary workers’ 
physical activity levels in Canada using a sealed pedometer and found a significant 
inverse correlation between steps/day and BMI, female waist circumference and 
diastolic blood pressure. Inactivity was also found to be associated with ischaemic 
heart disease, hypertension, hypercholesterolemia and diabetes (46).  
Exercise is essential in the management of type II diabetes mellitus, which patients 
with a TIA and/or stroke may have. Tudor-Locke et al (55) conducted a randomised 
controlled trial of a pedometer-based exercise programme over 16 weeks in 60 people 
from Ontario diagnosed with type II diabetes mellitus and treated with diet and/or oral 
hypoglycaemic agents. The authors found an increase of 3,000 steps/day from baseline 
associated with a 1.8cm reduction in waist girth at the end of the 16 weeks. Steps/day 
at baseline was also found to be inversely correlated with blood glucose, HbA1c and 
triglyceride concentrations in those treated with oral hypoglycaemic agents.  Thus, 
being more active helps improve plasma glucose control in type II diabetes mellitus 
and helps reduce the cardiovascular risk associated with this chronic condition.     
With regards the antidepressant effect of exercise, Rethorst’s review article (54) 
highlights that exercise has an equivalent antidepressant effect to antidepressant 
medication and a better antidepressant effect than psychotherapy, which is important 
as depression is a recognised risk factor for vascular disease (56). That is, physical 
activity:  
“has the capacity not only to add years to life, but to bring life to years”. (57)  
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Despite the benefits of physical activity being clear, 54% of men and 60% of females 
in Northern Ireland (NI) do not meet the current physical activity guidelines as per the 
NI Sport and Physical Activity Survey (SAPAS) report (58)(59). The NI SAPAS 
report was conducted via in-home interviews using a stratified random sample of NI 
households, to allow an assessment of the physical activity levels of the population. 
Physical inactivity is a clear risk factor for further vascular events and needs to be 
clearly promoted to patients who have recently suffered a TIA and/or ‘minor’ stroke 
(43).    
  
2.5.2 Cardiorespiratory fitness 
Cardiorespiratory fitness, measured by VO2max, is inversely correlated with mortality 
(29)(30)(31)(32), with the progression of carotid atherosclerosis (60) and with the risk 
of stroke. Myers et al (61) found that in male subjects with and without cardiovascular 
disease, peak exercise capacity after adjustment for age, was the strongest predictor of 
the risk of death and each one metabolic equivalent (MET) increase in exercise 
capacity conferred a 12% improvement in survival. Meanwhile Kurl et al (62) in a 
population-based cohort study in Eastern Finland of 2011 men with no history of 
stroke or coronary heart disease, with an average follow-up of twelve years, found that 
an increase in VO2max of 3.5 ml/kg/min was associated with a 17% decrease in stroke 
risk. This finding has been confirmed in a meta-analysis (63). Meanwhile previous 
authors have shown that cardiorespiratory fitness is reduced at one month (64) and up 
to 12 months (65) post-stroke compared to age- and sex-matched controls.  
Exercise can increase VO2max in sedentary persons (66) and in sub-acute stroke 
survivors (67). Indeed Duncan et al (67) conducted a pilot study of an assessment of 
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the impact of an eight week home-based therapist-supervised exercise programme 
undertaken three times a week in patients who had suffered a mild to moderate stroke 
thirty to ninety days previously and showed an improvement in the six minute walking 
test performance in the intervention group. However their study did not include 
patients in the acute phase following the initial stroke diagnosis. There is a paucity of 
published data linking post stroke/TIA exercise to change in subsequent stroke risk.     
 
2.5.3 Smoking 
Smoking is a well-recognised vascular risk factor. The landmark prospective 
observational study by Doll et al (68) found that British male doctors born between 
1900 and 1930 who continued to smoke, had a life expectancy that was ten years less 
than that of life-long non-smokers. Smoking has been identified as a vascular risk 
factor in many other studies (15)(34)(69), with those who currently smoke having a 2 
to 4 times higher risk of having a stroke compared to life-long non-smokers or to those 
who have stopped smoking more than 10 years previously (70).       
 
2.5.4 Diet 
With regards diet, the ‘Mediterranean diet’ has shown favourable effects on 
cardiovascular risk factors (71) and reduced salt intake improves blood pressure 
control, reducing the risk of cerebrovascular events (72). A recent meta-analysis has 
also shown that dietary fibre is inversely correlated with the risk of stroke (73) and 
being overweight increases your overall mortality risk (74). Thus weight loss is an 
important health message to advocate to patients. Moreover hypercholesterolaemia, of 
which dietary intake may be a source, is a modifiable risk factor for cardio- and 
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cerebro-vascular disease (75) and cholesterol levels were found to be positively 
associated with the risk of nonhaemorrhagic stroke (76). Dyslipidaemia was also 
identified as a significant risk factor for ischaemic stroke in the INTERSTROKE study 
(77), which was a case-control study across 22 countries.     
 
2.5.5 Stress 
Psychological distress is a known risk factor for TIAs and strokes. Indeed in the 
observational study by Everson-Rose et al (78), 6749 adults free of cardiovascular 
disease at base-line in the United States, aged 45 – 84 years old, were followed up for 
a median of 8.5 years as part of the Multi-Ethnic Study of Atherosclerosis (MESA). 
The authors found that higher levels of stress and depressive symptoms were 
associated with increased stroke and TIA risk, independent of other known vascular 
risk factors. Moreover the diagnosis of TIA and/or stroke often leaves survivors with 
stress, anxiety and depressive symptoms, with a recent systematic review (79), 




Alcohol excess is a well-known modifiable vascular risk factor, including for TIAs 
and strokes. Gill et al (80), report the ‘J-shaped’ association between alcohol and risk 
of stroke in a case-control study of approximately 1,200 patients. That is, alcohol at 
low levels may have a protective effect for cerebrovascular events, whereas heavy 
consumption predisposes to stroke. This is supported by a recent Swedish cohort study 
(81), following up 811,579 Swedish men from a mean age of 18, which found that 
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alcohol excess was an independent modifiable risk factor for stroke. Restriction of 
alcohol consumption should therefore be promoted to the population to reduce the risk 
of future TIA and stroke events (82).    
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3.0 - Secondary prevention of stroke 
3.1 The ‘evidence gap’ from research to practice 
 
Despite the knowledge surrounding vascular risk factors and the recognition that TIA 
and ‘minor’ strokes are often the precursors of disabling strokes, more needs to be 
done in reducing stroke as the leading cause of adult disability (83). Indeed the World 
Health Organisation (WHO), as part of their 2013 Global Action Plan For the 
Prevention and Control of Non-Communicable Diseases, has targeted a 25% relative 
risk reduction in premature mortality from cardiovascular diseases, including TIAs and 
stroke (84).    
 
 
3.2 Physical activity and pedometer use in stroke 
 
Physical activity is an important component of the strategy to meet the WHO 2013 
Global Action Plan targets (84). One method of promoting physical activity and 
potentially improving VO2max, two known vascular risk factors, is through the use of 
pedometers (85). Pedometers are commonly used to provide a measurement of 
physical activity, to provide patient feedback and as a motivational instrument through 
goal setting. Pedometers can be used with different Behaviour Change Theories, for 
example, the theory of planned behaviour (86).      
 Pedometers have been shown to be accurate and reliable in measuring ambulatory 
activity (46)(87)(88)(89) whilst also being relatively inexpensive. Yamax pedometers 
have been shown to be the most accurate waist-borne instrument (87) and total daily 
step count is an accurate descriptor of ambulatory activity (87)(88). Pedometers appear 
feasible for use by patients with stroke although their accuracy at slow walking speeds 
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has been questioned (90)(91). No reports have been identified regarding the use of 
pedometers as a physical activity promotion tool by patients with TIA or within the 
acute stroke setting and indeed a recent systematic review on the role of cardiovascular 
exercise post-stroke, has highlighted the lack of studies of this tool in the acute and 
sub-acute periods (92).     
Pedometer step counts correlate with cardiovascular health (88) and higher daily step 
counts are linearly associated with subsequent lower mortality (93). Increasing 
steps/day by an average of 2,500 led to modest weight losses and a mean reduction in 
systolic blood pressure of 3.8mmHg (94). Significant decreases in BMI and blood 
pressure have also been associated with a similar step count increase of 3,000 
steps/day (88)(95).  
Moreover, physical activity public health recommendations have been translated into 
pedometer targets (94). A cadence of approximately 100 steps per minute is 
considered the floor value for moderate-intensity activity (88) and approximately 130 
steps per minute is congruent with vigorous intensity activity although it has been 
suggested that stride rates for specific walking intensities should be adjusted for an 
individual’s height (96). Step-counts can therefore be used by patients to achieve the 
recommended levels of physical activity, including both the amount and intensity, 
helping to tackle the known vascular risk factor of physical inactivity. Pedometers also 
appear to promote physical activity in the long-term, with De Cocker et al (97) 
showing that after 4 years of follow-up, the pedometer intervention group had higher 
physical activity levels than the control group.      
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3.3 Risks of physical activity in stroke  
 
Exercise guidelines for stroke survivors have been established (98), with exercise in 
this cohort of patients considered to be safe (98) and to produce recognised health 
benefits (99)(100). A twelve week supervised exercise programme in sub-acute stroke 
survivors demonstrated improvements in flexibility, strength, endurance, mobility and 
balance, with no excessive adverse events reported (101).   
A supervised cardiac rehabilitation programme is reported to be safe in stroke 
survivors (102)(103)(104) and community-based exercise programmes are safe and 
effective in those who have had a stroke (105)(106). Moreover, the risk of any major 
cardiac event during cardiac rehabilitation, performed in a similar patient cohort to 
TIA and stroke patients, has been estimated as one event in 60,000 to 80,000 hours of 
supervised exercise (107).    
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4.0 Stroke and cardiovascular disease: pathological mechanisms and 
rehabilitation  
 
4.1 Cardiac rehabilitation and myocardial infarction 
Although cardio-vascular and cerebro-vascular disease share common underlying 
pathological mechanisms and risk factors, cardiac rehabilitation for secondary 
prevention is only offered to patients in the UK with cardiovascular disease (108), 
despite current scientific statements promoting its use in secondary prevention 
following a stroke (109). The WHO has defined cardiac rehabilitation as the:  
“sum of activity and interventions required to ensure the best possible physical, 
mental and social conditions so that patients with chronic or post-acute 
cardiovascular disease may, by their own efforts, preserve or resume their proper 
place in society and lead an active life” (110).   
NICE have recommended that the components of cardiac rehabilitation should include 
exercise, health education and stress management (108), helping to tackle the known 
vascular risk factors as previously documented in this Chapter. Health education 
would include addressing the known modifiable vascular risk factors as well as 
providing advice regarding work, mental health and sexual activity (108). These 
components are all addressed in the “Heart Manual” (111), a home-based cardiac 
rehabilitation programme.   
The “Heart Manual” is the only validated home-based cardiac rehabilitation 
programme supported by NICE for patients who have had a myocardial infarction 
(MI) (112). It is based on the Health Belief Model of behaviour change theory and 
uses cognitive behavioural techniques, including goal setting, and its use has been 
associated with reductions in depression, anxiety and cholesterol levels and improved 
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quality of life (113). The “Heart Manual” has also been associated with reductions in 
blood pressure, improved exercise capacity and smoking cessation rates that are 
comparable to those achieved with hospital-based cardiac rehabilitation programmes 
(114). Other work has also shown that use of the “Heart Manual” has been associated 
with reduced anxiety and depression, strengthened illness control beliefs (115) and 
increased confidence in recovery and self-perceived progress (116).   
Cardiac rehabilitation after a MI results in a statistically significant reduction in re-
infarction (odds ratio 0.53, 95% CI 0.38 – 0.76), cardiac mortality (odds ratio 0.64, 
95% CI 0.46 – 0.88), and all-cause mortality (odds ratio 0.74, 95% CI 0.58 – 0.95) 
(117). These findings concur with those of a Cochrane Review (118) although it was 
acknowledged that the studies included in the review mainly included middle-aged 
men who are generally at low cardiovascular risk. A recent review by Rauch et al 
(119) illustrated the continued benefit of cardiac rehabilitation despite recent advances 
in medical and surgical treatments.  
A Cochrane Review demonstrated hospital- and home-based cardiac rehabilitation 
programmes, most of which used the “Heart Manual”, could result in similar health 
gains (120), with home-based programmes improving adherence to the programme 
(121). This finding was again found in a recent Cochrane systematic review (122), 
illustrating that home-based cardiac rehabilitation produces similar health benefits to 
centre-based options. Moreover, home-based cardiac programmes have shown longer 
term sustainability of health benefits compared with hospital-based programmes (123).   
Thus there is strong evidence via meta-analysis and systematic reviews to support the 
use of a home-based programme in a patient population with cardiovascular disease. 
Furthermore, it may be hypothesised that it would also have value in the secondary 
		 48
prevention of cerebrovascular disease, which shares underlying pathological 
mechanisms and risk factors with cardiovascular disease. 
 
4.2 Cardiac rehabilitation and stroke 
Lennon et al (124) and McKay-Lyons et al (28) have described randomised trials of 
community-based cardiac rehabilitation programmes in both TIA and stroke 
patients. These studies did not review the use of home-based programmes, which we 
know are at least as effective as community-based options whilst being more cost-
effective (122), and did not include a pedometer arm. These studies finished early, 
with no results available in their clinical trials registry entries or published. Both 
described a relatively long period from the event to entry into the trial (up to 90 days 
for both studies). However other research has shown that vascular risk factors should 
be addressed as quickly as possible following the initial vascular event (11).  
Prior et al (103) have described a pilot study of a community-based cardiac 
rehabilitation post-TIA and ‘mild’ stroke and showed important reductions in 
biological markers linked to cardiovascular and cerebrovascular 
mortality. Approximately half of the TIA/“minor” stroke patients who were 
approached to enter the study consented to participate and roughly 80% of people who 
consented to participate in the study completed the study. Thus community cardiac 
rehabilitation programmes appear feasible in this patient group. Moreover Prior et al 
(103) report that they achieved significant changes in aerobic capacity, lipid profile, 
waist circumference, body mass index, body weight and smoking status at six months 
compared to baseline. There was also a statistically non-significant reduction in BP 
and HDL cholesterol. However the study did not include a control group, patients were 
eligible for inclusion up to one year post-event and the researchers did not offer home-
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based rehabilitation and did not include pedometers in the rehabilitation 
programme. Other authors have also piloted community-based cardiac rehabilitation 
programmes in the TIA and minor stroke population, with patients eligible for 
inclusion up to one year post-event (125)(126) but no authors have previously assessed 
the feasibility of adapting a home-based cardiac rehabilitation programme, with or 
without an added pedometer intervention, initiated within the first month post-event 
for this patient population.  
Therefore the use of cardiac rehabilitation programmes post-TIA/’minor’ stroke 
requires further research. Such research has immediate clinical significance and the 
potential to change guidelines for the management of TIAs and minor strokes, as well 
as the potential to reduce morbidity and mortality resulting from TIAs and strokes in 
Ireland and the UK, with clear benefit to patients.
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5.0 Conclusion  
 
5.1 The research question 
 
The literature shows the importance of stroke prevention and its relevance to 
healthcare services. The evidence presented in the earlier sections of this Chapter 
shows the significance of implementing early prevention after a TIA or minor stroke 
and this has been supported by a recent editorial in the Lancet (4). There are gaps in 
the evidence regarding the translation of secondary prevention initiatives from 
research into practice and a lack of evidence regarding the best approach to promoting 
secondary cardiovascular prevention to reduce subsequent stroke risk for patients with 
a TIA or minor stroke. However, cardiac rehabilitation, which combines approaches to 
lifestyle change with the provision of appropriate medication, is effective for reducing 
risk for patients with cardiovascular disease and there is a suggestion that a similar 
approach to patients with TIA or minor stroke may be effective. The research question 
that this thesis seeks to explore was:  
 Can a novel home-based rehabilitation programme, ‘The Healthy Brain 
Rehabilitation Manual’, with the use of an additional pedometer, be developed 
for use in patients with a first TIA or ‘minor stroke of atherosclerotic origin, 
utilising the core components of home-based CR.  
 I then wanted to test the practicality of using the intervention within feasibility 
and pilot studies and receive appropriate qualitative review of the intervention at 




5.2 Research objectives  
 
The overall aim of this project was to develop a novel home-based rehabilitation 
programme, ‘The Healthy Brain Rehabilitation Manual’, for patients with transient 
ischaemic attack (TIA) and/or ‘minor’ stroke and to determine the feasibility of 
conducting a randomised controlled trial to evaluate its effectiveness. The project 
aimed to use the Medical Research Council (MRC) guidelines for developing complex 
health service interventions (127) and the home-based cardiac rehabilitation manual, 
the “Heart Manual” (111), in the development of the novel programme.   
It was hypothesised that the “Heart Manual” would be able to be adapted to develop a 
rehabilitation programme (‘The Healthy Brain Rehabilitation Manual’) for patients 
with a TIA/‘minor’ stroke. It was also hypothesised that the programme would be 
perceived as being acceptable, relevant and valuable to patients, and that feasibility 
and pilot studies would show that its effectiveness could be tested in a randomised 
controlled trial, with potential for real-world patient benefit. The studies included an 
added pedometer intervention and tested if a specialist stroke nurse or a General 
Practitioner (GP) could deliver these interventions effectively.   
The proposed trial was the first to assess the effect of a home-based vascular 
rehabilitation programme on secondary cardiovascular risk factors in patients early 
after their first ‘minor’ stroke or TIA. The study was also the first to assess the 
acceptability of such an approach and the use of pedometers to increase physical 
activity levels in the acute TIA and ‘minor’ stroke setting. Pedometers act as a tool to 
prompt physical activity and provide a means of objective personal feedback regarding 
achievement of goals and promote longer-term behaviour change. The study also 
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attempted to assess how best to deliver the intervention through utilising either a 
stroke nurse or a GP. The intervention proposed for this trial was based on an effective 
home-based cardiac rehabilitation programme, the ‘Heart Manual’, and incorporated 
characteristics shown to maximise adherence whilst emphasising early intervention, 
being initiated within four weeks of the TIA or ‘minor’ stroke to maximise patient 


























Rehabilitation Programmes with Secondary Prevention 
Lifestyle Interventions Initiated within 90 days following a 
TIA or ‘minor’ stroke: Systematic Review and Meta-analysis 
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Aims 
This section of the thesis was a systematic review of comprehensive rehabilitation 
programmes that included secondary prevention lifestyle measures, initiated within 90 
days of a TIA and/or ‘minor’ stroke. It aimed to examine the effects of these 
programmes and to identify the ‘active’ ingredients in each by identifying the 
behaviour change techniques (BCTs) that had been utilised. The information from this 
systematic review of the literature was then used in the initial development of ‘The 
Healthy Brain Rehabilitation Manual’.  
 
Objectives 
This review aimed to investigate the effect of comprehensive rehabilitation 
programmes that included secondary prevention lifestyle measures, initiated within 90 
days of a TIA or ‘minor’ stroke in adults and to identify and categorise the BCTs (128) 
that were employed in these programmes.  
 
Introduction 
There is a need for clearer guidance regarding optimal early prevention and 
rehabilitation strategies and interventions to promote lifestyle change following TIAs 
and ‘minor’ strokes. Some current guidelines (129)(130) advocate the promotion of 
early non-pharmacological secondary prevention after all cerebrovascular events but 
lack detail regarding effective methods of their delivery. There have been reports of 
lifestyle interventions post-TIA and minor stroke (131)(132)(133). However, no 
previous systematic reviews of the evidence of the effectiveness of early post-TIA 
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rehabilitation or secondary prevention programmes that describe non-pharmacological 
and lifestyle interventions have been identified.  
Whilst TIA and ‘minor’ stroke patients are typically without residual physical 
functional disability, they often have residual functional impairment, particularly with 
regard to post-event fatigue and psychological issues which may lead to more 
significant disability (79)(134). These issues, however, are not highlighted currently 
within early rehabilitation or secondary prevention programmes for patients with 
TIA/minor stroke, although the novel adaptation of cardiac rehabilitation programmes 
for TIA and stroke patients has been advocated (103)(124)(125).  
Comprehensive programmes, which try to alter participants’ behaviours, are complex: 
information about their ‘active’ ingredients, such as specific BCTs (128), would 
facilitate their replication and the implementation of guidelines for good clinical 
practice (135)(136). Thus this systematic review was undertaken to help produce an 
evidence base upon which rehabilitation interventions can be developed for this patient 




This systematic review is reported in line with the Preferred Reporting Items for 
Systematic Reviews and Meta-analyses (PRISMA) guidance (137) and has been 
reported as per previous authors (138). The study protocol was published prior to 
starting the review (139). I planned to include human randomised and quasi-
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randomised controlled trials of rehabilitation programmes initiated within 90 days of 
patients suffering a TIA or minor stroke.   
The review focused on adults, males and females, aged 18 years or older, that received 
a diagnosis of a TIA and/or ‘minor’ stroke, based on clinical diagnosis, or on findings 
from brain imaging (e.g. CT or MRI head). Studies that included only moderate or 
severe stroke patients, which did not provide outcome data specifically for patients 
with TIA/minor stroke and/or in which the intervention was initiated later than 90 days 
post-event were excluded.   
Any rehabilitation programme, identified as a set of measures to achieve and maintain 
a patient’s optimal functioning (83), following an initial TIA or ‘minor’ stroke, was 
eligible for inclusion.  The review included any 1:1 or group-based intervention which 
was undertaken in hospital, outpatients, community or the home, trials with a 
comparative control group and trials with multiple intervention arms (comparing 
different forms of rehabilitation).  The review did not include population or 
community-wide interventions.  
 
Types of outcome measures 
i)  Primary outcomes 
•  Quantitative between-group differences for modifiable cardiovascular risk factors 
(e.g. blood pressure, lipid and triglyceride profiles, markers of insulin resistance and 
obesity, validated cardiovascular risk score, measures of physical activity, tobacco 




ii) Secondary outcomes 
  Secondary cardiovascular events: stroke, myocardial infarction, or vascular death.   
  Any adverse events (e.g. exercise-related musculoskeletal injuries). 
  Any indicator of patient adherence to secondary prevention medication, e.g. self-
reported medication adherence.   
 
Search methods for identification of studies 
Detailed search strategies were developed for each electronic database searched with 
input from a medical librarian to allow identification of studies for inclusion in this 
review. The searches were based on the strategy developed for Medical Literature 
Analysis and Retrieval System Online (MEDLINE) (Appendix 1) but revised 
appropriately for each database. I searched the Cochrane Library, Ovid MEDLINE(R) 
1946 to March 2015, Ovid Embase 1974 to March 2015, Web of Science, EBSCO 
Cumulative Index to Nursing and Allied Health Literature (CINAHL) plus 1937 to 
March 2015 and Ovid PsycINFO 1806 to March 2015. Any systematic reviews of 
rehabilitation interventions in the acute period following a TIA or ‘minor’ stroke were 
screened for additional references. The titles and abstracts of publications from the 
search strategy were independently screened by myself and a supervisor (NH 100%, 
MEC 100%). Additional studies were identified from reviewing the reference lists of 
the retrieved papers through a hand search. Articles not meeting the inclusion criteria 
were discarded. A standardised form (Appendix II) was used to select the trials 
eligible for inclusion in the review with, if necessary, a second supervisor (FK) 
resolving disagreements. A record was kept of all articles excluded at this stage and 
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the reason for their exclusion. No language restrictions were made although all papers 
were written in the English language.  
Data on methodological issues, eligibility criteria, interventions (including the number 
of participants treated, intervention provider) and study design, study duration, follow-
up, comparisons, outcome measures, results, withdrawals and adverse events were 
extracted independently by myself and a supervisor (NH, MEC). There was no 
blinding to study author, institution or journal and a record was kept of each study 
included in the review.   
 
Assessment of quality and risk of bias 
The PEDrO scale (140) was used to assess the quality of included papers in the 
review.  Also, I and one supervisor (MEC) independently assessed each included study 
for risk of bias (‘high’, ‘low’ or ‘uncertain’) using the risk of bias tool, following 
guidance from the Cochrane Handbook of Systematic Reviews of Interventions (141), 
a second supervisor (FK) acting as arbitrator as required.  
 
Measures of treatment effect 
For each study, relative risk and 95% confidence intervals were calculated for 
dichotomous outcomes and mean differences and 95% confidence intervals were 
calculated for continuous outcomes. Where continuous outcomes were pooled on 
different scales, standardised mean differences were used. Where available, changes 
from baseline (mean change scores) were used in preference to follow-up scores. 
When combining results for the individual studies, I generally used mean differences 
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and a random effects model apart from two variables, deaths and falls, when I used 
odd ratios with a random effects model.  
 
Assessing for heterogeneity 
Diversity across the studies was assessed qualitatively in terms of intervention 
(content, duration, frequency, provider and setting), participant demographics, 
outcome measures and follow-up.  If two or more studies were considered clinically 
homogenous according to the above terms, data were assessed for statistical 
heterogeneity using RevMan version 5.1. The chi-squared (χ2) test was used in 
conjunction with the I2 statistic, which describes the percentage of variability in effect 
estimates due to heterogeneity. The level of significance for the χ2 was set at p < 0.1. 
Values of I2 from 30% to 60% were considered to represent moderate heterogeneity 
and 60% to 90% substantial heterogeneity (141).  
 
Data synthesis 
Careful consideration was given to the appropriateness of conducting a meta-analysis. 
Data were summarised statistically when the data were available, sufficiently similar 
and of sufficient quality and the statistical analysis was performed in accordance with 





Behaviour change techniques (BCTs) 
Two trained review authors (NH, MAT) independently screened studies included in 
the review for the reported use of BCTs. Michie’s BCT taxonomy (128), comprising 
93 hierarchically clustered techniques, was used to identify the BCTs and a narrative 
approach was used to describe their use within the rehabilitation programmes. 
 
Results 
I reviewed the full text of 47 studies and identified 31 studies for possible inclusion in 
this review (Figure 1). Only two of the 31 studies were included and an additional two 
studies were retrieved from the reference lists of the previously identified 31 studies 
(see Table 1); 3 papers could not be traced. Fourteen studies were excluded because 
the sample comprised participants with moderate or severe stroke and six studies were 
excluded because they included participants with varied stroke severity and did not 
provide outcome data for patients with TIA/minor stroke. A further 6 studies were 
excluded because they were protocols (2), editorials/overviews (2) or did not have 
appropriate outcome measures (2).    
 
Programme design and evaluation  
Four studies were included in the review. Allen et al, 2009 (142) evaluated whether a 
comprehensive post-discharge care management for 380 minor stroke survivors was 
superior to organised acute stroke department care with enhanced discharge planning. 
Toledano-Zarhi et al, 2011 (143) examined the feasibility, safety and effectiveness of 
an early aerobic rehabilitation programme for 28 patients between one and three weeks 
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post minor ischaemic stroke. Boysen et al, 2009 (144) investigated the effect of 
repeated verbal instructions about physical activity delivered to 314 patients within 90 
days of a minor ischaemic stroke, three-monthly for the first year and six-monthly for 
a second year. Tanne et al, 2008 (145) assessed the tolerability, safety and effect of an 
outpatient supervised exercise training programme, in 52 patients after a non-disabling 
stroke, initiated within a mean time of 65 days. Two of the included studies were 
conducted in Israel (143)(145), one in the United States (142) and one in China and 
Europe (Denmark, Poland, and Estonia) (144). All patients had a diagnosis of TIA 
and/or ‘minor’ ischaemic stroke and were recruited from secondary care, typically 
from stroke units. Three studies delivered the intervention in secondary care 
(143)(144)(145) whilst one (142) was delivered at home by a multi-disciplinary team 
after an initial consultation in hospital. Outcomes were assessed after 6 weeks (143), 3 
months (145), 6 months (142) and 2 years (144).   
 
Behavioural Change Techniques in Included Studies      
The BCT identified as, ‘instruction on how to perform a behaviour’, was employed in 
all four studies. ‘Goal setting’ was used in three of the four studies and a range of 
other BCTs was used by different studies (Table 2). One outpatient exercise 
programme (145), a feasibility study, was the only programme that used the BCT of 
‘discussing behavioural consequences’ with patients and this study reported a 
statistically significant improvement in post-event exercise capacity.  
Within the BCT Taxonomy (128), individual BCTs are clustered into hierarchical 
groups that commonly appear together in behavioural interventions. The commonest 
group of BCTs used in the 4 included studies was ‘goals and planning’, whilst the 
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second most common group utilised was ‘sharing knowledge’. Of all the groups of 
BCTs listed in the taxonomy (128), 5 did not appear within any of the studies: these 
were ‘reward and threat’, ‘antecedent identity’, ‘scheduled consequences’, ‘self belief’ 
and ‘covert learning’.  
Regarding use of the BCT ‘instruction on how to perform a behaviour’, one study 
reported that a physiotherapist or neurologist provided “repeated encouragement and 
verbal instructions on being physically active” (144). Toledano-Zarhi et al (143) 
reported that they provided all participants with a home exercise booklet, including 
information on strength and flexibility exercises, as well as encouraging them to 
maintain their normal physical activity routine in the community. The participants in 
the active group then additionally received a supervised exercise programme twice 
weekly for 3 hours per week over a duration of 6 weeks. Meanwhile in Tanne et al 
(145) the intervention group were entered into a supervised exercise training 
programme performed twice weekly over a 3 month duration. A physiologist 
prescribed the exercise programme, with specific guidance regarding intensity, type 
and duration of exercise. Allen et al (142) reported that they offered general lifestyle 
modification advice to address secondary prevention factors.  
 
Risk of bias in included studies 
Allen et al, 2009 (142) and Boysen et al, 2009 (144) were deemed to be at low risk of 
bias whilst Tanne et al, 2008 (145) was assessed as being at high risk of bias as it was 
a pilot, quasi-randomised controlled trial (see Table 1). Toledano-Zahri et al, 2011 
(143) was assessed as being at uncertain risk of bias as there was no detail reported 
regarding randomisation or blinding of participants and assessors. The application of 
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the PEDrO scale (140) supported these assessments. Allen et al, 2009 (142) and 
Boysen et al, 2009 (144) had allocation concealment within their study design, thus 
reducing their risk of bias, in contrast to Tanne et al, 2008 (145) and Toledano-Zarhi et 
al, 2011 (143). The paper by Allen et al, 2009 (142) is unclear regarding blinding of 
participants and personnel for study allocation but outcome measurements were 
blinded. Tanne et al, 2008 (145) and Toledano-Zarhi et al, 2011 (143) did not detail 
how their groups were allocated or if personnel were blinded to study allocation. 
Boysen et al, 2009 (144) described how personnel undertaking their outcome 
assessment, the Physical Activity Scale for the Elderly (PASE), were blinded to group 
allocation. The proportion of study participants completing follow-up ranged from 
92% in the intervention arm (144) to 100% (142)(143). All studies fully accounted for 
the study participants and provided reasons for any missing data. No other potential 
sources of bias were identified.   
 
Assessment of reporting bias 
Funnel plots were not produced as only two studies were included in each of the 
outcome measures.   
 
Outcomes 
One study reported the percentage dead at the end of study, percentage smoking and 
percentage exercising (142); one reported change in the PASE, number of vascular 
events and change in modified Rankin Scale (144) and two (143)(145) shared similar 
outcome measures (six minute walk test (6 MWT), exercise test results (metabolic 
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equivalents (METS) achieved) and resting and peak blood pressure). Although there 
was a high risk of bias in Tanne’s work (145) and an uncertain risk of bias in the study 
by Toledano-Zahri (143), their results were included in a meta-analysis, to explore 
potential insights, whilst being cautious about interpretation. A sensitivity analysis was 
not undertaken because the results of the meta-analysis were non-significant.         
The overall treatment effect showed no improvement in the resting systolic blood 
pressure (Figure 2) or in peak systolic blood pressure. There was no treatment effect 
for resting heart rate nor for the 6MWT (Figure 3), although improvement in the 
6MWT was shown by one study, a three month outpatient exercise programme (145). 
The overall treatment effect showed no improvement in the exercise testing result 
(Figure 4), although one study showed improvement in metabolic equivalents (METs) 
(145). There was no effect shown on the number of falls experienced by the 
participants during the rehabilitation programme or in rates of death following the 
rehabilitation programme. Of note, two studies (143)(145) reported no deaths during 
their studies and so these results were unable to be incorporated into the meta-analysis.    
 
Discussion 
This systematic review comprised four studies that initiated rehabilitation programmes 
that included lifestyle and non-pharmacological interventions within 90 days of a 
diagnosis of TIA or ‘minor’ stroke, though only two studies were of high 
methodological quality. Many other potentially eligible studies were excluded from 
the review because they did not present results specifically for patients with TIA or 
minor stroke. This highlights that previous secondary prevention rehabilitation 
programmes have focused on moderate and severe stroke patients. A meta-analysis 
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found no evidence of significant effects on subsequent stroke risk or on vascular risk 
factors although two studies reported improved measures of exercise capacity 
(143)(145). 
This review, the first to report collated observations on the BCTs used in studies of 
rehabilitation programmes for patients with acute TIA or minor stroke, suggests that 
providing individualised instruction to patients about how to perform specific 
behaviours and behavioural goal setting, are key programme components but many 
other BCTs have been used. One programme, which reported improved exercise 
capacity (145), was the only one that included discussion of behavioural consequences 
with patients, hinting at the importance of using this BCT in future programmes. As 
the emphasis on early recognition of stroke and TIA in clinical practice increases, it is 
important to know more about appropriate comprehensive management programmes 
for these patients who may not have obvious residual disability and whose need for 
non-pharmacological support and rehabilitation may be overlooked. 
 
Comparison with previous literature 
Evidence is growing regarding the contribution of change in modifiable risk factors to 
reductions in cardiovascular deaths (15) and there is a need to consider how to 
promote non-pharmacological measures within secondary prevention (16). Indeed five 
modifiable risk factors are reported to account for 82% of strokes: hypertension, 
smoking, obesity, unhealthy diet and physical inactivity (33). A pilot study of a 
community-based cardiac rehabilitation post-TIA and ‘mild’ stroke, for patients up to 
one year post-event, showed reductions in biological markers linked to cardiovascular 
and cerebrovascular mortality, including aerobic capacity, lipid profile, waist 
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circumference, body mass index, body weight and smoking status at six months but 
did not include a control group (103). Similarly, Kirk et al (125) found that 
community-based cardiac rehabilitation programmes for 12 post-TIA and minor stroke 
patients can be effective at reducing modifiable vascular risk factors. Reviews 
identifying effective components of rehabilitation following the diagnosis of a TIA 
and ‘minor’ stroke have begun to emerge (131)(132)(133)(146) but, to our knowledge, 
this is the first systematic review of the use of rehabilitation programmes in the acute 
period (within 90 days) of the diagnosis of a TIA or ‘minor’ stroke.  
No significant effect on vascular risk factors was found within this review, which is a 
similar finding to a recent systematic review assessing lifestyle interventions after 
TIAs and stroke (147), which only found an improvement in systolic blood pressure in 
their analysis.  However, Brook et al (148) reviewed non-pharmacological treatment 
effects on blood pressure and found Class 1, level A evidence for the blood pressure 
lowering effects of exercise in patients with cardiovascular disease. Billinger et al 
(149) performed an eight week exercise programme in ten moderate severity stroke 
subjects in the sub-acute period following their diagnosis, with a reduction in resting 
heart rate and improvement in six minute walking test (6MWT) performance post-
intervention. Duncan et al (150) found that an eight week home-based therapist-
supervised exercise programme undertaken three times a week within 30 to 90 days of 
a mild to moderate stroke improved 6MWT performance in the intervention group. 
These 2 studies are supported by a recent meta-analysis (151), which found that 
exercise interventions in those with chronic disease, including stroke patients, can 
improve functional capacity and reduce disability in these patients, improving their 
quality of life. However, MacKay-Lyons et al (152) showed no change in peak 
systolic blood pressure when following stroke survivors, undifferentiated by severity, 
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for six months despite improvements in aerobic capacity. Thus, whilst previous work 
shows improvements in vascular risk factors associated with exercise for stroke 
survivors, our review highlights the lack of evidence of this effect following 
rehabilitation programmes initiated early after a TIA and/or ‘minor’ stroke. This is 
clearly an important area that requires urgent further research.   
No significant reduction in the number of falls was found. However, Taylor-Piliae et 
al (153) found that exercise, particularly Tai Chi based programmes, improved balance 
and reduced falls in patients aged over 50 years, who had suffered a stroke up to three 
years previously. A recent systematic review and meta-analysis including 88 trials and 
19,478 participants (154), showed that exercise can prevent falls in community-based 
older people, with programmes of a higher dose producing larger effects, stating that 
programmes which consist of a high challenge to balance and last for more than 3 
hours/week have the greatest fall prevention effects, reducing fall rates by 39%. 
However a Cochrane review (155) has shown no consistent evidence for exercise 
programmes preventing falls in stroke survivors. Thus the evidence is mixed in 
relation to the effects of exercise on falls reduction post-stroke and further high-quality 
studies are required in this area.   
No excess deaths were found in those undergoing rehabilitation programmes 
compared to those not undergoing rehabilitation and thus acute and sub-acute 
rehabilitation programmes appear safe in this patient cohort.  Indeed exercise 
guidelines for stroke survivors have been established (98), with exercise in this cohort 
of patients considered to be safe (98).  
NICE published guidance in 2014 on individual-level behaviour change interventions 
for promoting change in modifiable cardiovascular risk factors (136).  These 
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guidelines recommended that behaviour change programmes, including lifestyle 
management programmes, should include BCTs relating to goals and planning, 
feedback and monitoring, and social support. In keeping with these guidelines (136), 
the most frequent BCTs found within this review were facilitating patients to set goals 
for behavioural changes and providing instruction on how to perform the new 
behaviours. However, the provision of social support was only implemented in two of 
the four studies (142)(144). These specific BCTs represent only a small fraction of 
those available in Michie’s taxonomy, so that there is clear scope for further research. 
Moreover, this review highlights the poor reporting of BCTs used within 
interventions. It is clearly important to identify the specific BCTs used within studies 
to allow their replication. Future studies of rehabilitation and secondary prevention 
following a TIA and ‘minor’ stroke should therefore develop descriptions of the use of 
these techniques within their interventions. 
 
Strengths and Limitations  
A limitation of the review was the lack of consistency in the outcome measures used 
in included studies and combining results in a meta-analysis was therefore difficult.  
Another study limitation related to the duration of follow-up, which varied from six 
weeks to two years. The results should therefore be interpreted with caution, as shorter 
study durations may not allow sufficient time for the rehabilitation interventions to 
produce an impact on modifiable vascular risk factors.   
Intervention intensity is generally a poorly defined concept (146), and differences in 
this are considered to be a source of heterogeneity within complex interventions (146). 
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Intervention intensity was different across the included studies and could be a potential 
source of bias within the review.   
A comprehensive search strategy attempted to identify all studies of potential 
relevance to this review and this was supported through hand searching reference lists 
of all the full text articles examined. All eligible studies regardless of publication 
language were sought, although all studies were in English. Visual inspection of 
funnel plots did not raise any concerns regarding publication bias although this was 
limited as generally only two studies were included for each outcome measure.   
This systematic review and meta-analysis is limited by the few studies available in this 
expanding and novel area of research; only four met the inclusion criteria. The search 
strategy focused on ‘rehabilitation’ rather than secondary prevention programmes, so 
that it is possible that potentially relevant studies may have been missed.  However, 
this has served to highlight the lack of research focus on rehabilitation or early 
initiation of lifestyle interventions in secondary prevention for patients with TIA. The 
most common reasons for exclusion of potentially eligible studies were that they 
included moderate and severe strokes, with no focus on TIA and minor stroke or 
outcomes not specified for these patients. Another common reason to exclude 
potentially eligible studies was that the rehabilitation programme was not initiated in 
the acute period following diagnosis.    
 
Conclusions 
Few studies have reported the effects of early initiation of rehabilitation programmes, 
with or without pharmacological interventions, on secondary prevention for patients 
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with a TIA or ‘minor’ stroke.  Rather, the focus of previous work has been on patients 
with ‘moderate’ and ‘severe’ strokes. This review has identified gaps in knowledge 
regarding the effectiveness of rehabilitation programmes, that include non-
pharmacological and lifestyle measures, initiated in the acute period following a TIA 
or ‘minor’ stroke when the risk of further vascular events is highest. Further 
randomised controlled trials that include lifestyle interventions and details regarding 


















Behaviour change techniques in home-based cardiac 
rehabilitation programmes for patients with cardiovascular 
disease: a systematic review 
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Aim 
This section of the thesis was another systematic review but this time I wanted to 
identify and describe the use of behaviour change techniques (BCTs) used specifically 
in home-based cardiac rehabilitation programmes. I also wanted to try to appraise their 
effectiveness in reducing cardiovascular disease risk factors. The information from this 
systematic review of the literature as well as the information from the previous 




To identify and describe the use of BCTs in home-based cardiac rehabilitation 




Cardiovascular diseases (CVD) are one of the leading causes of death, with survivors 
often being left with considerable morbidity and disability (156). Cardiac 
rehabilitation (CR) is an effective form of secondary prevention for CVD patients, 
endorsed by international guidelines (120)(157)(158). CR is a complex health service 
intervention that uses BCTs to assist patients to improve adherence to health-related 
behaviours in order to effect changes in different modifiable vascular risk factors. 
According to the MRC guidelines (127)(159), the application of behaviour change 
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theory is required in order to understand the interaction between patients and their use 
of complex health service interventions (86).  
Guidance on individual-level behaviour change interventions for promoting change in 
modifiable cardiovascular risk factors (136) has indicated that the three behavioural 
change areas that are associated most positively with change in modifiable vascular 
risk factors are: (1) goals and planning, (2) feedback and monitoring, and (3) social 
support. These areas correspond to Michie’s BCT taxonomy (128), which is an agreed 
list of 93 distinct labels to report the ‘active ingredients’ within a behaviour change 
intervention. This taxonomy (128) clusters individual BCTs into hierarchical groups 
that appear together commonly in behavioural interventions. Its use should allow more 
rigorous and precise reporting of the content of interventions, with better interpretation 
of outcomes.   
There is strong evidence via a systematic review and meta-analysis (120) to support 
the use of CR programmes, including home-based approaches, in a patient population 
with cardiovascular disease, particularly for patients who have suffered a myocardial 
infarction. Audit data do not differentiate home-based programmes from those 
delivered in other settings but indicate that whilst only approximately 45% of those 
invited participated, almost 80,000 patients received CR in the UK in 2014 (160). 
Reasons for non-participation include problems with transport and a dislike of group 
rehabilitation: adherence is better with home-based than hospital or centre-based 
programmes (161). However, despite the evidence for this positive treatment option 
for vascular secondary prevention, there is not a clear understanding about how this 
complex health service intervention influences modifiable CV risk factor behaviours. 
This review, therefore, aimed to identify the BCTs which have been used in home-
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based CR programmes and to describe the frequency of their use in relation to 
programme effectiveness in reducing CVD risk factors.  
There has been little focus on the use of specific BCTs, particularly within secondary 
prevention programmes in the setting of a patient’s home. An understanding of which 
BCTs have been utilised in interventions, will allow a more accurate replication and 
implementation of them within clinical practice and in research. Understanding which 
BCTs are used allows also an exploration of causal pathways, thereby facilitating 
intervention refinement by, for example, removing programme content that is not 
working and improving further aspects that are functioning well. This systematic 
review was designed to identify associations between particular BCTs and 
improvements in specific modifiable cardiovascular risk factors; and to contribute to 
the further development and refinement of home-based rehabilitation interventions for 
CVD patients.  
 
Methods 
The protocol for this review was previously published (162) and the Behaviour 
Change Taxonomy v1 (128) was used to identify the specific BCTs used within 
included studies. The lead authors attended a training workshop by the taxonomy’s 
developers and one author (MAT) is a recognised ‘expert coder’.    
This systematic review is reported in line with the Preferred Reporting Items for 
Systematic Reviews and Meta-analyses (PRISMA) guidance (163)(164). Key criteria 
for considering studies for inclusion included randomised and quasi-randomised 
controlled trials of home-based CR programmes initiated following a cardiovascular 
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event, e.g. post-myocardial infarction or following a heart failure exacerbation, 
published between 2005 and 2015. The publication period 2005 – 2015 was chosen to 
provide an up-to-date review on the effectiveness of cardiac rehabilitation for 
cardiovascular patients despite improvements in medical and surgical care, for 
example use of angioplasty for myocardial infarction patients. The review focused on 
adults, males and females, aged 18 years or older. Any CR programme, defined by 
previous authors (120) as “a structured programme, with clear objectives for the 
participants, including monitoring, follow-up, visits, letters, telephone calls from staff, 
or at least self monitoring diaries”, which was a comprehensive biopsychosocial 
intervention aimed at targeting traditional risk factors for CVD, delivered within the 
home environment, initiated following a cardiovascular event, was eligible for 
inclusion. Studies that reviewed, for example, only an exercise or training programme 
for the patient were excluded. Trials with a control group and trials with multiple 
intervention arms (comparing different types of rehabilitation interventions) were 
included but the review did not include population or community-wide interventions.  
 
Types of outcome measures 
We identified and classified, using Michie’s Taxonomy, the particular BCTs that were 
used in home-based CR programmes for cardiovascular secondary prevention. In 
addition, we assessed the frequency of use of BCTs in programmes that reported 
reductions in CVD risk factors. A meta-analysis of differences in effect between 
home-based and comparator programmes in relation to CVD risk factor outcomes 
illuminated key BCTs. 
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Search methods for identification of studies 
Detailed search strategies were developed for each electronic database searched 
including Ovid MEDLINE(R) 1946 to June 2015, Ovid Embase 1974 to June 2015, 
EBSCO Cumulative Index to Nursing and Allied Health Literature (CINAHL) plus 
1937 to June 2015, Cochrane Database and Ovid PsycINFO 1806 to June 2015. The 
searches were based on the strategy developed for Medical Literature Analysis and 
Retrieval System Online (MEDLINE) (Appendix III) and revised appropriately.  
The titles and abstracts of publications obtained by the search strategy were 
independently screened by two authors (NH 100%, MEC 100%). Articles that did not 
meet the inclusion criteria were removed. All remaining publications were retrieved 
for further assessment. One supervisor and I independently (NH, MEC) selected the 
trials eligible for inclusion in the review with, if necessary, a second supervisor (FK) 
resolving disagreements. A record was kept of all articles excluded at this stage and 
the reason for their exclusion. No language restrictions were made. Additional studies 
were also identified from reviewing the reference lists of the retrieved papers through 
a hand search.  
Data on methodological issues, eligibility criteria, BCTs  (128), interventions 
(including the number of participants treated and intervention provider) and study 
design, study duration, follow-up, comparisons, outcome measures, results, 
withdrawals and adverse events were extracted independently by myself and one 
supervisor (NH, MEC) (Table 3). There was no blinding to study author, institution or 
journal.   
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Assessment of quality and risk of bias 
The PEDrO scale (140) (Table 3) was used to assess the quality of included papers in 
the review.  In addition, I and one supervisor (NH, MEC) independently assessed each 
included study for risk of bias (‘high’, ‘low’ or ‘uncertain’) using the risk of bias tool, 
following guidance from the Cochrane Handbook of Systematic Reviews of 
Interventions (141), a second supervisor (FK) acting as arbitrator as required.  
 
Measures of treatment effect 
For each study, relative risk and 95% confidence intervals were calculated for 
dichotomous outcomes and mean differences and 95% confidence intervals were 
calculated for continuous outcomes. Where continuous outcomes were pooled on 
different scales, standardised mean differences were used. Where available, changes 
from baseline (mean change scores) were used in preference to follow-up scores. 
When combining results for the individual studies, I generally used mean differences 
and a random effects model due to the clinical variation within studies.  
 
Assessing for heterogeneity 
Diversity across the studies was assessed qualitatively in terms of the intervention 
(content, duration, frequency, provider and setting), participant demographic 
characteristics, outcome measures and follow-up. If two or more studies were 
considered clinically homogenous according to the above terms, data were assessed 
for statistical heterogeneity using RevMan version 5.1. The chi-squared (χ2) test was 
used in conjunction with the I2 statistic, which describes the percentage of variability 
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Careful consideration was given to the appropriateness of conducting a meta-analysis.  
Data were summarised statistically when the data were available, sufficiently similar 
and of sufficient quality and the statistical analysis was performed in accordance with 
guidelines (141).  
 
Behaviour change techniques (BCTs) 
I and another trained reviewer (NH, MAT) independently screened included articles 
and extracted BCTs using Michie’s BCT taxonomy (128).  
 
Results 
The search criteria returned 2,448 articles and the full text articles of 31 papers was 
reviewed, identifying 24 possible studies for inclusion in this review (Figure 5). From 
a hand search of the reference lists of the 24 studies, 6 additional potentially eligible 
studies were identified. Eleven studies were included in the final review; of the 19 
excluded, 10 were excluded because there was no randomisation, 7 were excluded as 
they did not assess a home-based CR programme and 2 were excluded as there was no 
appropriate outcome measure.   
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Programme design and evaluation  
Of the 11 studies included, 4 used the ‘Heart Manual’ as their home-based CR 
programme (114)(165)(166)(167). Three used technology to assist delivery of the 
home-based CR intervention, including a smartphone (168), the internet (169) and 
telemonitoring (170). In the remaining 4 studies CR was delivered in the participant’s 
home by physiotherapists (171)(172) or nurses (173)(174). 
In 7 studies the control group was hospital- or centre-based CR 
(114)(166)(167)(168)(170)(173) whilst in 2 studies the control groups received ‘usual 
care’ (165)(174) and in 2 they received no active treatment (169)(172) (Table 3). One 
study was conducted in each of the following countries: Canada (169), Australia (168), 
Poland (170), Norway (174) and China (165); 2 were conducted in Denmark 
(171)(172), and 4 in England (114)(166)(167)(173).  
In 10 studies, patients were post-MI or post-angioplasty/CABG and one study 
included exclusively patients with heart failure (170). All participants were recruited 
from secondary care. Outcomes were assessed from 8 weeks (170) to 1 year 
(114)(171)(172).  
  
Quality and risk of bias  
Using the PEDrO scale (140) (see Table 4), all included studies were deemed to be of 
high methodological quality. All were randomised controlled trials with a low risk of 
bias (141). The study by Dalal et al, 2007 (166) also had a patient-preference arm so 
that only data for the randomised patients were included in the meta-analysis. Jolly et 
al, 2009 (114) and Lee et al, 2006 (167) were the only two studies that had blinding of 
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assessors to the outcome measures. Study follow-up overall varied from 77% (168) to 
100% (167)(172) and all studies accounted fully for study participants and provided 
reasons for any missing data. No other potential sources of bias were identified.     
  
Assessment of reporting bias 
Funnel plots were produced to assess reporting bias and no obvious reporting bias was 
found as illustrated in Figures 6 and 7 in respect of systolic blood pressure and 
diastolic blood pressure outcomes.   
 
Effects of interventions 
All but one study (174) reported a positive effect for home-based CR on modifiable 
CVD risk factors. Combined outcome data from all types of comparator groups in the 
included studies were used to compare the effectiveness of home-based and 
comparator programmes. For both Oerkild et al studies (171)(172) the data at the three 
month review, which reported the change from baseline, were used for meta-analysis 
and in the study by Dalal et al (166) only randomised study data were used.     
A meta-analysis was undertaken on 8 individual variables to compare outcomes 
between home-based and comparator programmes in the included studies. There was 
no significant difference between home- and hospital centre-based CR on resting 
systolic blood pressure (1.02mmHg, 95% CI -1.74 to 3.78, p-value = 0.3)  (Figure 8), 
resting diastolic blood pressure (-0.89mmHg, 95% CI -4.35 to 2.58, p-value = 0.62), 
peak VO2max (1.19 ml/kg/min, 95% CI -0.78 to 3.16 p-value = 0.24) and the distance 
covered in the six-minute walk test (8.47m, 95% CI -10.98 to 27.92, p-value = 0.39). 
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There was also no significant difference between home- and hospital-/centre-based CR 
in terms of overall treatment effect for total cholesterol (0.07mmol/l, -0.16 - 0.29, p-
value = 0.56) (Figure 9), HDL-cholesterol (0.01mmol/l, 95% CI -0.06 to 0.07, p-value 
= 0.79), and LDL-cholesterol (0.02mmol/l, 95% CI -0.25 to 0.29, p-value 0.88) or for 
the anxiety (0.02, -1.29 to 1.32, p-value = 0.98) (Figure 10) and the depression 
sections of the HADs questionnaire (-0.21, -0.74 to 0.32, p-value = 0.44).  
 
Behaviour Change Techniques in Included Studies      
It was not possible to compare the relative effectiveness of different BCTs or to 
conduct a meta-regression of the BCTs as only a limited number of studies had 
comparable outcome data (141). The BCT identified as ‘social support (unspecified)’ 
was employed in all 11 studies whilst the BCT ‘goal setting (behaviour)’ was 
employed in 10 studies (Table 4). The ‘Heart Manual’ intervention utilised the BCTs 
of goal setting (behaviour), monitoring of behaviour by others without feedback, self-
monitoring of behaviour, self-monitoring of outcome(s) of behaviour, social support 
(unspecified), instruction on how to perform the behaviour, pharmacological support 
and reducing negative emotions. All studies except one (174) reported significant 
positive effects in change of measured CVD risk factors: the BCTs which were not 
utilised in Lie et al (174) but were generally included in other successful programmes 
included those related to monitoring, instruction on how to perform the behaviour and 
credible source. The BCTs that were employed in this study (174) were social support, 
goal setting, reducing negative emotions, pharmacological support, information about 
health and problem solving.  
 
		 84
The commonest group of BCTs used in the 11 included studies was ‘feedback and 
monitoring’, whilst the second most common group utilised was ‘social support’. Of 
all the groups of BCTs listed in the taxonomy (128), 6 were not identified as having 
been used within any of the studies: these were ‘associations’, ‘reward and threat’, 




This systematic review comprised 11 randomised controlled studies of home-based 
CR programmes for CVD patients with comparator programmes, the majority of 
which were centre- or hospital-based CR. This is the first review to identify, collate 
and analyse observations regarding the use of BCTs within home-based CR 
programmes, including the Heart Manual. A wide range of different BCTs were used 
in the included studies, with ‘social support (unspecified)’, ‘goal setting (behaviour)’, 
monitoring, instruction on how to perform the behaviour and credible source being 
used commonly in effective programmes. The ‘Heart Manual’ intervention utilised 
these BCTs, as well as ‘pharmacological support’ and ‘reduce negative emotions’, and 
was consistently effective in modifying CVD risk factors in the included studies.   
 
Comparison with existing literature 
Previous studies have highlighted the comparable effects of home-based CR and 
hospital-based programmes (120)(175)(176). This study supports these findings by 
illustrating in the meta-analysis that home-based CR provides comparable 
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improvements in CVD risk factors to other treatment options, including hospital-based 
approaches. Indeed all but one study illustrated the positive effect of home-based CR 
on modifiable CVD risk factors. My study adds to previous findings by including a 
wider range of cardiovascular patients, including heart failure and post-coronary 
vascularisation patients and programmes delivered utilising latest technology (e.g. 
smartphones), which were not included in previous reviews (120). Also, it includes 
more recent publications (from 2005-2015) than were included in previous reviews 
(120)(175)(176), which therefore has relevance to current medical management. 
Home-based CR programmes are attractive to patients due to their accessibility 
(120)(176) that helps to improve compliance (121). Also, they tend to be less costly 
than hospital- or centre-based programmes (121) and fit with the aim of shifting 
patient management from a hospital base, into the community – a current theme within 
modern healthcare (177).  
Guidance on individual-level behaviour change interventions for promoting change in 
modifiable cardiovascular risk factors in the public (136) recommends that these 
programmes should include support for individuals to make change through self-
monitoring, goal setting, social support and relapse prevention strategies and the 
provision of relevant information on the health consequences of the behaviour. The 
findings in this review are in keeping with these guidelines: the BCT ‘social support 
(unspecified)’ was employed in all effective studies included in this review and the 
BCT ‘goal setting (behaviour)’ was utilised in all but one (169). Few studies utilised 
self-monitoring and relapse prevention strategies. Indeed only 6 studies 
(114)(165)(166)(167)(168)(169) utilised the BCTs of ‘self-monitoring of behaviour’ 
and ‘self-monitoring of outcome(s) of behaviour’. Within the taxonomy (128) there is 
no specific BCT for relapse prevention but this could be covered by other BCTs such 
		 86
as ‘action planning’. Future studies aimed at developing home-based CR programmes 
for cardiovascular patients should consider how best to use these techniques (self-
monitoring, goal setting, social support and relapse prevention strategies), to maximise 
the likelihood of establishing and maintaining new behaviours to optimise secondary 
CVD prevention. In particular, self-monitoring and relapse prevention strategies 
should be further developed and their impact assessed on tackling modifiable CVD 
risk factors.   
 
Limitations and strengths 
I have attempted to identify all studies of potential relevance by developing a 
comprehensive search strategy and supporting this through hand searching reference 
lists of all full text articles assessed for inclusion in the review. Visual inspection of 
funnel plots provided little evidence of publication bias. All eligible studies, regardless 
of publication language, were included.   
A limitation of this review is that included studies lacked consistency in the outcome 
measures used and follow-up duration varied from 8 weeks to one year, so that 
combining results in a meta-analysis was difficult. Shorter follow-up durations may 
not allow sufficient time for interventions to produce an impact on modifiable vascular 
risk factors and early changes may not be sustained. Intervention intensity was also 
different across the included studies and could be a potential source of bias within the 
review. Further studies should compare and contrast the use of BCTs within home-
based CR compared to programmes delivered in other settings.    
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Conclusions   
This review offers new understanding about some of the key features that characterise 
effective home-based CR programmes. The BCTs of ‘social support (unspecified)’ 
and ‘goal setting (behaviour)’ were frequently found as components within 
programmes that showed a reduction in CVD risk factors. Failing to provide a credible 
source or instruction on how to perform a behaviour was linked with lack of 
effectiveness. Thus, the likelihood of delivering a beneficial CR programme appears to 
be enhanced when patients are supported by family, friends and patient-peers to 
engage and persist with the programme; facilitated to set goals regarding lifestyle 
behaviours; given professional feedback via ongoing monitoring; and taught or trained 
to execute or change specific behaviours. However, further robust trials that describe 
and evaluate the use of different BCTs (128), building on NICE guidance (136), are 
required in order to refine the design of home-based CR programmes for optimal 
secondary cardiovascular disease prevention. These study findings have been used to 





















Patients’, health professionals’ and academics’ views 
regarding ‘The Healthy Brain Rehabilitation Manual’, 




To test and refine version 1 of ‘The Healthy Brain Rehabilitation Manual’ for people 
who experience a TIA and ‘minor’ stroke (139)(162)(178)(179).  
 
Objectives 
To elicit patients’, carers’, health professionals’ and academics’ views about the initial 
version of ‘The Healthy Brain Rehabilitation Manual’ for use in the acute period 
following a first TIA and ‘minor’ stroke of atherosclerotic origin. In particular, a key 
objective was to capture views about the usability, accuracy and helpfulness of the 
manual.   
 
Method 
 I completed systematic reviews (SRs) of relevant literature (as detailed in Chapters 2 
and 3) and then used the results from the SRs to adapt the ‘Heart Manual’ (180)(181) 
for the TIA and ‘minor’ stroke population. The ‘Heart Manual’ was chosen as it is 
well evidenced for secondary cardiovascular prevention (122)(166) though it has never 
been used with cerebrovascular patients, despite these conditions sharing similar 
underlying risk factors and pathology.  
This first draft of ‘The Healthy Brain Rehabilitation Manual’ (Appendix IV) was 
appraised by analysing the data from 3 focus groups (FG) consisting of 4 patients and 
1 carer (FG 1), 9 health professionals (FG 2) and 4 public health intervention 
researchers (FG 3). Participants were emailed an electronic version of the manual 
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approximately 2 weeks before the interview to allow them time to review the manual. 
They were also given a paper copy of the manual approximately 30 minutes before 
starting the focus group. The topic guide for the focus group discussions is included 
within Appendix V and no repeat interviews were carried out. Field notes were made 
during and immediately after the focus groups were conducted.     
The focus group participants for focus groups 1 and 2 were recruited through 
opportunistic sampling whilst focus group 3 participants were purposively selected for 
their clinical and research experience. The participants in the first focus group were 
recruited through the Chest, Heart and Stroke (NI) charity (1 female and 3 male 
patients (1 post-TIA; 3 post-‘minor’ stroke) and one female carer), with an age range 
from 29 to 76 years old. The participants were contacted by the charity on my behalf 
and were asked to attend the charity headquarters on a certain date for the focus group. 
All 5 participants (4 patients and 1 carer) who were contacted by the charity agreed to 
attend the focus group. Meanwhile all health professionals who worked within an 
acute stroke unit in one of the recruiting hospitals for the pilot study were invited to 
attend the focus group via an open letter from the researcher. This focus group of 
hospital professionals was held for convenience during a lunchtime period in the 
hospital on the stroke ward. It comprised 9 health professionals, all females, including 
3 stroke nurses, 2 physiotherapists and one each of the following: a stroke consultant, 
a pharmacist, an occupational therapist and a speech and language therapist. The age 
range of this group was 31 to 58 years old. The participants in both these focus groups 
did not have any previous relationship with the interviewer.    
A third focus group comprised public health intervention researchers from the Centre 
for Public Health, Queen’s University Belfast. The 4 individuals were selected 
purposively because of their experience in intervention and service development and 
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their varied disciplinary backgrounds: 1 female and 3 males, including a General 
Practitioner, a social scientist-social worker, a public health medicine consultant and 
epidemiologist and a health services researcher-health psychologist. The age range of 
these participants was 30 to 63 years old. These individuals were also selected because 
of their knowledge and experience of working with TIA patients, stroke services and 
preventative medicine and health care. These focus group participants had a 
professional, working relationship with the interviewer, NH. Each group was informed 
that the purpose of the focus group discussions was to appraise the initial version of 
‘The Healthy Brain Rehabilitation Manual’ and to further refine it.     
Each focus group discussion was audio-recorded with the consent of study participants 
and lasted approximately one hour. The researcher, NH, led each focus group and 
there was a topic guide to direct the discussion. The interviewer, NH, undertook a non-
scheduled standardised focus group approach (182) with all 3 groups and the focus 
group discussions were transcribed from audio recordings by the researcher, NH. A 
content analysis with the practical purpose of eliciting views about the acceptability 
and usability of the intervention or programme manual was conducted and how the 
manual could be further refined. A male GP, NH, and a male health services 
researcher/health psychologist, MD, read and reread the transcripts and coded the 
content independently. NH and MD met to discuss the transcripts and agree the main 
areas covered within the transcripts. MC, a female professor of GP, acted as a referee 
as required as well as appraising critically the categories and the degree to which the 
transcript extracts and quotations supported the themes. The transcripts were not 
returned to participants for comment and/or correction and participants were not asked 
to provide feedback on the qualitative results. NH has basic training in qualitative 
research methods whilst MD and MC are relatively experienced qualitative 
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researchers. The independent results of the qualitative analysis and data interpretation 
were discussed with the entire research team, to ensure clear definition of themes and 
that appropriate supporting evidence was identified for each. The reporting of this 
qualitative study and findings followed the guidance set out in Murphy et al (182) and 
other authors (183) as well as the COREQ checklist (184).  
 
Results 
As noted above, the practical purpose and focus of this interrelated component of the 
PhD research project was to elicit views about the acceptability and usability of the 
‘The Healthy Brain Rehabilitation Manual’ and how it might be improved. Four over-
arching areas emerged from the focus group analysis, all of which were discussed to 
some extent in the all 3 FGs: 
 Manual format and content;  
 Information to be added to the manual; 
 Items to be omitted from the manual; and 
 Use of the manual.   
Each focus group focused on an area particular to their group as well as covering the 
same general areas. Indeed, the patient focus group tended to focus on the impact of 
diagnosis, the health professional group gave greater emphasis to the content of the 
manual and the academic focus group enquired about and discussed supporting 
evidence for the manual. The results of the focus groups are discussed collectively, 
mindful of the aims and objectives of this part of the PhD investigation. In order to 
preserve anonymity, quotes are presented with a participant’s age and sex. 
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1: Manual format and content 
a) Format  
The front cover of the manual was well received by patients and appeared to help 
people want to engage with the manual. The general view from the FGs was that the 
manual was very readable, with content appropriate to the target level of readership, 
though a readability score was suggested to be undertaken to support these subjective 
feelings.  
“I think it’s really good. Most of the other front covers would put you off 
reading their material but that makes me want to read that.” (29yo, female) 
“I thought it was comprehensive but not over-bearing, not over-powering.” 
(57yo, male) 
“I found the practical tips and the stress section very easy to follow. With the 
exercises, they are things you could do in the house and you don’t need any 
equipment – I think that’s what you need – I think that’s what you’d want as 
a health professional and service user.” (30yo, male)  
 
b) Content  
 
The manual content was generally well received, with the medication chapter, Section 
5, particularly well received and, according to patients, the knowledge that they 
acquired through reading and using the manual helped them to engage in appropriate 
conversations with their health professionals: 
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“I thought it (the manual) covered everything, very comprehensive.” (76yo, 
male) 
“I thought it (Section 5) gave just enough information….it covered all the 
general ones (medication) which are used and gave you points to talk to your 
doctor about….” (52yo, female) 
The smoking section was also well received by patients who appreciated the practical 
advice with regards smoking cessation: 
“I think the section on smoking is very useful. I’m an ex-smoker and I would 
have used most of the hints in the book to help me stop. The hints are very 
good, to get you out of the habit of smoking.” (52yo, female) 
Participants reported that they enjoyed the diary and the section in the manual in 
which they were requested to write down questions or points of information. They also 
appreciated the section on sexual health and relationships and commented that most 
health professionals tended to avoid discussing this aspect of health and rehabilitation: 
 “the wee diary is very good, to write things down…” (52yo, female) 
 “I think that was a good section (sexual health) to have because no one ever 
said anything about it…” (52yo, female) 
“I think it’s good because a lot of people would have issues around this 
(sexual issues) and would be too scared to talk about it…” (42yo, female) 
The practical advice included in the diet section was also well received by patients, 
with people making positive behaviour changes due to the information contained 
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within the manual and the health professionals felt that the knowledge contained 
within the manual could support them to do their job: 
 “I’ve started eating an apple, a banana and a pear everyday…” (76yo, male) 
“For me working as a social worker in the community, I would find it (the 
manual) very useful. I thought the practical tips were very good and I don’t 
think as a healthcare professional, that it would take up too much of my 
time…” (30yo, male) 
Anxiety and stress were viewed as a significant cause of strokes by patients, with 
patients being positive about how the manual managed these symptoms by providing 
appropriate information: 
“I was doing my finals and I was completely stressed out. I think that they 
don’t know what caused my stroke but to this day I think it was the stress and 
that I put too much pressure on myself……Yes, stress was a big thing for 
me…The book is brilliant in explaining that.” (29yo, female) 
Inclusion of information about post-TIA and post-stroke fatigue was welcomed. These 
symptoms had a big impact on patients and this was compounded by the lack of 
knowledge about these conditions by health professionals. Someone also commented 
that when they mentioned fatigue/tiredness to their health professional, they were 
‘made to feel’ that they were fabricating their symptoms: 
“That’s the thing I can’t take, the tiredness, I just can’t take it….” (57yo, 
male) 
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 “I went to a locum (GP) and was telling him about the tiredness and fatigue 
and he told me that fatigue and tiredness has nothing to do with the stroke. I 
just got up and left, I didn’t even want to speak with him.” (49yo, male) 
“when P goes to the doctor, he is made to feel that he is over anxious, that he 
is imagining these things and he’s not.” (52yo, female) 
Employment information following the event was clearly important to patients and 
patients generally agreed that there was confusion about the length of time to take off 
work following the event: 
“I would just like to add about going back to work, that I was given a lot of 
mixed messages – some people were like give it a couple of months, others 
were like a couple of weeks…others said 6 months…That’s the question, 
when should you go back to work?..... I was never told how long.” (29yo, 
female)  
The academic group were also keen to know the evidence-base for the content of the 
manual and that appropriate resources had been consulted when compiling the manual. 
For example: 
“…..have you taken most of this information from the current smoking 
cessation services?” (57yo, male) 
They also commented about moving the section on general information about TIA and 
strokes from the back of the manual to the front: 
“I would move that general information section at the end to the beginning so 




2: Information to be added to the manual 
Health professionals were keen for people to be made aware of existing exercise and 
health advice classes in the community, e.g. the Chest Heart and Stroke (NI) Post-
rehab Exercise Programme (PREP) exercise classes and the ‘Healthwise’ GP referral 
schemes. They also wanted a section in the manual where they, as health 
professionals, could write down information for the patient and questions for the 
patient to ask other health professionals, supporting the home exercises with simple 
diagrams to make them easier to understand was suggested. Patients also felt unsure 
about how much exercise and physical activity to do. One patient in particular wanted 
to know when he was able to start running after a TIA or stroke and requested further 
information be added to the physical activity and exercise section of the booklet. 
Academics also suggested using more lay language for the alcohol section.   
“On the physical activity section, I would include a section on a diary so that 
people can write down their goals and plans and record what they are 
doing…” (46yo, female).   
 “they really need to keep their own diary and put in it how much physical 
activity they are doing….” (57yo, male) 
“I would have a section for health professionals to write advice on….” (42yo, 
female) 
“I found the heel dig exercises difficult to follow…and a bicep curl – I don’t 
think the lay public will cotton onto that….” (63yo, female) 
“…he just doesn’t know how much exercise he should do…” (52yo, female) 
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“I would have brackets ‘small glass’ when describing what a unit of wine is.” 
(57yo, male) 
 
Health professionals were also keen that cholesterol as a cardiovascular risk factor be 
discussed in greater detail and the need to take statins life-long, regardless of their 
cholesterol level, with the manual being developed into different formats, for example, 
‘an app’. To support the dietary information, it was suggested to add further detail on 
how to increase olive oil consumption and to include contingency plans within the 
manual to help prevent relapses: 
“What about discussing cholesterol and telling them about that. I think it is 
something which people generally struggle with understanding.” (42yo, 
female, 2) 
 “Could they have an app (version of the manual)?” (42yo, female) 
“…give people practical tips on increasing their olive oil consumption, e.g. 
use it over your potatoes instead of butter, etc”. (57yo, male) 
“the other technique which applies to most of these sections is a writing of a 
‘if when plan’. For example, if I feel hungry, take low sugar chewing gum…” 
(57yo, male) 
The health professionals also felt that more information was required relating to 
fatigue and mood disturbance post-TIA and stroke, reporting that it causes significant 
issues for patients post-TIA/‘minor’ stroke and that it could be treated with ‘energy 
conservation’ techniques, particularly as symptoms might be prolonged: 
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“I think it’s good that you have tried to tackle this (fatigue and mental health 
issues) but one of the big things which is lacking for people after a TIA or 
stroke is psychological support.” (42yo, female) 
 “I think post-stroke fatigue really frightens people. People describe it as 
overwhelming – like someone has just pulled out their energy source…. 
(42yo, female)  
 “I would highlight to people that stroke fatigue is different from normal 
fatigue – this is not something which gets better with rest and sleep….I would 
highlight energy conservation techniques to them – how to do things in a 
certain manner to conserve energy.” (37yo, female) 
 “The important thing to tell patients as well is that it is not always something 
which goes away or gets better but that it is about managing it…it also makes 
them feel more normal knowing that it might not get better….” (37yo, female) 
The health professionals felt it was better to educate patients about managing the 
fatigue symptoms when they were back in the community and able to assess what 
impact the fatigue symptoms were having on their lives, rather than in the acute 
hospital setting. The health professionals were also aware of the non-visible signs of 
this condition and need for a recovery period following the cerebrovascular incident: 
“Sometimes it is also not best to discuss this (fatigue) in the ward but better 
discussed in the community when they are back into their routine and they see 
what an impact it is making on their life….” (37yo, female) 
“I think they (patients) forget that because they don’t have a visible scar, like 
an operation, that their brain has a scar, that their nervous system is 
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recovering and that this will take time to recover just the same as a physical 
scar would heal.” (42yo, female) 
Patients asked for more information about the potential side-effects of medication, 
though they acknowledged that such information might make them less likely to 
comply with their medication regimes. They also thought it was important to let 
people know that they might only get visual symptoms as part of their TIA and stroke, 
which is not currently included within the UK public health FAST campaign (185). 
One patient thought that visual symptoms should be included in the manual for 
alerting patients to the fact that they may be having a TIA or stroke: 
“I think that (vision) is something you should put in the booklet so people are 
aware of it.” (29yo, female patient) 
 
3: Items to be omitted from the manual 
The health professionals did not want ‘thrombolysis’ included within section 5, the 
medication section, because they felt that if patients did not receive it, then they would 
view this negatively: 
“no (don’t include a thrombolysis section) because if they don’t get it then 
people will be saying, ‘why didn’t I get that?’….It is discussed in hospital if 
they get it.” (42yo, female) 
They also did not want home blood pressure (BP) monitoring devices included in the 
manual as they felt it caused unwarranted anxiety for the patient: 
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“I would generally discourage people from using home BP monitors.” (37yo, 
female, health professional).  
Neither of these points was raised in the other 2 FGs. It was also suggested to reduce 
the size of section 3 relating to diet and to include the title of each chapter with 
numbering for each manual section.  
“I felt it (Section 3) was a bit repetitive in places – I think you could cut it 
down…” (58yo, female) 
“I would add the section headings to the numbering throughout the book so 
it’s easier to follow.” (30yo, male) 
 
4: Use of the manual  
a) Facilitator  
The academic group viewed the manual facilitator as an important tool for the success 
of the intervention: 
“So I wouldn’t underestimate the facilitator’s role – I think this is the key 
mechanism for effecting change.” (46yo, male) 
There was also some discussion about who was best placed to be the facilitator – GP, 
stroke nurse or peer and it was suggested to try to tease this out within the pilot study 





Patients thought that the most appropriate time to receive the manual would be near or 
around the point of discharge or when they were leaving the hospital after they had 
received their diagnosis: 
“I was just going to say that when I was discharged from hospital, something 
like this would have been fantastic….It’s great to just let people know, to just 
be more aware (of TIA and stroke symptoms).” (29yo, female) 
 
c) Target Audience  
Patients also considered that the manual could be used for a wider audience. They 
wanted the general public, particularly children and younger adults, to be educated 
about the causes and consequences of strokes. This education was seen as particularly 
key because family members and carers were viewed as important in spotting the 
diagnosis and ensuring they receive appropriate treatment: 
“I would love to see people getting into schools and advising people about 
stress, especially in the run up to exams and educating them about TIAs and 
strokes…” (57yo, male) 
“I collapsed in the bathroom and the wife was there, otherwise I wouldn’t 
have known what would have happened to me…she saw the signs straight 
away and got straight onto the ambulance and they then talked her through 





Collectively, the focus groups were successful in terms of providing critical feedback 
about the initial version of ‘The Healthy Brain Rehabilitation Manual’, adapted from 
the ‘Heart Manual’ (111). I used the results of the analysis of the focus groups’ data to 
refine and adapt the manual for use in the acute period following a first TIA and 
‘minor’ stroke of atherosclerotic origin. The main areas of discussion within these 
focus groups were manual format and content; information to be added to the manual; 
items to be omitted from the manual; and use of the manual. The manual was well 
received by all groups, particularly in terms of managing mental health symptoms and 
tackling potentially embarrassing topics, e.g. discussions around sexual health. 
Perceived benefits of the manual included increasing knowledge about the condition 
and that it facilitated family involvement in the rehabilitation process. The facilitator 
was viewed as a key delivery mechanism for the manual and the main suggestions to 
improve the manual included making the home exercise sections easier to follow for 
patients. Particular post-event issues that the patients identified were returning to work 
and the impact that the diagnosis had on employment, how much physical activity to 
do and managing fatigue and mood symptoms. Another issue for patients was that the 
consequences following the TIA or ‘minor’ stroke were often not visible to others and 
they therefore felt it was difficult to justify, e.g. absences from work.  
 
Post-TIA/stroke fatigue and mental health issues  
Fatigue is common after both TIA (186) and ‘minor’ stroke although it is more 
common following a stroke – being reported to occur in 29% of post-TIA patients with 
an incidence of 56% in stroke patients (134). Fatigue interferes with a patient’s 
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rehabilitation potential and is an independent predictor of post-stroke disability and 
level of care (187). Thus this is an important area that is currently being inadequately 
managed for these patients. Although there are no definitive treatment options for this 
challenging symptom, there are different treatment options which could be helpful 
(188)(189) and which can be promoted within the manual and by the facilitator. These 
options could include graded exercise and cognitive behavioural approaches as well as 
pharmacological approaches. Anxiety and depression are also common post-TIA and 
stroke (190). These psychological symptoms can overlap with the fatigue diagnosis 
and are often treated in a similar fashion.     
 
Health Literacy  
Participants were keen to engage and find out further information about TIAs and 
strokes and their future health risks, helping to improve their health literacy, which is 
supported by other authors (186)(191)(192). Patient engagement was helped by the 
manual having a readability score of 13 to 14 year olds 
(http://www.webpagefx.com/tools/read-able/check.php) and this assessment was 
undertaken following the comments from the focus group of academics. Indeed a 
Cochrane review (193) highlighted the fact that stroke survivors and caregivers are 
keen to engage in information exchange with service providers and that this improves 
their knowledge of cerebrovascular conditions, improves satisfaction with the services 
offered and reduces patient depression scores. This is important as research has 
highlighted the direct association between low levels of health literacy and poor health 
outcomes (194)(195), with patients with low health literacy less likely to ask questions 
of health professionals and engage in shared decision making with the health 
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professional caring for them (196). However improving health literacy can potentially 
have negative consequences, including increasing health anxiety amongst patients 
through inappropriate Internet searches (197), which can be overcome by having 
repeated contacts with the patient as well as appropriate communication skills.   
Focus group participants generally felt that there was not enough knowledge in the 
general population about TIAs and strokes and this is in keeping with previous studies, 
highlighting that knowledge of cerebrovascular disease in the general population is 
poor (191)(198). Patients wanted to particularly highlight to the general population 
that TIAs and strokes do not just affect older people, also affecting younger members 
of the population, with one stroke survivor in the patient focus group, for example, 
being 29 years old. Patients also felt it was important to emphasise that when you 
experience a TIA or stroke, people might only experience visual symptoms and not 
just the traditional face, arm and speech symptoms promoted within the UK FAST 
public health campaign (185). Patients therefore wanted the public to know about and 
to act on these symptoms and to not simply ignore them, through appropriate public 
health campaigns and through promoting use of the manual.  
 
Social impacts following a TIA/minor stroke 
As well as the physical and psychological consequences following a TIA or ‘minor’ 
stroke, there are also social implications, with patients reporting that the diagnosis 
impacts on their ability to drive, employment and obtaining insurance (e.g. travel 
insurance) (186). Patients also found it difficult to adopt the ‘sick role’ (199), as there 
was often no outward physical sign of illness following the TIA or ‘minor’ stroke. 
Indeed this often manifested itself in patients being unsure about how much time to 
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take off from work as well as a feeling by patients that people in their work would be 
thinking that they were taking too much time off. Previous authors (200) have reported 
that this makes the patient feel like a “fraud”. Moreover, these authors commented that 
the main reason for people taking time off from work following a TIA was due to non-
visible impairments and that a lack of understanding of these symptoms from their 
employer, often leads to difficulties for them in returning to and continuing in work 
(200). The commonest non-visible impairment reported was fatigue (200) although 
other common non-visible problems can include personality changes, pain and 
memory difficulties with employer ‘support’ viewed as important in allowing people 
to return to work. Moreover other authors (191) have commented that this lack of 
enduring physical signs of ill-health from a TIA or ‘minor’ stroke has resulted in 
patient non-compliance with medication although participants in this current study did 
not report this. Medication and treatment compliance is therefore important to 
emphasise to TIA and ‘minor’ stroke patients.      
 
 Improving intervention adherence and compliance   
Patients generally enjoyed writing down goals in their rehabilitation manual and 
completing a diary as well as being able to talk to a health professional about these. 
Indeed a recent systematic review was conducted into exercise adherence in patients 
with mild cognitive impairment, which occurs in over a third of TIA patients (201), and 
found that exercise prescription adherence improved if it was individually tailored, 
sufficient information was provided to participants and phone calls, pedometers and 
exercise logs were used as well as supervision provided (202). These features are in 
keeping with the National Institute of Health and Care Excellence (NICE) guidance on 
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individual-level behaviour change interventions for promoting change in modifiable 
cardiovascular risk factors (136) and all these elements are included within ‘The 
Healthy Brain Rehabilitation Manual’. Furthermore, a recent Cochrane review has 
highlighted the effectiveness of self-management programmes, similar to ‘The Healthy 
Brain Rehabilitation Manual’, in improving quality of life and self-efficacy for post-
stroke patients (203). Health professionals also wanted ‘if-then’ plans (204) included 
within the manual so that patients could identify opportunities to act for their health 
and then the next steps to be taken in carrying out that good intention. Hospital health 
professionals cautioned against the use of home blood pressure monitoring within the 
manual. This is contrary to a recent study published in the Lancet (205), which found 
that self-monitoring improved blood pressure management in primary care 
hypertension patients. Blood pressure is a key modifiable risk factor for stroke 
(34)(206) and I would therefore like to do further qualitative work on home blood 
pressure monitoring to understand its potential role within the intervention.        
 
How the manual changed following the qualitative work 
The content of the manual was adapted following the review and analysis of 
comments received from the patients, health professionals and academics. The 
changes included: 
 Adding a blank section to allow patients to write down questions which they 
could ask health professionals at their next medical visit;  
 Visual symptoms were added to the traditional UK FAST alert about TIA or 
stroke signs and symptoms at the start of the manual (185).  
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 Further information was included about physical activity and exercise advice 
in section 2 of the manual, with patients being ‘signposted’ to the Chest Heart 
and Stroke (NI) PREP exercise classes (https://nichs.org.uk/how-we-can-
support-you/stroke-support/) as well as community available resources, e.g. 
Healthwise (http://www.publichealth.hscni.net/news/get-healthwise-new-year), 
which the GP could refer them to in the community. Further space within the 
manual was also created for the physical activity diary.  
 Section 3 on diet was refined and reduced in size, with practical tips added to 
the dietary section to increase olive oil consumption.  
 A general readability score was also undertaken 
(http://www.webpagefx.com/tools/read-able/check.php showing it to be readily 
understandable by 13 to 14 year olds).  
 Section headings were included with numbering and the ‘SPRITE’ title was 
removed from the front cover of the manual, both based on general comments to 
the interviewer.  
 The alcohol section was altered to include more user-friendly language with 
‘small glass of wine’ added, replacing ‘a unit of alcohol’ based on some general 
comments received by the interviewer within the focus groups.  
 
Strengths and Limitations 
The strengths of this chapter of thesis are the diverse backgrounds of patients, carers, 
academics and health professionals that reviewed the manual. In particular, the health 
professional focus group had a range of professions involved in TIA and stroke patient 
management. More than one researcher then reviewed the focus group feedback 
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independently and the review adhered to specific recognised qualitative methods. The 
patient focus group was recruited through the NI Chest Heart and Stroke charity and 
these patients might therefore be more aware of TIA and stroke issues than the 
‘typical’ general population patient, providing me with a high-level of qualitative 
information. I was the lone facilitator of each focus group and participants knew that I 
was a GP and the lead developer of ‘The Healthy Brain Rehabilitation Manual’. 
Ideally, someone independent of the intervention development process should have 
facilitated the focus groups in order to avoid the possibility of influencing participants 
unduly. However, I conducted the focus groups mindful of my position and of the role 
of reflexivity (182) in qualitative research. For example, I contributed only minimally 
to the focus group, generally only asking the pre-designed questions in the topic guide. 
Furthermore, the flow of conversation, interactive nature of discussion and content of 
the transcript suggested that my role as FG facilitator or moderator did not appear to 
impact significantly.   .    
 
Conclusions 
‘The Healthy Brain Rehabilitation Manual’ was developed according to the MRC 
Guidelines for developing complex health service interventions (127). The preparation 
of the first draft of this manual was based upon best available evidence from 
systematic reviews of the literature (Chapters 2 and 3 of the thesis) and the design was 
modelled on the successfully trialled ‘Heart Manual’. This chapter presented the 
results of a qualitative study of the views of patients, carers, academics and health 
professionals regarding the initial draft of the manual. In addition, the chapter sets out 
how the results from this qualitative research were used to produce a revised draft of 
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‘The Healthy Brain Rehabilitation Manual’. The next stage in the developmental and 
testing process involved designing and conducting a feasibility study of the early 































Stroke Prevention Rehabilitation Intervention Trial of 
Exercise (SPRITE) - A Feasibility Study 
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 Introduction 
Strokes and transient ischaemic attacks (TIAs) are highly prevalent conditions 
(1)(207), with these patients being at high risk of further vascular episodes post-event 
(8). Therefore, the immediate period after a TIA and ‘minor’ stroke is a crucial time to 
intervene to reduce the risk of future strokes and the impact that these conditions have 
on society.  
Cardio- and cerebro-vascular disease share common underlying pathological 
mechanisms and risk factors, but cardiac rehabilitation for secondary prevention is 
only offered to patients in the UK with cardiovascular disease (108) and further 
research has been highlighted as required in assessing the impact of lifestyle 
interventions post-stroke and TIA (208). Physical inactivity is one of the most 
important recognised risk factors for cerebrovascular disease (33) and pedometers 
have been shown to be effective in promoting physical activity (209). Pedometers also 
appear feasible for use by patients with stroke (90)(91) and promote walking, which is 
one of the commonest forms of physical activity for older adults to engage in (210). 
Other research has shown that vascular risk factors should be addressed as quickly as 
possible following the initial vascular event (11) but no authors have previously 
assessed the feasibility of adapting a home-based cardiac rehabilitation programme, 
with or without an added pedometer intervention, for use within the TIA and ‘minor’ 
stroke population in the sub-acute period following diagnosis. With home-based 
approaches reported to improve compliance as well as uptake to the rehabilitation 
programme (121) and have shown longer-term sustainability of health benefits 
compared with hospital-based programmes (123).  
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Information about the ‘active’ ingredients, such as specific BCTs (128), used within 
comprehensive programmes, such as ‘The Healthy Brain Rehabilitation Manual’, 
would facilitate their replication and the implementation of guidelines for good 
clinical practice (135)(136). Identifying behaviour change techniques (BCTs) used in 
different behaviour change programmes has also been identified as a national research 
priority (136). Thus ‘The Healthy Brain Rehabilitation Manual’, adapted from the 
‘Heart Manual’, is being developed following the MRC guidelines for developing 
complex health service interventions (127), to maximise secondary prevention post-
TIA and/or minor stroke.   
 
Aim 
The aim of this study is to assess the feasibility of evaluating the effectiveness of a 
novel adapted home-based cardiac rehabilitation programme, ‘The Healthy Brain 
Rehabilitation Manual’, with or without a pedometer intervention, initiated within 4 
weeks of a first TIA or minor stroke of atherosclerotic origin. I aimed to assess rates of 
recruitment, completion of outcome measures and follow-up, to explore participants’ 
views of the programme and research methods, and to identify the BCTs used within 
the programme. I also aimed to assess if patients preferred to use a pedometer or a 
Fitbit to support the physical activity section of the manual.   
 
Objective 
To: (1) determine if it is feasible to initiate ‘The Healthy Brain Rehabilitation 
Manual’, with or without a pedometer, within 4 weeks of a patient suffering a first 
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TIA or ‘minor’ stroke;  
(2) assess the patient acceptability of the intervention(s),  
(3) identify the BCTs utilised within the manual, and  
(4) determine what patients prefer to use to monitor their physical activity levels, a 
pedometer or a Fitbit.  
 
Methods  
Trial registration and Ethics Approval  
The study was approved by the Office for Research Ethics Committees, Northern 
Ireland (REC reference 15/NI/0001, 21/09/2015) and registered (ClinicalTrials.gov, 
NCT02712385). CONSORT guidelines for reporting randomised feasibility trials 
(211) as well as National Institute of Health Research (NIHR) guidance for feasibility 
studies (212) and the PREPARE trial guide (213) have been used in this report.     
 
Study Setting and participants 
Patients attending one TIA/ ‘minor’ stroke assessment unit at the Ulster hospital in 
Belfast (UK) were given information about the study by a nurse and asked for their 
consent to be telephoned by the lead researcher (NH) the following day to invite their 
participation. Those who agreed attended the Northern Ireland Clinical Research 
Facility (NICRF), Belfast City Hospital, for an initial meeting where, with consent, 
baseline data were collected.  
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Patients were eligible for inclusion if they were aged 18 years or older and within 4 
weeks of their first symptoms of a TIA or ‘mild’ stroke. The diagnosis was made by 
the consultant at the clinic, based on history, neurological examination and 
neuroimaging (17). Using the TOAST classification system (214)(215) only TIAs and 
‘minor’ strokes attributed to atherosclerosis or small vessel occlusion were included. 
Excluded patients were those who had unstable cardiac conditions or contraindications 
for exercise training (216), were unable to give informed consent or had a previous 
cerebrovascular event.  
 
Data collection 
At their initial meeting, lasting approximately one hour, the researcher measured 
height and weight (in light clothing, using a Seca scale, model 799), waist 
circumference (as per (217)), resting blood pressure and heart rate (using BpTRU, 
model BPM-200 (218), checked the heart rhythm manually to exclude any 
dysrhythmias (radial pulse for 1 minute) and recorded other variables including sex, 
age, marital status, smoking status, alcohol intake (units in a typical week before 
diagnosis), time from initial event to study enrolment, level of education (high school, 
apprenticeship, further education college or University) and current employment. A 
measure of deprivation (multiple deprivation measure (MDM)) was derived from their 
postcode (219). Data were also collected about family history of cardiovascular 
disease (CVD), physical activity levels (validated International Physical Activity 
Questionnaire (IPAQ) questionnaire (220)(221)) and a Mediterranean Diet Score 
calculated using a validated questionnaire (222). A 2-minute walk test was performed 
twice, separated by a rest period of at least 30 minutes (223), and the average distance 
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walked in metres was calculated (224). During the two minutes of testing, participants 
were encouraged to walk as fast and as far as they could. A Hospital Anxiety and 
Depression (HADs) questionnaire (225) was used to assess anxiety and depression 
symptoms, a EQ5D-5L questionnaire (http://www.euroqol.org/eq-5d-products/eq-5d-
5l.html) to assess quality of life, a Modified Rankin scale (226) to assess level of 
disability and a Prochaska stages of change questionnaire relating to physical activity 
was administered (227). The EQ5D-5L index score was derived from the published 
UK data-set (228). All participants were offered VO2max exercise testing via either a 
treadmill or bike and had their follow-up assessment undertaken at 6 weeks post-
enrolment when the above measurements were repeated. These assessments were then 
repeated at the 6 week follow-up review appointment. All assessments, both at 
baseline and follow-up, were undertaken in the Northern Ireland Clinical Research 
Facility (NICRF).  
 
The Intervention – ‘The Healthy Brain Rehabilitation Manual’  
In terms of programme content, ‘The Healthy Brain Rehabilitation Manual’ contained 
an introduction, telling the user how to use the manual, medical and social information 
about TIAs/‘minor’ strokes and how to set goals and action plans for changing certain 
aspects of their lives. It included sections focusing on topics relevant to cardiovascular 
risk (smoking, physical and sexual activity, mental health issues (primarily anxiety 
and depression), community resources (e.g. smoking cessation support; exercise 
classes), diet and secondary prevention medication). The manual was supported with 
telephone follow-up by a health professional, a General Practitioner (GP). Participants 
were given advice about how to know that they were participating in moderate 
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intensity activity. Those with a pedometer were advised that a cadence of 100 
steps/minute corresponds to moderate physical activity and for those who did not have 
a pedometer, they could use the ‘talk/sing test’ (229). This was explained to patients at 
their baseline assessments and was included in the manual as well as being reinforced 
through the telephone follow-up contacts at 1 and 4 weeks.   
 
Randomisation and blinding 
Computer generated randomisation was carried out prior to recruitment and the 
allocations were concealed in sealed, opaque envelopes until baseline assessments 
were completed. NH, who was not blinded to intervention allocation, undertook post-
intervention assessments.   
 
Study design  
There were 3 study arms: the control group, Group 1, received current standard post-
TIA/minor stroke care as per current UK guidelines (39)(112). In addition to standard 
care, Groups 2 and 3 received the intervention programme (‘The Healthy Brain 
Rehabilitation Manual’). Group 3 also received a pedometer or a Fitbit Charge, with 
each participant choosing which they wanted to use, and being encouraged to keep a 
daily step-count diary. NH advised Groups 2 and 3 regarding the use of the manual 
and pedometer/diary at the end of their initial meeting and assessment. Participants in 
Groups 2 and 3 were informed about the national UK physical activity guidelines as 
well as how to achieve moderate and vigorous physical activity intensity (230). The 
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pedometer was used to allow participants to set and monitor goals to increase their 
physical activity levels.  
All participants, including Group 1, were telephoned at 1 and 4 weeks to answer any 
questions regarding their care or use of the manual and, for Group 3, NH encouraged 
participants to self-set step count targets after reviewing the previous week’s daily step 
counts (209). Step counts were recorded, as reported by participants at the end of week 
1 and diary records were reviewed by NH at the 6-week follow-up. Average step-
counts for weeks 1 and 6 were calculated by adding the daily totals and dividing by the 
number of days/ week worn by the participant. During the initial meeting and 
telephone contacts NH used motivational interviewing techniques (231) and adopting 
the ‘5 As’ approach to behaviour change (231), which have all been utilised within 
different healthcare settings (232), including primary care and the community.   
 
Data treatment and statistical analysis 
No formal power calculation was undertaken as this was a feasibility study but 5 
patients in each of the 3 treatment groups was considered sufficient to allow 
assessment of the feasibility of recruitment, conduct of proposed assessments and 
retention. It was also considered that 15 patients’ views could provide useful 
information regarding our research methods and the acceptability of the intervention 
programme and its refinement for potential use in a pilot trial. Descriptive statistics 
were reported for baseline and post-intervention measurements, using Statistical 
Package for Social Sciences (SPSS, version 23) but the main outcomes were rates of 
recruitment, retention and completion of measures and the acceptability of the 
intervention. Participants were encouraged to keep a step diary of their pedometer use 
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and this was reviewed through the telephone contacts at 1 and 4 weeks and then at 
follow-up (6 weeks). A daily step count average for each of these 3 time points (1, 4 
and 6 weeks) was then calculated for each participant using the pedometer.   
Two trained review authors (NH, MAT) independently assessed the manual to identify 
BCTs included, using Michie’s BCT taxonomy (128) of 93 hierarchically clustered 
techniques and a narrative approach was used to describe the use of BCTs within the 
rehabilitation programme. They met to discuss the BCTs which they had identified 
and resolve any discrepancies. A third reviewer (FK) was available to arbitrate in case 
consensus could not be reached, but was not required.  
 
Qualitative work  
All participants were invited to attend a focus group that took place at least two 
months after their completion of the study and they were encouraged to bring their 
partner or a family member to the focus group. The primary questions of the topic 
guide (Appendix VI) related to research participation and the acceptability of the 
different stages of the research study (233). The focus group discussion was led by 
NH, audio-recorded with the consent of participants, lasted approximately one hour 
and was transcribed by NH. Content analysis was undertaken with the practical 
purpose of eliciting views about the acceptability and usability of the intervention and 
research methods and how these could be refined. NH, a male GP, and MD, a male 
health services researcher/health psychologist, read and reread the transcripts and 
coded the content independently. NH and MD met to discuss the main areas covered 
within the transcripts. MC, a female professor of GP, acted as a referee as required as 
well as appraising critically the categories and the degree to which the transcript 
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extracts and quotations supported the themes. The transcripts were not returned to 
participants for comment and/or correction and participants were not asked to provide 
feedback on the qualitative results. NH has basic training in qualitative research 
methods whilst MD and MC are experienced qualitative researchers. The independent 
results of the qualitative analysis and data interpretation were discussed with the entire 
research team, to ensure clear definition of themes and that appropriate supporting 
evidence was identified for each. The reporting of the qualitative study and findings 
followed the guidance set out in the Consolidated Criteria for Reporting Qualitative 
Research (COREQ) checklist (184).  
 
Results 
Recruitment, retention and completion of assessment measures  
During an 18-week recruitment period (March to July, 2016) 107 patients with 
confirmed TIA/minor stroke attended the hospital TIA clinic. From the hospital data 
recorded, we were unable to determine how many of these were eligible for the study 
but 28 eligible patients (15 male; 13 female) agreed to telephone contact from NH. Of 
these, 15 (10 male; 5 female; 53.6%) consented to participate. All of these completed 
the study and attended the 6-week follow up assessment. Participants completed all the 
outcome measures apart from the maximal exercise tests for VO2max assessment, which 
was declined by all participants at baseline and follow-up. Four participants in Group 
3 chose to use a Fitbit Charge initially as their pedometer; 2 reported positive 
experiences using this device, particularly in goal setting and competition with other 
users but 2 others were unable to use it and transferred to use a pedometer, Yamax 
Digi-Walker CW-701, with which no patients reported any problems.        
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Baseline characteristics 
The participants’ mean age was 69 years; 9 were diagnosed with a TIA and 6 a minor 
stroke (Table 5a, b and c). Mean time from event to enrolment was 20.5 days. Only 
one had attained University level education; most had retired. The majority (10) lived 
in the 50% least disadvantaged areas of Northern Ireland. Although 7 were ex-
smokers, only one participant currently smoked; mean alcohol intake was <14 
units/week. Ten participants had a first degree relative with CVD and most 
participants were married (13/15). Baseline IPAQ scores indicated that 10 were either 
inactive or minimally active and many (9/15) reported sitting for over 5 hours daily. In 
their first week, Group 3 participants averaged over 8,000 steps/day. Baseline mean 
systolic and diastolic blood pressure (SBP and DBP) were <140/90mmHg in all 
groups. The total HADs score was elevated in all 3 groups, particularly for anxiety 




Groups 3’s mean daily step counts increased over the 6 weeks of the intervention by 
1407, with a concomitant fall in the numbers in the IPAQ categories of ‘inactive’ and 
‘minimally active’ (Table 6). Participants reported good compliance with the 
pedometer, wearing it on most days, as recorded in the step-count diary. IPAQ data for 
Group 2 also showed an increase in physical activity and a reduction in hours sitting 
per day. The two-minute walk distance increased in all groups, with the greatest 
increase in Group 3. HADs scores, particularly for anxiety, improved in Groups 2 and 
3. There was a wide variation in the rest of the measurements and overall they showed 
only small changes.  
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Qualitative findings  
Seven research participants (3 male; 4 female) and one partner (female) attended the 
focus group. Their ages ranged from 55 to 82 years. Four participants were from 
Group 3, 2 from Group 1 and 1 from Group 2. Qualitative findings were analysed in 
order to determine participants’ views of the manual, the study design and changes 
needed for a pilot study of the effectiveness of a novel home-based programme for 
rehabilitation for patients with TIA or minor stroke. The analysis, supported by 
anonymised quotes (coded by age (years) and sex (M/F)), is reported within three 
themes relating to the content of the data.  
1. Use of the manual 
2. The study design  
3. Suggested changes  
1. Use of the manual  
All participants had positive views about the manual. Its content provided reassurance 
and support, particularly in differentiating between symptoms for which they should 
seek medical help and those that were not of such significance. Some reported how 
they referred to it after having received varying information about their condition and 
risk factors from different healthcare professionals.  
“…there was some days when I was panicking a bit and I got the book out 
and I was like, no, that symptom is ok, that’s normal….” (55 yrs, F)  
“I think this (the manual) should be at doctor (GP) surgeries as well because 
when you go to speak to the doctor you get conflicting advice at times.” (55 
yrs, F)  
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Participants’ comments reflected their fear and uncertainty about their future health, 
attributed to their experience of sudden onset of symptoms for their TIA or minor 
stroke. Some appeared to be in denial of their diagnosis, based on a rationale that their 
symptoms had been mild (predominantly affecting vision and speech; one had right-
sided weakness) and transient but their comments also reflected a sense of uncertainty. 
However, the manual was welcomed by all as a reference source for credible 
information that helped them to understand their diagnosis.  
“It (the TIA) just frightened me and knocked my confidence… because you 
get no warning.” (72 year old female)  
“You know, for just 10 minutes’ worth of symptoms, surely nothing serious 
could have happened?” (79 year old female)  
“I thought it was excellent…….. like a bible” (70 yrs, M)  
Family members also used the manual in supporting decision-making about seeking 
medical help. Some did so effectively but others were less helpful: one participant’s 
comments indicated how her family members wished they could deny the significance 
of her symptoms.  
“…I was just going to go to my bed but my daughter phoned and I said to her 
the symptoms I was having and she took me straight to Accident and 
Emergency (A&E) department.” (79 year old female)  
“My daughters didn’t want to read it because if you read it, then it’s true…” 
(55 yrs, F)  
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Other information in the manual provided reassurance for those who felt guilty about 
not being able to fulfil their previous work-life commitments, particularly as they had 
no visible physical manifestations of illness. Information regarding the relevance of 
healthy lifestyle behaviours in helping to reduce risk of further events was valued and 
participants reported having continued to access it after the study programme had 
ended: some reported that they put the manual in a prominent place to remind them to 
sustain preventive behaviours. Other comments indicated how family members used 
the manual to encourage maintenance of healthy behaviours. Those who had received 
positive feedback about progress in reducing their risk factors attributed this to having 
followed guidance in the manual.  
“I felt an awful fraud cause I was off work but there was nothing physically 
wrong with me…nothing to show ” (55 yrs, F)  
“I lift it every morning, read a wee bit, remind myself why I’m not smoking, 
why I’m not eating a whole load of pastries and why I’m avoiding salt….I 
might just read a line but it’s the very fact that it’s sitting there, reminding me 
of what to do right….I find that very important…” (70 yrs, M)  
“my grand-daughter has read it from page to page and every time she comes 
up to see me, she’s like, ‘grandad, have you done that? Are you keeping to 
that?” (70 yrs, M)  
“The fact that my blood pressure is a lot lower is also very encouraging for 
me to stay with the programme as I feel the things which I have done have 
definitely helped me…” (79 yrs, F).  
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2. The study design  
Recruitment and randomisation  
None of the participants considered that any change was needed to the process of 
recruitment or method of being allocated to study groups.  
Intervention components – telephone follow-up  
The structure and timing of telephone follow-up calls were well received by all 
participants who considered that they reduced their need to seek other medical advice. 
Comments revealed how participants valued the opportunity to share concerns with a 
professional and ask questions. For example, many participants expressed how they 
had fears for the implications of their diagnosis on future travel plans and being able to 
obtain travel insurance  
“………they made me feel that there was someone out there interested in me 
and who cares for me.” (70 yrs, M)  
“...it put your mind at rest because you were thinking, NH is phoning me 
soon, so I don’t need to go to see the GP. I enjoyed the explanations.” (55 
yrs, F)  
“…..are we going to get to go on holiday and will I be able to fly?” (58 yrs, 
F)  
Intervention components - pedometers  
All Group 3 participants enjoyed using their pedometers, setting step-count targets and 
competing with others regarding their achievement of these. One participant reported 
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her appreciation of the Fitbit with its provision of weekly email feedback on her 
performance. However, two participants discontinued using the Fitbit despite research 
team support, one because of battery problems and one lacked confidence in its 
accuracy: both used the Yamax pedometer without difficulty.  
“…it’s a competition between me and the wife who walks the furthest” (70 
yrs, M)  
“ It was just so addictive …. I had that visual target to aim for…It would also 
send me an email at the end of the week, telling me how much activity I had 
done and I just thought it was brilliant.” (55 yrs, F)  
“…and the pedometer would always be less (in step-count measurement 
compared to Fitbit)….” (58 year old, F)  
Outcome assessments  
All participants were also content with the number and duration of assessments and 
with all outcome measures except treadmill exercise testing. They were apprehensive 
that they would be unable to complete it, given their recent diagnosis. However, 4 
participants expressed a readiness to consider undertaking it at the time of the focus 
group, approximately 2 months after having completed the rehabilitation programme.  
“I doubt that I would have been able to do the treadmill exercise test within 4 
weeks of having the TIA….” (70 yrs, M)  
“I would be interested in doing it now…” (58 yrs, F and 79 yrs, F)  
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3. Suggested changes  
The only changes suggested by study participants related to the manual. One 
suggestion was to move the explanations about TIA and minor stroke to the beginning 
of the manual and another was to include a patient’s story.  
“…. the explanation for the TIA (and minor stroke) is at the back of the 
manual. I think it should be at the start?’” (58 yrs, F)  
“people are interesting and it’s good to hear their experiences…” (79 yrs, F) 
 
BCTs used within the manual 
Overall, 36 individual BCTs, from 14 different BCT groups were utilised. Examples 
of how the BCTs were used in each section of the manual are included in 
Supplementary Files 1 to 8. Within Section 1 (Smoking) 16 individual BCTs were 
used and in section 2, dealing with physical/sexual activity, 11 being used. The 
commonest BCTs used were “1.1 Goal setting (behaviour)”, “3.1 Social Support 
(unspecified)” and “3.3 Social support (emotional)” – all being used within 5 of the 8 
manual sections. The commonest groups of BCTs used within the manual were “1 
(Goals and Planning)”, being detected 18 times and Social Support (12 times). Two 
groups of BCTs were not used within the manual, “14 (Scheduled consequences)” and 
“16 (Covert learning)”.  
 
Discussion 
These findings indicate that the evaluation of a novel home-based rehabilitation 
programme, ‘The Healthy Brain Rehabilitation Manual’, implemented within 4 weeks 
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of a first TIA or ‘minor’ stroke is feasible. There was 100% retention of participants 
and more than 50% of patients who were invited by the researcher agreed to 
participate, although it is uncertain that all eligible patients consented to allow contact 
by the researcher. All but one of the proposed assessments, the VO2max testing, were 
fully completed at baseline and follow-up. This study also illustrates the acceptability 
of pedometers as an appropriate method of promoting physical activity to generally 
inactive TIA and minor stroke patients. The rehabilitation programme was centred on 
the use of ‘goals and planning’ and social support as BCTs as well as the manual being 
a credible source of information to promote behaviour change. A Logic Model has 
been developed for this feasibility study and is included in Figure 11 (234)(235).   
 
Comparison with previous literature 
In comparison with previous studies of community-based cardiac rehabilitation for 
patients with TIA or ‘mild’ stroke, this study has achieved higher rates of recruitment 
(50% of those invited) and retention (100%). A feasibility study (126) reported 62% 
retention of 85 patients enrolled and, in a pilot study (103), approximately 50% of 100 
invited patients consented to participate and roughly 80% completed the study. Of 
note, home-based cardiac rehabilitation programmes are reported to improve 
programme adherence (121) and to show longer-term sustainability of health benefits 
compared with hospital-based programmes (123). 
An interesting finding was that all participants declined to undertake a maximal 
VO2max test, both pre- and post-intervention, whereas all other assessments were well 
received. To my knowledge, this is the first study to report this finding. Exercise 
testing is safe to undertake among patients with TIA and stroke (236) as well as 
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generally within the elderly population (237) but the current study participants felt 
unable to complete it. Thus, for further work, the maximal exercise test has been 
omitted, in its place adding the Timed Up and Go test (238) and accelerometer 
assessments of physical activity pre- and post-intervention, which are reliable 
objective measures of physical activity in stroke survivors (239) and amongst the 
elderly population (240).  
The Group 3 participants increased their physical activity by 1,400 steps/day over the 
study period of 6 weeks. Indeed, walking ability has been demonstrated to be strongly 
associated with cardiorespiratory fitness (241) as well as being helpful in guiding 
prognosis in patients with cardiovascular disease (242). Moreover, an increase in 
steps/day walked after cardiac rehabilitation has been shown to reduce overall risk of 
mortality and hospitalization (242). Therefore the improvement in physical activity 
levels (steps/day) demonstrated within this feasibility study could contribute to making 
our TIA and ‘minor’ stroke patients live longer as well as healthier lives. Previous 
studies have also shown that there is potential for larger increases to be achieved with 
pedometer interventions (88)(94)(95)(243), with potential to reduce cardiovascular 
risk factors further, particularly amongst those who are the least active.  It has been 
suggested that healthcare workers should enquire regularly about the walking status of 
their patients and that this should be viewed as another ‘vital sign’ in healthcare (244). 
Pedometers are also accurate and reliable in measuring ambulatory activity 
(46)(87)(88)(89) whilst also being relatively inexpensive. Yamax pedometers have 
been shown to be the most accurate waist-borne instrument (87)(88).  
The intervention appeared to improve quality of life as measured by the EQ-5D-5L 
VAS scale and mental health, as measured by the HADs questionnaire (225), although 
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numbers were small and no significance testing was carried out. In keeping with 
previous work (190) that found a prevalence within TIA survivors of anxiety 
symptoms of up to 30% and depression symptoms of up to 21%, the focus group 
participants were anxious and fearful about having future events. Patients appreciated 
the explanations and reassurance provided by the manual. 
‘The Healthy Brain Rehabilitation Manual’ includes goal-setting for behaviour 
change, with agreed action plans and relapse prevention (‘if-then’) plans for each 
behavioural cardiovascular risk factor.  These goals and plans are reviewed and refined 
in follow-up contacts with the health professional/facilitator. The manual includes 
feedback and monitoring as a BCT, for example, based on review of pedometer step 
counts. Social support is promoted through contact with health professionals and 
encouraging the person to share the manual with their family and friends and to get 
them to join in the behaviour change.  
 
Strengths and Limitations 
This is a feasibility study and therefore no statistical analysis was undertaken on the 
outcomes. Baseline assessments were completed before participants were allocated to 
different groups, to avoid allocation bias. The qualitative work undertaken included 
participants from each treatment group, of varying age and both sexes, with a range of 
different symptoms and experiences and they identified valued components of the 
rehabilitation programme. The educational attainment of participants was less than 
third level (post secondary school education), with only one having a University 
degree and no one reported any difficulty in following guidance or understanding 
information within the manual. This was reassuring since, in developing it, a 
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readability check (http://www.webpagefx.com/tools/read-able/check.php), showed it 
to be readily understandable to 13 to 14 year olds.   
The pragmatic approach, whereby TIA and ‘minor’ stroke diagnosis was made by the 
lead clinician at each clinic, may have led to variation in the case mix due to differing 
interpretation of clinical data but this was accepted as a reflection of ‘real-world’ 
practice. There was no post-intervention blinding of assessments so that it is possible 
that some measurement bias may have occurred. Also, Group 3 participants were not 
blinded to their step counts in the first week of the study, so that the baseline measure 
may be inflated and not a true reflection of levels of physical activity at this time in 
TIA and minor stroke patients.  
Whilst initial discussions with clinical staff regarding the process of identification and 
invitation of eligible patients had included a plan to record anonymously the numbers 
of all eligible patients, this information was not recorded. Thus, although data 
suggested that 79 of the 107 clinic attendees during the recruitment period were 
ineligible, this could not be confirmed and limits our interpretation of the feasibility 
and acceptability of the research.  
A strength of this study is the careful approach that has been taken to identifying the 
‘active ingredients’ of the intervention (BCTs). However, this focused on the manual 
content whilst other BCTs were also involved in the delivery of the programme, 
during telephone contacts. No monitoring of the fidelity of these contacts was 




Implications for future work 
To allow further development and evaluation of the intervention, ‘The Healthy Brain 
Rehabilitation Manual’, a pilot study was planned (Chapter 6). This involved: 
 More hospital clinics, increasing from recruiting in 1 hospital to 4.   
 Ensuring appropriate information was recorded at the recruiting hospitals 
regarding all eligible patients to allow completion of a study recruitment log.  
 Setting step-count goals for physical activity, only Yamax Digi-Walker CW-
701 pedometers were used and given to all intervention group participants, with 
the Fitbits no longer used.  
 The maximal VO2max exercise test was discarded and replaced by the Timed 
Up and Go test (238) pre- and post-intervention, with accelerometer 
assessments, providing reliable objective measures of physical activity in stroke 
survivors (239) and older people (240).  
 A ‘patient story’ being included in ‘The Healthy Brain Rehabilitation 
Manual’, in-keeping with previous authors’ work (245).  
 
Conclusion  
These findings showed the feasibility, acceptability and potential significance of 
implementing a novel home-based rehabilitation programme, ‘The Healthy Brain 
Rehabilitation Manual’, with or without an added pedometer, in patients diagnosed 
with a first TIA and/or minor stroke. The main BCTs used within the manual included 
use of a credible source, social support and goal setting, in keeping with current UK 
national guidance for behaviour change. This preliminary work then informed the 
design of the pilot study (Chapter 6), with longer follow-up, recruitment from a range 
of settings and refined methodology (clinicaltrials.gov (NCT02712385)). This work 
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should then provide evidence of the value of an early secondary cardiovascular 
prevention intervention that focuses on behaviour change for patients following TIAs 
































Stroke Prevention Rehabilitation Intervention Trial of 
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 Introduction 
Previous chapters documented (i) the service user input to ‘The Healthy Brain 
Rehabilitation Manual’ (Chapters 4 and 5), (ii) systematic reviews of the underlying 
evidence (Chapters 2 and 3 with a literature review in Chapter 1) and then (iii) a 
feasibility study (Chapter 5) – the results of these investigative activities were used to 
develop the intervention to this point. This chapter explains the next step in the 
development of the intervention, the pilot study. The pilot study differed from the 
feasibility study by recruiting from 4 instead of 1 hospital (only the Western Trust in 
NI did not recruit), compared GP telephone follow-up to stroke nurse telephone 
follow-up as well as having longer follow-up (increasing to 12 weeks from 6 weeks), 
tested new outcome measures and the new intervention, which included pedometers, 
developed from the feasibility study comments. Information from this pilot study will 
be used to refine the intervention further if necessary and to plan for the next stage in 
terms of the evaluation of this complex intervention, a full randomised controlled trial.   
 
Reporting a Pilot Study - CONSORT extension for pilot studies (246) 
The National Institute of Health Research (NIHR) defines a pilot study as (see ‘Pilot 
studies’ entries at http://www.nets.nihr.ac.uk/glossary):  
“……a smaller version of the main study used to test whether the 
components of the main study can all work together. It is focused on the 
processes of the main study, for example to ensure that recruitment, 
randomisation, treatment, and follow-up assessments all run smoothly. It 
resembles the main study in many respects, including an assessment of the 
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primary outcome. In some cases, this will be the first phase of the substantive 
study and data from the pilot phase may contribute to the final analysis; this 
can be referred to as an internal pilot. Or, at the end of the pilot study, the 
data may be analysed and set aside, a so-called external pilot.” 
Reflecting this definition of a pilot study, Lancaster (247), supported by a recent 
editorial (248), advise 7 key areas to report in a pilot study to allow judgment on its 
success: 
1) to test out the study protocol and ensure all study components work well 
together; 
2) to perform a sample size calculation for the future randomised controlled 
trial. That is, the pilot provides an estimated effect size;  
3) test out data collection, including outcome assessments and blinding; 
4) test randomisation; 
5) help estimate rates of recruitment, those consenting and retention. This 
includes the processes of recruitment, identification of study population, 
selection of participants, process of consent and of arranging baseline 
assessment; 
6) determine the acceptability of the intervention, including study duration, 
assessment of compliance and fidelity of delivery and cost/measures captured to 
allow cost analysis; 
7) select the most appropriate primary outcome measure for the future 
randomised controlled trial.  
These 7 areas are very similar to the 14 outcome measures for reviewing pilot studies 
reported by other authors (249)(250) as well as the CONSORT extension for pilot 
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studies (246) and I have therefore reported my findings from this study based on the 
CONSORT guidelines (246). 
Aim 
The aim of this study was to pilot an adapted home-based cardiac rehabilitation 
programme, ‘The Healthy Brain Rehabilitation Manual’, with an added pedometer 
intervention and telephone follow-up from either a GP or stroke nurse, in the acute 
period (within 4 weeks) following a first TIA or ‘minor’ stroke of atherosclerotic 
origin and from 4 recruitment sites. The aim was also to obtain an initial estimate of 
the effectiveness of the intervention in improving cardiovascular risk factors in the 
TIA and ‘minor’ stroke population.   
 
Objective 
To: (1) determine if it is feasible to pilot ‘The Healthy Brain Rehabilitation Manual’, 
with a pedometer intervention and telephone follow-up from either a GP or stroke 
nurse, within 4 weeks of a patient suffering a first TIA or ‘minor’ stroke with 12 
weeks of follow-up and from 4 recruitment sites;  
(2) assess the patient acceptability of the intervention;  
(3) assess rates of recruitment, completion of outcome measures and follow-up;  
(4) explore participants’ views of the intervention and research methods; and  
(5) obtain a first estimate about the potential effectiveness of the intervention in 
terms of improving cardiovascular risk factors.  
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The a priori criteria for success within this pilot study were that 30% of eligible 
patients agreed to the initial study contact, with more than 50% retention of recruited 
patients.   
 
Methods  
Trial registration and Ethics Approval  
The study was approved by the Office for Research Ethics Committees, Northern 
Ireland (REC reference 15/NI/0001, 21/09/2015) and registered (ClinicalTrials.gov, 
NCT02712385) and I have followed CONSORT guidelines for reporting randomised 
pilot trials (211)(251) as well as the PREPARE trial guide (213).     
 
Study Setting and participants 
Patients attending 4 TIA/ ‘minor’ stroke assessment units in Northern Ireland (one 
each at the Royal Victoria Hospital, Belfast; the Ulster hospital, Belfast; Antrim Area 
hospital, Antrim; Craigavon Area hospital, Craigavon) were given information about 
the study by the clinical stroke nurse at their hospital assessment visit and asked for 
their consent to be telephoned by the lead researcher (NH) the following day to invite 
their participation. Those who agreed attended the Northern Ireland Clinical Research 
Facility (NICRF), Belfast City Hospital, for an initial meeting where, with consent, 
baseline data were collected.  
 
   
		 142
Pilot study amendments  
On the 11/10/2017, a minor amendment was accepted to allow home assessments for 
the baseline and follow-up measurements in addition to the option of having the 
assessments at the NICRF. This amendment was submitted in recognition that 
participants were travelling across NI to participate in the study, with some return car 
journeys being up to 4 hours in duration, depending on where the participant resided.  
 
 Eligibility Criteria  
Eligibility criteria for the pilot were the same as for the feasibility study. To recap, 
patients were eligible for inclusion if they were aged 18 years or older and within 4 
weeks of their first symptoms of a TIA or ‘mild’ stroke. The diagnosis was made by 
the consultant at the clinic, based on history, neurological examination and 
neuroimaging (17). Using the TOAST classification system (214)(215) only TIAs and 
‘minor’ strokes attributed to atherosclerosis or small vessel occlusion were included. 
Patients who had unstable cardiac conditions or contraindications for exercise training 
(216), were unable to give informed consent or had a previous cerebrovascular event 
were excluded.  
In each hospital, the clinical and research stroke nurses completed the on-site 
recruitment log. The recruitment log was either kept on the ward and/or at the clinic. 
This recorded: the number of patients attending the clinics diagnosed with a TIA 
and/or ‘minor’ stroke; those eligible for the study; the numbers of patients accepting 
the invitation to be contacted by the researcher; and the numbers then entering the 
study. 
		 143
Once the patient gave their initial consent, the clinical and/or research stroke nurses 
emailed the lead researcher with the contact details to enable him to telephone the 
patient the following day to invite them into the study. The Ulster, Royal, Craigavon 
and Antrim hospitals all operate daily ‘drop-in’ TIA clinics whilst also operating set 
scheduled outpatient clinic times for patients to be assessed. Patients could also be 
recruited if they were admitted to the hospital directly from, for example, the Accident 
and Emergency department.   
I visited the recruiting centres either once a week or fortnightly to review recruitment 
processes and records, maintain enthusiasm amongst the staff for recruitment and 
answer any questions which the staff might have as well as maintaining visibility of 
the study. All hospitals had a stroke research nurse who was able to support the 
clinical stroke nurses in the recruitment process. However the research nurse in the 
Ulster was only in post for a few weeks during the research period. The research 
nurses in the Royal Victoria hospital were also involved in a number of other research 
projects and their available time to have input into my study was therefore limited.  
 
Data collection 
At the initial and 12 week follow-up meeting, lasting approximately one hour, the 
researcher and research nurse who was blinded to patients’ treatment allocations, 
measured the same variables as were recorded for the feasibility study (see Data 
Collection, Chapter 5), except the maximal VO2max treadmill test which was removed 
following patient feedback after the feasibility study (Chapter 5). The EQ5D-5L index 
score was derived from the published UK data-set (228). All participants additionally 
underwent a Timed Up and Go test (238) and were invited to wear a single wrist-worn, 
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tri-axial accelerometer, Axivity AX3, for one week on their dominant wrist as per the 
UK Biobank study (252), as an objective measure of physical activity levels. The 
accelerometer was set-up to start recording from midnight on the first day it was put 
on by the lead researcher until up to 7 days later. Participants were encouraged to wear 
the device for 24 hours a day, only removing it for water-based activities, e.g. 
showering. It was set-up to capture triaxial accelerations at 100Hz and participants 
were given a stamped addressed envelope to post the accelerometer back to the 
research centre at the end of the wear period.  
 
The Intervention – ‘The Healthy Brain Rehabilitation Manual’  
The content of the intervention, ‘The Healthy Brain Rehabilitation Manual’, and the 
specific BCTs used within the manual have been described in Chapter 5. A copy of the 
manual that was used in the pilot study is included within Appendix VII. The manual 
was supported with telephone follow-up at 1, 4 and 9 weeks, by a health professional, 
either a General Practitioner (GP), who was the lead researcher (NH) on the project, or 
a stroke nurse. Two stroke nurses (Band 6) completed all the telephone follow-up for 
this study. Participants were given advice regarding how to know that they were 
participating in moderate intensity activity: if the participants were using their 
pedometer, they were advised that a cadence of 100 steps/minute corresponds to 
moderate physical activity; an alternative is the ‘talk/sing test’ (229). This was 
explained to patients at their baseline assessments and was included in the manual as 
well as being reinforced through the telephone follow-up.  
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Randomisation and blinding 
For the randomisation, an independent medical statistician generated random permuted 
blocks of 3, using numbers from 1 to 3 and placed these in sealed, opaque envelopes, 
which were opened by the lead researcher after the baseline assessments were 
completed and before the study was started. A research nurse, who was blinded to 
intervention allocation, undertook post-intervention assessments. The accelerometry 
data were analysed by an independent research scientist. Study results were analysed 
by a medical statistician independent to the research study and who was blinded to 
participant study allocation.  
 
Study design  
There were 3 study arms: the control group, Group 1, received current standard post-
TIA/minor stroke care as per current UK guidelines (39)(112)(181). In addition to 
standard care, Groups 2 and 3 received the intervention programme (‘The Healthy 
Brain Rehabilitation Manual’) and a pedometer, Yamax Digi-Walker CW-701, whilst 
being encouraged to keep a daily step-count and physical activity diary. NH advised 
Groups 2 and 3 regarding the use of the manual and pedometer/diary at the end of their 
initial meeting and assessment. Participants in Groups 2 and 3 were informed about 
the national UK physical activity guidelines as well as information on how to achieve 
moderate and vigorous physical activity intensity (230) and to reduce sedentary time. 
The pedometer was used to allow participants to set and monitor goals to increase their 
physical activity levels. These goals were discussed and set during the telephone 
follow-up.   
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All participants, including Group 1, were telephoned at 1, 4 and 9 weeks to answer any 
questions regarding their care or use of the manual and, for Groups 2 and 3, the 
GP/stroke nurse encouraged participants to self-set step count targets after reviewing 
the previous week’s daily step counts (209). Step counts were recorded, as reported by 
participants at the end of weeks 1, 4 and 9 and diary records were reviewed by NH at 
the 12-week follow-up. Average step-counts for weeks 1, 4, 9 and 12 were calculated 
by adding the daily totals and dividing by the number of days/week worn by the 
participant. During the initial meeting and telephone contacts by the GP (NH) or 
stroke nurse, motivational interviewing techniques (231) were used and the ‘5 As’ 
approach was adopted to promote behaviour change (231). These techniques have 
been utilised previously within different healthcare settings (232), including primary 
care and the community. A standard approach to the telephone follow-up was adopted 
by the GP and stroke nurses, who received face-to-face training with the lead 
researcher, NH, on how to conduct this follow-up as well as standardised forms being 
completed (Appendix VIII).     
 
Data treatment and statistical analysis 
No formal power calculation was undertaken as this was a pilot study but 40 patients 
in the whole study, spread evenly across each of the 3 treatment groups, were 
considered sufficient to allow assessment of recruitment, conduct of proposed 
assessments and retention. It was also considered that a sample of these 40 patients’ 
views and of the recruiting stroke nurses’ views could provide useful information 
regarding our research methods and the acceptability of the intervention programme 
and its refinement for potential use in a full randomised controlled trial. Descriptive 
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statistics were reported for baseline and post-intervention measurements, using 
Statistical Package for Social Sciences (SPSS, version 23) but the main outcomes were 
rates of recruitment, retention and completion of measures and the acceptability of the 
intervention. The statistician was independent to the research team and was blinded to 
group allocation. No statistical tests were performed on the baseline data as per 
previous authors (253); ANCOVA was performed to compare baseline and post-
intervention mean results across the 3 groups (254).  
It has been shown that 72 hours of accelerometer wear time is required to be within 
10% of the 7 day value (252) and I therefore analysed all output with data for more 
than 72 hours. The accelerometer data was compared to the individual’s physical 
activity diary and non-wear time was defined as consecutive stationary periods lasting 
60 minutes or longer as per previous authors (252), with all non-wear time being 
removed prior to analysis. The output data was split up into sedentary time and then 
light, moderate and vigorous physical activity, with an average taken for each of these 
variables during the true wear period. The moderate and vigorous physical activity 
averages were added together to allow the moderate-vigorous physical activity 
(MVPA) values to be calculated.   
 
Blinding 
Blinding of participants, the GP and stroke nurses was not possible due to the nature of 
the study intervention. However an independent nurse carried out all the 12-week 
follow-up assessments, ensuring blinding of the study group allocation for the follow-
up assessments. The study statistician and the research assistant for the accelerometer 
analysis were both blinded to study group allocation when carrying out their analysis. 
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Qualitative study  
Seven participants were invited to attend a focus group, selected purposively to 
include a range of different genders, ages, clinical conditions and research group 
allocations. Four of these seven then attended the focus group, which took place at the 
completion of the study. There was also an end of study focus group undertaken with 
the 2 stroke research nurses who delivered the follow-up contacts within the 
intervention for Group 3 within the study. The primary questions of the topic guide 
(Appendix IX) related to research participation and the acceptability of the different 
stages of the research study (233). The focus group interviews were led by NH, audio-
recorded with the consent of participants, lasted approximately one hour and 20 
minutes, respectively, and were transcribed by NH. Content analysis was undertaken 
with the practical purpose of eliciting views about the acceptability and usability of the 
intervention and research methods and how these could be refined. NH, a male GP, 
and MD, a male health services researcher/health psychologist, read and reread the 
transcripts and coded the content independently. NH and MD met to discuss the main 
areas covered within the transcripts. MC, a female professor of GP, acted as a referee 
as required as well as appraising critically the categories and the degree to which the 
transcript extracts and quotations supported the themes. The transcripts were not 
returned to participants for comment and/or correction and participants were not asked 
to provide feedback on the qualitative results. NH has basic training in qualitative 
research methods whilst MD and MC are experienced qualitative researchers. The 
independent results of the qualitative analysis and data interpretation were discussed 
with the entire research team, to ensure clear definition of themes and that appropriate 
supporting evidence was identified for each. The reporting of the qualitative study and 
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findings followed the guidance set out in the Consolidated Criteria for Reporting 
Qualitative Research (COREQ) checklist (184).  
 
 Patient and Public Involvement (PPI) Group 
The PPI group included 2 participants, one female who volunteered to be part of this 
group following the feasibility study, and a gentleman who had suffered a stroke and 
who was a member of the local Stroke Association. Part of their remit was that they 
were asked to grade the outcome measures, from 1 (perceived as being most 
important) to 15. This was done by giving the participants a list of all the outcome 
measures on a piece of paper and they then wrote beside each outcome measure the 
score/number they had given it. I also met with them on a regular basis and discussed 
the study’s progress and encouraged their regular critique of the study methods and 
findings.  
 
 ‘Stop criteria’ for the pilot study 
Criteria for stopping the pilot study prematurely were developed as per recent 
guidelines (255) and included: 
 Failing to achieve the a priori criteria of recruiting 30% of eligible patients to 
the study; 
 Failing to retain more than 50% of recruited patients to the study; 
 More than one cardio- or cerebrovascular event, for example a further stroke 
event or myocardial infarction, in the treatment arms of the study (Groups 2 and 
3); 
		 150
 Recruiting centres being unable to recruit eligible patients; 
 Recruiting centres not completing the on-site recruitment log; and, 
 Protocol non-adherence, including for the research measurements and the 
actual study intervention.  
  
Results 
Recruitment, retention and completion of assessment measures  
During 32 weeks of recruitment (week beginning 08/05/2017 to 22/12/17) 443 patients 
with confirmed TIA and/or ‘minor’ stroke attended the 4 recruiting hospitals (see 
Figure 12 for CONSORT study flow diagram). From the hospital data recorded, there 
were 125 eligible patients (28.2%) and 44 (35.2%) of these agreed to telephone contact 
from NH (see Table 8). Of these, 40 (90.9%) (24 male, 60%; 16 female) consented to 
participate and all participants were white British and/or Irish citizens. Thus the a prior 
objective of at least 30% of eligible patients agreeing to the initial study contact was 
achieved.  
From the 4 recruitment centres: 16 were recruited from the Ulster Hospital; 12 from 
the Royal, Belfast; 8 from Craigavon Area Hospital; and, 4 from Antrim Area 
Hospital. Three eligible patients from the Royal site were not given an invitation to 
enter the study in December due to time constraints on clinical staff and this was not 
identified in time by the research nurse to allow the patients to be given the 
opportunity to enter the study. These patients have still been included in the 
recruitment numbers relating to eligible patients. The main reasons for people not 
being eligible for the study included having previous cerebrovascular events, the event 
being more than one month ago and the cerebrovascular event being non-
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atherosclerotic in origin or not due to small vessel occlusion, as per the inclusion 
criteria.    
There was 1 study drop-out: 1 female subject (randomised to group 3) dropped out 
after she had completed baseline assessments, including wearing the accelerometer but 
before beginning the actual intervention due to work commitments. The remaining 39 
patients completed the study and attended the 12-week follow up assessment (see 
Figure 12, CONSORT flow diagram). All participants completed all the outcome 
measures. Twelve patients (8M, 4F) were randomised to Group 1 (control) whilst 14 
were each randomised to Groups 2 (GP follow-up) (10 M, 4 F) and 3 (stroke nurse 
follow-up) (6M, 8F) respectively.  
Two patients had home baseline assessments after a non-substantial amendment was 
accepted on 11/10/2017 and in both cases, primarily due to geographical distance from 
Belfast and not being able to drive a car one month following their event, they would 
not have been able to participate in the study if the home assessment was not in place. 
They were both able to attend the NICRF, Belfast for the follow-up assessment at 12 
weeks, ensuring blinded follow-up assessment.   
 
Baseline characteristics 
The participants were aged from 38 to 88 years old with an average age of 63 years old 
in Group 3 to 70 in Group 1; 26 were diagnosed with a TIA and 14 a minor stroke 
(Table 9a and b). Group 1 (control) contained 6 TIAs and minor strokes; Group 2 had 
12 TIAs and 2 minor strokes; whilst Group 3 had 8 TIAs and 6 minor strokes and thus, 
there was a slight preponderance of TIAs in the intervention arms. Mean time from 
event to enrolment ranged from 15 days in Group 2 to 19 days in Group 1. Only a 
minority of participants had attained College or University level education with the 
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majority (27/40, 67.5%) being educated to High school level. In terms of employment, 
18 participants remained in active employment following the diagnosis with 3 
unemployed and 19 retired. There was essentially an even split between participants 
living in the 50% least and most disadvantaged areas of Northern Ireland. Although 9 
were ex-smokers, only 11 participants currently smoked and just under half (19/40, 
47.5%) had never smoked; mean alcohol intake was <14 units/week in all 3 groups. 
Nineteen participants had a first degree relative with CVD, with 5 (12.5%) participants 
having no significant contact with health services prior to their TIA/‘minor’ stroke and 
most participants were married (25/40).  
Baseline IPAQ scores indicated that 21 participants rated themselves as inactive and 
the majority (29/40, 72.5%) reported sitting for 5 hours or more daily. The objective 
accelerometry sedentary data was similar in all 3 groups at baseline, being 
approximately 20.5 hours per day. In their first week, Group 2 and 3 participants 
averaged 5,546 (SD 4,127) and 6,538 (SD 3,993) steps/day, respectively. Whilst the 
average moderate-vigorous physical activity (MVPA) durations each day varied from 
2 hours in Group 1 to 3 hours in Group 3. Baseline mean systolic and diastolic blood 
pressure (SBP and DBP) were <140/90mmHg in Groups 2 and 3 with baseline mean 
SBP being slightly higher at 140.4mmHg in Group 1. Baseline SBP and DBP was 
lowest in Group 3 and only 14 patients at baseline had their SBP within the treatment 
target of less than 130mmHg (14). The total HADs score was elevated in all 3 groups, 
particularly for anxiety symptoms and the highest levels were seen in Group 3. Most 
participants within the study were classed as ‘overweight’, with the highest average 
waist circumference (104cm) seen in Group 1. The average 2MWT performance 
varied from 128 metres in Group 1 to 144 metres in Group 2, whilst the average 
TUGT varied from 10.5 seconds in Group 3 to 13.3 seconds in Group 1. Compliance 
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with the Mediterranean diet was poor across all 3 groups, with the mean score varying 
between 3 and 4.  
 
 Post-intervention results 
The follow-up results are included within Table 10a, 10b, 11a and 11b. In terms of 
the cardiovascular risk factors, smoking status improved in all 3 groups. Average SBP 
reduced in Group 2 (from 137.9, SD 16.36 to 127.6, SD 9.95) whilst remaining stable 
in Groups 1 and 3. DBP and mean resting heart rate essentially remained unchanged in 
all 3 Groups. The improvement in SBP in Group 2 was reflected by an increase in the 
number of patients being within treatment guidelines for their SBP (14), that is, SBP 
less than 130mmHg, whilst Group 1 had fewer people within this target at follow-up. 
The average 2MWT performance deteriorated in Group 1 at follow-up (126.6m, SD 
45.84) compared to baseline (127.5m, SD 33.09) whilst it improved in both Groups 2 
(from 143.5m, SD 53.76 to 159.0, SD 50.27) and 3 (from 142.2m, SD 38.59 to 160.4, 
SD 37.79). All 3 groups improved their average TUGT performance although the 
largest improvement was seen in Group 2 (from 12.9 seconds, SD 7.04 to 9.34 
seconds, SD 5.80). There was also a decrease/improvement in the average total HADs 
and anxiety score of the HADs questionnaire in all 3 groups whilst the total mean 
depression score of the HADs questionnaire improved in Groups 2 and 3 but 
deteriorated in Group 1 (from 3.08, SD 1.93 to 3.75, SD 2.70). The biggest reductions 
for the HADs questionnaire within Groups 2 and 3 were seen in the anxiety scores. 
The HADS scoring was reflected in the mean EQ5D-5L score, which improved in 
Groups 2 and 3, with the biggest improvement in Group 3, whilst deteriorating in 
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Group 1. The average EQ5D-5L VAS score improved in Groups 2 and 3 from baseline 
but Group 1 essentially remained unchanged.  
Mean alcohol intake increased in Group 1 and 3 and remained unchanged in Group 2 
at follow-up compared to baseline. However all 3 groups had a mean alcohol intake 
which was within recommended national UK alcohol limits both at baseline and at 
follow-up. Average weight increased in Group 1 from baseline and reduced in Groups 
2 and 3 with the biggest reduction in Group 2 (from 88.05kg, SD 21.43 to 86.45kg, SD 
20.43). This finding was similar for mean body mass index (BMI) and waist 
circumference. There was no significant change in scores on the modified Rankin 
scale or in the number of patients reporting appropriate secondary prevention 
medication at follow-up compared to baseline.  
In terms of physical activity measures, all 3 groups increased their mean IPAQ scores 
(MET.minutes/week), with the biggest increase in Group 3 and smallest in Group 1. 
This corresponded with more people being categorised as highly physically active 
(HEPA) at follow-up in all 3 groups. Again all 3 groups reduced the amount of self-
reported time sitting from baseline to follow-up but the biggest reduction was in 
Group 2 and there was a reduction in the number of people sitting for 5 or more hours 
per day at post-intervention in Groups 2 and 3. The number of steps/day achieved in 
both Groups 2 and 3 increased at follow-up although the biggest increase was in 
Group 3 (6,710, SD 4585 versus 8,423, SD 4,686 steps/day, respectively). Groups 2 
and 3 also reported an increased intention to engage in physical activity. Group 3 had 
the lowest number of total health contacts (31 compared to the highest of 38 in Group 
1) although Group 2 had the lowest mean number of health contacts (2.07, SD 1.39) 
due to the study drop-out. The between group differences in health contacts were, 
however, generally small.  
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In relation to use of the pedometer, 18 out of the 28 (64.3%) participants given a 
pedometer reported a good user experience and continued to use it throughout the 
research study. Three participants, all aged over 80 years (2 females and 1 male, 2 
from Group 2 and 1 from Group 3) and who were generally frail, felt that the 
pedometer was under-counting their daily steps but they continued to use it and their 
data were included in the results reported although on reviewing these participants’ 
step and physical activity diaries, the pedometer did appear to be under-counting. One 
participant was unable to use the pedometer as they were in a wheelchair, whilst 5 
(17.9%) participants lost their pedometer. A further female participant stopped using 
the pedometer as she felt it was irritating her waist when she wore it.  
One of the participants, randomised to Group 3, was permanently in a wheelchair and 
their 2MWT, TUGT, height and weight could not be measured.  
 
Further stroke events and adverse events 
There was one further stroke event during the follow-up period that occurred in a 
female participant in the control group. There were no other adverse events reported 
during the follow-up period.  
  
Accelerometer Data 
Forty patients completed the baseline accelerometer assessment, wearing the device on 
their dominant wrist for 9 consecutive days. Thirty nine patients completed the post-
intervention accelerometer assessment: one patient completed her baseline 
accelerometer assessment but did not start the actual study intervention. Two post-
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intervention accelerometers were lost in the post as both participants reported 
returning it in the pre-paid envelope but it was not delivered to the research office. The 
accelerometer data were compared to the physical activity and step-count diary 
records, which each participant was asked to keep, to encourage physical activity and 
ensure accelerometer fidelity. Accelerometer data were only used for people with at 
least 72 hours’ worth of monitoring. The baseline data of one participant, randomised 
to Group 3, were excluded as they only had 48 hours of data. The accelerometer data 
was analysed by day and non-wear time was excluded. For the analysis, I used the 
Esliger formula within the Axivity software for either the left or right wrist, depending 
on the person’s dominant hand (and therefore the hand on which they wore it). 
Although there was no statistically significant difference in accelerometer data 
between the control group and either intervention groups, there was an overall trend 
for Group 2 to increase their objectively measured physical activity from baseline and 
to reduce their average daily sedentary time. Indeed Group 2 increased their baseline 
MVPA from 163.6, SD 68.75 minutes/day to 190.2, SD 103.9 minutes/day at follow-
up and the biggest increase was seen in the amount of moderate physical activity being 
undertaken. The sedentary and MVPA times in Groups 1 and 3 remained unchanged 
from baseline.  
  
 PPI Group 
The PPI group ranked the outcome measures used within the feasibility and pilot 
studies based on their perception of their importance. Systolic blood pressure was 
consistently ranked as the number 1 outcome measure.  
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 Qualitative findings  
Four research participants (1 male; 3 female) and 2 stroke research nurses (2 female) 
attended the focus groups. Their ages ranged from 50 to 83 years. Three study 
participants were from Group 3 and 1 from Group 2. Qualitative findings were 
analysed in order to determine participants’ views of the manual, the study design and 
changes needed for a randomised controlled trial of the effectiveness of a novel home-
based rehabilitation programme for patients diagnosed with either a TIA or minor 
stroke. The analysis, supported by anonymised quotes (coded by age (years) and sex 
(M/F) whilst N1 and N2 was used for the nurses), is reported within four themes 
relating to the content of the data.  
1) Use of the manual; 
2) Study design 
3) TIA or ‘minor’ stroke sequelae  
4) Suggested changes to the study/manual for future work 
 
1) Use of the manual 
The manual was generally well received and overall the stroke research nurses 
reported positive patient feedback about the manual, particularly the physical 
dimensions of the manual: 
“So the size was nice, it was nice to handle and it was very clearly written. 
There was good feedback from patients in general about the manual.” (N1) 
Participants read the manual in different ways. One participant in the focus group read 
the manual once to get the main health messages: 
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“I just read it as a one off and got the gist of it and that was good enough for 
me but it might not be good enough. I read it and then just got an idea about 
diet and exercise, so the message was there.” (60yo, male).  
Another focus group participant supported this although the telephone contacts also 
caused her to re-read the manual: 
“yes, I read the manual like you said and then when the nurses rang, I was 
like, oh I better get the manual out again and read over those sections 
again…” (83yo, female) 
Other participants enjoyed reading small segments of the manual and then discussing 
the information with the health professional through the telephone follow-up. Whilst 
the diet section and physical activity diary of the manual were particularly well 
received by participants. Other participants reported that their family read the manual 
and this helped them to adopt the healthy living advice contained within the manual: 
“it works well when you read it and then discuss it with someone. I thought 
the follow-up telephone calls were very good and you could discuss what was 
in the manual with the stroke nurse on the phone. She could then point out 
things which might be useful and things to pick up on…” (57yo, female) 
“I think it did encourage me to eat better and so I now, for example, try to eat 
more green vegetables, eat more fruit and generally try to eat a better 
breakfast, porridge in the morning for example. So it has influenced my diet.” 
(83yo, female) 
“I think the activity diary is a good idea.” (57yo, female) 
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 “yes my daughter too (read the manual)….. well my daughter was taking in 
the information in the manual very closely and then she was getting me to, 
you know, better diet and all the rest of it. …So she tried to help me with easy 
to make healthy food, that’s good for you. So she took an interest in the 
manual.” (60yo, male) 
Participants enjoyed having diagrams to support the information contained within the 
text of the manual and this encouraged them to adopt the appropriate behaviour 
change: 
“the easiest thing for me was, with regards eating, was the picture of the 
plate with the proportions you should have on it. So for example, half your 
plate should be vegetables.” (60yo, male) 
 
2) Study design 
a. Recruitment and randomisation 
Participants did not have any issues with the recruitment process and were keen to 
participate in the research project as they felt it provided them with some follow-up 
following the TIA or ‘minor’ stroke, which is not currently available within routine 
care in the National Health Service (NHS).  
“I thought that was a good thing. It was good to have some aftercare so to 
speak.” (60yo, male). 
“I was exactly the same. I was really glad that there was something there as a 
back up because I wasn’t sure myself about the medication. At the start I 
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wasn’t sure if I was taking it at the right time or whatever, so I was really 
glad that there was something there.” (78yo, female)  
“….yes I was the same. I was quite pleased to have some follow-up as I got 
quite a shock after my stroke, as I didn’t realise what I had. It was quite a 
mild one but nevertheless, I was glad to have someone follow me up and to 
know if there is something I can do to avoid having another one…” (83yo, 
female) 
This was supported by the stroke research nurses who were assisting with study 
recruitment and who also reported that putting information about the research groups 
onto 3 pieces of paper, a ‘study plan’ as they called it, in addition to the study 
paperwork provided, aided recruitment: 
“One of the things we did was made up a study plan and gave people the 3 
options so they could easily and more quickly see the 3 study options. Once 
you explained the study to participants, people were really interested but 
most were very keen to get into the intervention arm.” (N2) 
Participants did not have any issues with attending the Northern Ireland Clinical 
Research Facility (NICRF), based in Belfast, despite the fact that it was often quite a 
distance from their home or their recruiting hospital although travel expenses were 
covered for study participants: 
“I thought it was easy (to get to the NICRF).” (57yo, female) 
Again the stroke research nurses supported the patients’ views on this although they 
recognised that perhaps the travel distance and the logistics of actually getting to the 
NICRF potentially discouraged more elderly, frail patients: 
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“maybe it put a couple of people off if they knew they had to travel that 
distance. But I don’t think it was a major factor….it maybe put off some of the 
more elderly participants, who perhaps didn’t have any form of transport.” 
(N1)  
Some study participants commented on the logistical challenges of attending the 
NICRF, which is based on a ward of one the local hospitals in Belfast, for example car 
parking: 
“this time I took a taxi but I’m not sure if you remember the last time I left 
here, it was bucketing (raining), I had to push my rollator up to the top of the 
car park…..Anyway I had to walk up there to the car park and by the time I 
got home, I was drenched. So today I thought, I’ll take a taxi. I live outside 
xxxx, so it was handy….” (83yo, female) 
The patient focus group discussed an alternative recruitment method involving holding 
a recruiting clinic for the research study at the same time as the hospital clinic or in 
their local hospital a few days later. Although people recognized the potential benefits 
of this approach, they did not feel that it was better than attending the NICRF for 
recruitment to the study.  
In terms of increasing access to the research study, the stroke nurses felt that including 
participants who had previous cerebrovascular events as well as including those who 
had a TIA and/or ‘minor’ stroke due to, for example, atrial fibrillation, could widen 
study eligibility criteria: 
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“the 2 things which restricted our recruitment was the past medical history of 
TIAs and strokes and then people who had an event due to cardioembolic 
causes…” (N2) 
“yes….having a previous event, ruled out a lot of people….” (N1) 
 
b. Intervention components  
i.Baseline assessment  
One participant felt that the baseline meeting with the researcher was an integral 
component of the intervention, when the goals for the research study were set and the 
intervention was tailored to their needs. They also reported that they enjoyed the 
monitoring performed through the use of the pedometer as well as the review 
telephone calls and appointments to monitor their compliance with the behaviour 
change: 
“I think the actual meeting with you is more powerful than reading the 
manual. I think if you’re saying, look, this is what you need to do – try and do 
7500 steps/day, here’s a pedometer, I thought that was a really good idea, 
then it’s back to the individual to either do it or not do it. The other thing was 
you know you’re coming back, so you have that accountability, so you’re 
saying, well try and do this amount of exercise and can you come back and 
here is a pedometer to monitor yourself, I think that was very 
good…accountability. You know, put the onus back on yourself and knowing 
what you had to do.” (60yo, male) 
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ii. Telephone follow-up 
Participants enjoyed the telephone follow-up and reported no difference between the 
stroke nurse and GP follow-up. The group also felt that the telephone follow-up helped 
their compliance with the programme whilst not being too time consuming. Indeed the 
average length of a telephone call was approximately 5 minutes. The stroke research 
nurses also reported that it wasn’t too time consuming to undertake the telephone 
follow-up from their perspective, with most participants answering the phone on their 
first attempt at trying them: 
“I don’t think it makes a difference if you’re followed up by a GP or stroke 
nurse because it’s all about the conversation and the questions you were 
asked.” (57yo, female) 
 “I thought it was motivating…. they would give you a call and it was good 
that someone was showing an interest in you.” (60yo, male) 
“….it (the time duration) wasn’t significant.” (83yo, female) 
 “most of the people I phoned, I got them first time. There was only a couple 
of people who I had to phone a couple of times.” (N1) 
All focus group participants reported that having the 3 telephone calls over the 12 
weeks of follow-up was sufficient and they did not identify any other form of follow-
up (e.g. online) as an alternative to this.  
The stroke research nurses enjoyed the telephone calls overall and felt confident in 
performing them but felt that it could be initially challenging phoning a patient as they 
had little clinical information about them. They suggested that this could be overcome 
by giving them access to their electronic healthcare record.  
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“The thing which I found difficult was the fact that we were phoning people 
up from other trusts, ‘cold’ if you like, there was no background.” (N2) 
 “I suppose one way round that would be to give us access to their health and 
care number, so that if something does crop up then you can go in and you 
have their medical history and medication….” (N2) 
 
iii.Pedometers  
The pedometers were generally well received as a monitoring tool for physical activity 
levels although one participant commented that it was under-counting the number of 
steps they took: 
“….it didn’t work for me. Sometimes it said I had done a few hundred steps 
and other days, thousands. It wasn’t recording all my steps which I had done. 
I’m not sure what it was but it didn’t work.” (83yo, female) 
The stroke research nurses did not generally feel confident about counselling the 
patients regarding the pedometers and recognised that this could have been overcome 
with some training: 
“I wasn’t too good at that (advising participants about the pedometer) 
because I’m not too good with technology plus I hadn’t actually seen the 






All the participants commented that the baseline and follow-up measurements were 
appropriate and had no issues with performing any of these.  
“…..they were fine to do.” (57yo, female) 
 
v.Dissemination  
In terms of research dissemination, all the participants wanted to know about the 
outcomes from the study but key to this was keeping their information anonymous.  
“if there is anything which would be useful, then I would want to know. For 
example, what I want to know about is the risk factors for having a stroke and 
then recommendations about what I should be doing to prevent having 
another one. So I think information like that in the public can’t be anything 
other than good. As long as we are anonymous.” (83yo, female) 
“certainly from my point of view, I would be interested to know how it turned 
out for different kinds of people with different types of stroke and how this 
compared to people who didn’t do the programme, if that is possible.” (57yo, 
female) 
“But like I say, if people in our position (who have had a TIA or minor 
stroke), could be told about the programme, then that would be good.” (60yo, 
male) 
It was also suggested that efforts could be made to target information to those 
considered to be at high risk of having cerebrovascular events so they could modify 
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potential risk factors. Although it was recognised that health information can 
potentially have negative consequences.  
“…..maybe also tell family members who have a strong family history of 
strokes and are perhaps predisposed.” (57yo, female) 
 “…..but even with a family history, you don’t want to be scaring the life out 
of people and them thinking they are going to have a stroke just because their 
relative has had one…” (83yo, female) 
The stroke research nurses felt it was important to let the local and national stroke 
charities know about the research findings as well as publicising the results through 
appropriate conferences and the scientific press: 
“I would let the Stroke Association (UK) and Chest, Heart and Stroke (NI) 
know about the research findings, so they could publicise this. Also the NI 
Stroke Forum to present your research at and then publish your findings in 
appropriate journals. “ (N1) 
They also identified displaying the results of the project in clinical areas to let patients 
know about the findings: 
“also have something at the TIA clinics about the research project and 






3) TIA or ‘minor’ stroke sequelae   
Participants attributed various symptoms to their event, including hoarseness, and 
described a sense of shock following the diagnosis as well as reporting a continual 
worry about having further cerebrovascular events.  
“sorry I’m a bit hoarse….this hoarseness is definitely a result of the 
stroke…” (83yo, female) 
 “yes I got a shock as well when mine was diagnosed….” (78yo, female) 
 “my fear is taking another one….” (78yo, female) 
Whilst others reported an increase in anxiety following the initial event and fatigue: 
“The other thing I would mention is anxiety, it’s definitely a factor after my 
stroke. Just worrying about stupid things, things which might never happen.” 
(83yo, female) 
 “But what I do find, particularly if I try to do as much as I used to, then the 
next day I’m very tired. Is that part of the stroke?” (83yo, female) 
Expressive language was also an issue for some patients with others identifying effects 
on memory or cognition: 
“one thing I found after my stroke, is struggling over words. Even now. I 
thought it would be better by now.” (60yo, female) 
“yes, or you get up to do something and you forget why you got up?” (83yo, 
female) 
These are all persistent symptoms which the patients therefore felt should be addressed 
within the manual.  
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4) Suggested changes to the study/manual for future work  
The research study was generally well received: 
“….in general it was very good and I think it was a very positive thing to be 
involved with, with lots of positive feedback from the patients themselves.” 
(N1) 
However there were some suggested changes for developing the project further.  
 
a. Electronic version of the manual 
For the next stage in the development of the manual, participants suggested an 
electronic version, for example as an app on a phone: 
“I think it’s (an app on the phone) a good idea…” (83yo, female) 
However the stroke research nurses recognised the need to provide both electronic and 
paper copy versions to allow patients to decide which version they preferred: 
“I think you would have to give people both options but yes, it’s a good 
idea.” (N2) 
 
b. Cognitive tests 
One patient made comment that they felt it would be useful to include an assessment 
of cognition for the follow-up tests: 
“you could maybe do some mental tests as well? Just a thought. You could 
ask for people to do calculations or something and compare them between the 
beginning and end.” (57yo, female) 
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c. Accelerometers  
The group recognised that the season of the year influenced their activity levels and 
that using the accelerometer for longer than a week would be more reflective of their 
activity levels: 
“it might be better to wear it for longer than a week because, for me anyway, 
walking in the bad weather just doesn’t happen. The good weather then 
comes along and you’re doing 7500 steps or more everyday, no problem. In 
the bad weather it might just be 2000 steps or so a day….. Maybe even a 
couple of months would be a better reflection.” (60yo, male) 
“yes there is a difference between winter and summer.” (57yo, female) 
Feedback was important for participants. Indeed one participant commented that they 
were keen to know the result of the accelerometer and that this should have been 
discussed with them after the baseline and follow-up assessments.  
“we never heard how we did with the black watch (accelerometer).” (83yo, 
female) 
 
d. Open questions  
Despite the baseline and follow-up assessments having offered a number of 
opportunities to ask questions, one participant made comment about potentially having 
some more open questions during the assessments to allow more of a conversation to 
develop. They also wanted the researcher to encourage the participants to write down 
appropriate questions to ask the health professionals at their next contact.  
		 170
“….So instead of asking a set number of questions, leave it a bit more open 
and then ask the person how did they find everything and do they have any 
questions? You know you asked questions about are you fearful and how are 
you feeling but there were things which you didn’t ask, that when I went away 
and thought about things, there were a few things that I would have liked to 
have been asked. So I think if there was more of a conversation, they might 
have come out, I don’t know but they might have. So maybe leave a space for 
more free speech or whatever…. Perhaps even say, before the next time you 
come down or see me, write down a few questions in the manual which you 
would like to ask me.” (60yo, male) 
 
e. Food diary  
It was suggested by 2 study participants that a food diary be added to the manual: 
“I did get into the habit of keeping a food diary and it wasn’t too bad to do. 
It’s just unbelievable to see how many sweets I eat. You don’t know how bad 
your diet is until you write it down and then you read it. I mean I wouldn’t 
have thought I would eat more than 3 bars of chocolate a month but then 
when it is written down, it’s more like 10 or 12.” (57yo, female) 
One way of doing this, is by utilising technology, for example, apps on smartphones 
and participants felt this would put the emphasis back on the patient to allow them to 
take ownership of changing different aspects of their unhealthy lifestyle: 
“yes I have an app, MyFitnessPal, and it has a food diary, so you tap into it. 
It recognises foods, so you can scan bar codes and it tells you the calories 
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and so on. I thought it was really good. It’s good again for accountability.” 
(60yo, male) 
Some commented on the potential adverse effects of monitoring behaviour too closely: 
“you can’t let it control your life though! You can begin to get a bit 
tyrannical.” (57yo, female) 
 
f.             Longer duration follow-up  
The 12 week study duration was well received by the study participants: 
“…not too long, not too short. It was enough time to see an improvement.” 
(57yo, female).  
The idea of a longer study duration was also well received: 
“….it wouldn’t be a problem for myself”. (60yo, male) 
This view was also supported by the stroke research nurses and 6 months was 
suggested as an appropriate study duration: 
“Yes, I think that would be good actually, as 12 weeks is quite short. Yes 6 
months would be good and I think people would benefit from it as well.” (N1) 
The longer study duration was seen as a positive in combating complacency which can 
occur following the diagnosis of a TIA or ‘minor’ stroke, particularly as the person 
gets further from the event, and in ensuring that the positive behaviour changes 
become habitual. 
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“….for me, it’s hard to keep motivated. In the first few months you are like, as 
I mentioned, you’re out walking, you’re careful with your diet. As time goes 
on and you get the confidence that you’re not going to have another one, 
there is a danger that you can just drift back into bad habits, same old, same 
old……. yes, bad habits can come back and maybe having the 6 month review 
might motivate you further to get into a real life change habit.” (60yo, male) 
 
Discussion 
This is the first pilot study on the use of an adapted home-based cardiac rehabilitation 
programme, ‘The Healthy Brain Rehabilitation Manual’, for use in those with a TIA 
and/or ‘minor’ stroke of ischaemic or atherothrombotic origin. The pilot study a priori 
hypotheses were achieved: 35.2% of eligible patients who were invited to consent to 
an initial telephone contact agreed; 90.9% of patients who received an initial telephone 
contact to explain the study consented to participate, with 97.5% of these completing 
the full study. All the outcome assessments were completed and positively received by 
participants. However, there was no pedometer data for 7 of the 39 participants. 
The intervention Groups (2 and 3) generally improved their cardiovascular risk factors 
compared to the control group (Group 1). In terms of objectively measured physical 
activity, Group 2 increased the amount of MVPA being undertaken as measured by 
accelerometry at follow-up compared to baseline and reduced their sedentary time, 
suggesting a potential positive effect of the intervention. As was evident from the 
focus group findings and the recruitment and retention rates, this intervention was 
acceptable to and welcomed by patients. These positive findings indicate the need to 
further develop the intervention, ‘The Healthy Brain Rehabilitation Manual’, and to 
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evaluate its effectiveness in managing cardiovascular risk factors for the TIA and 
‘minor’ stroke population within an appropriately powered randomised controlled 
trial.   
 
Eligibility, Recruitment and Logistics of a Multi-centre Trial  
Recruitment was from 4 centres from across the region and of 125 eligible patients, 44 
(35.2%) consented to telephone contact from the main researcher to be invited into the 
study. Of these 44, 40 (90.9%) agreed to enter the study and all the 40 patients 
appeared happy to be randomised, including to a control arm, for the 12 week study 
duration. The process for achieving randomisation worked smoothly.  
The sample size of 40 within the study was appropriate for a pilot study. Indeed Cocks 
(256) has argued that pilot studies should have at least 9% of the main study’s sample 
size whilst other authors (257) advocate having a minimum of 12 patients in each 
treatment arm, giving a total potential sample size of 36 for my study. There was one 
drop out from the study and this one subject stopped her participation before actually 
starting the intervention but she did complete her baseline assessments, including her 
accelerometer. Thirty nine participants completed the full study and their 12-week 
follow-up assessment. This study adherence (97.5% of people randomised completed 
the study) again illustrates the acceptability of the study procedures as well as the 
study intervention.   
Greaves et al (258) carried out a pilot study in UK primary care of a weight reduction 
intervention in those identified to be at high cardiovascular risk and overweight. They 
reported that 22% of those approached to enter the study actually agreed to enter the 
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study and 89% remained in the study, providing data at 12 months of follow-up. 
Greaves et al (258) reported that these recruitment and retention rates were acceptable 
and proved that their pilot could be trialled in a full-scale randomised controlled trial. 
A further study reviewed the use of physical activity prescription in post-TIA patients 
(259) and had a drop out rate of 30%. The a priori criteria for success in the current 
pilot study was that 30% of eligible patients would consent initially to participate in 
the study and that 50% of those entering the study would complete it. From the 
recruitment (35.2%) and retention rates (97.5%) and the positive feedback from the 
study participants, this intervention was well received and acceptable. 
In terms of recruitment, a research nurse appointed to one hospital to help with 
recruitment, unfortunately left the post within one month of the study commencing. 
The majority of the responsibility for recruitment within that hospital then fell to one 
clinical stroke nurse, who did this in addition to her normal, already busy, clinical 
duties. Due to clinical staff commitments, another hospital found it difficult to give 
patients appointments within 4 weeks of their first event, and there was other on-going 
research making it difficult to get a ‘recruitment champion’ at this site. Recruitment in 
the other two hospitals was helped by the presence of research nurses who kept 
accurate and current recruitment logs. Having dedicated stroke research nurses at each 
recruitment site would further improve recruitment numbers for a definitive trial. 
Another suggested improvement to aid recruitment was for the research team rather 
than the clinical team to recruit directly from the TIA clinics and wards. This 
suggested approach would take away the need for a further visit for baseline 
assessment and was approved in post-study qualitative work. However this method of 
recruitment would need to be agreed by the ethics committee and by the recruiting 
hospitals allowing use of their premises for recruitment.  
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A study by Jancey et al (260) described the effective recruitment strategies used by the 
PALS study, which was a randomised controlled study of a community-based walking 
programme for adults aged 65-75 years in Australia and who were classed as 
insufficiently active. They found that females were more likely than males to be 
recruited, in keeping with previous study findings (261). They also found it harder to 
recruit less educated people and had an overall drop-out rate of 28%. Recruits to the 
PALS study deemed feedback important and the intervention was based locally: these 
factors all helped with study retention. In contrast to the PALS study, the current study 
recruited more males than females (24 v 16, 60% v 40%), with a large proportion of 
patients only educated to high school level and from a high level of socio-economic 
deprivation, which may reflect the gender and socio-economic distribution of those 
who were eligible for the current study. These are patients who need targeted 
secondary cardiovascular prevention to help address some of the known health 
inequalities (262). The high levels of recruitment within these groups may be 
explained by the intervention being home-based, recognising that home-based 
interventions promote greater adherence than community- or hospital-based 
approaches (121), as well as by the use of specific behaviour change techniques which 
have been shown to promote better intervention adherence (136).  
Noah et al (263) performed a meta-analysis of randomised controlled trials reviewing 
the effect of wearable technology across different health conditions. Although no 
statistically significant difference was found for the clinical outcomes, they found that 
interventions based on health behaviour theories and “personalised coaching” were 
most effective. Indeed the current intervention includes feedback, monitoring, goals 
and planning being provided to participants via health professionals through telephone 
follow-up, as well as social support (136). Whilst participants enjoyed the telephone 
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follow-up and feedback, they perceived no difference in this being provided by a GP 
or stroke nurse. Thus the plan for a future roll out of this intervention would be to have 
only stroke nurse telephone follow-up.   
 
 Acceptability of the intervention 
From the recruitment and adherence rates it can be seen that the intervention and study 
protocol were acceptable to participants. It would have been interesting to elicit the 
views of the 81 eligible patients who never consented to telephone contact from the 
researcher as well as the 4 who never entered the study, but ethical approval was not 
given to do this. Acceptability of the intervention was also assessed qualitatively 
through focus group work and it can be seen from participants’ and stroke nurses’ 
comments that the intervention and research assessments were positively received.  
Previous authors (264) have reported that having a qualitative aspect to research, 
“investigating the beliefs, attitudes, needs and situation of the people who will be 
using the intervention”, allows the intervention to be “more relevant, persuasive, 
accessible and engaging”. This person-based approach has been at the heart of the 
development process for this complex health service intervention, with patient 
involvement throughout the whole process, including forming a patient and public 
involvement (PPI) group, which has helped with the acceptability of our intervention.  
 
Sample size calculation 
Forty participants were recruited to the pilot study although I had initially hoped for 60 
within the allocated time frame. However, a sample of 40 provides sufficient data to 
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allow a sample size calculation for a definitive randomised controlled study of the 
intervention, based on the primary outcome measure of a reduction in systolic blood 
pressure. Systolic blood pressure has been selected because it is the most important 
risk factor for stroke (34) as well as it having been ranked unanimously as the most 
important outcome measure by the PPI Group. A clinically important reduction in 
systolic blood pressure of 10 mmHg has been shown to reduce the risk of future 
strokes by a third (206), with bigger reductions in blood pressure showing greater 
reductions in stroke risk. Based upon a standard deviation of the change in systolic 
blood pressure of 19 mmHg at 12 weeks of follow-up (taking an average of change 
from across the 3 groups in the pilot trial), a sample size of 60 in each group is 
sufficient to detect a difference in the change in systolic blood pressure of 10mmHg 
between the intervention and control groups with over 80% power and α =0.05. This 
sample size calculation allows for a 10% drop-out rate and this reduction in blood 
pressure is similar to that seen in Group 2 of the pilot study. However I recognise that 
a 10mmHg reduction in systolic blood pressure is optimistic. I have therefore re-run 
the power calculation with a reduction in systolic blood pressure of 3.6mmHg as per 
Deijle et al (147) who used lifestyle interventions in post-TIA and stroke patients, with 
the same standard deviation of the change in systolic blood pressure of 19mmHg at 12 
weeks of follow-up, with 90% power and α =0.05, I would need 651 in each group, 
allowing for a 10% drop-out.  
An alternative to this sample size calculation would be to use the Minimal Clinically 
Important Difference (MCID). The MCID has recently been reported to be 1.1 – 1.5% 
for safe acute ischaemic stroke treatments (265). An alternative to a sample size 
calculation based on improvement in systolic blood pressure could be an improvement 
in quality of life, as measured by the EQ5D-5L index score. The MCID for EQ5D-5L 
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index score in stroke patients undergoing rehabilitation has been recently shown to be 
0.1 (266). However the best approach to the sample size calculation could be explored 
further with the PPI group and then a revised sample size calculation undertaken if 
required.  
 
 Cost and duration of the intervention 
No economic assessment has been conducted as part of this study. However I have 
begun to collect data that would inform this in a future randomised controlled trial and 
will be reported as per the CHEERS guidelines (267) as well as other authors who 
have recently published in this area (268). Information to collect will include cost of 
printing the manual, cost of a stroke nurse telephone contact (band 6 nurse), number of 
future vascular events, number of health contacts per participant and length of any 
hospital admissions. The current study duration was 12 weeks but the plan for future 
trials would be to extend this to 6 months as per the qualitative feedback.   
 
 Outcome assessments  
Data collection was generally successful although could clearly be improved for 
disabled participants. For example one participant in a wheelchair did not have 
recorded data for several variables, including height, weight, 2MWT performance and 
TUGT. Exercise interventions, similar to ‘The Healthy Brain Rehabilitation Manual’, 
in those with chronic diseases, including post-stroke, can improve functional capacity, 
reduce disability and improve quality of life (151). Thus one measure to consider 
including in the next stage of this intervention’s development is functional capacity, 
		 179
which can be measured via the SF-36 Physical Function Scale (269) and this measure 
can be completed by wheelchair users. I will also review the need for additional 
equipment to measure height and weight within this patient group. Rather than the 
2MWT exercise performance measure I will consider the use of the 6 minute wheel 
test for wheelchair users as per previous authors (270)(271).  
Five of the 28 (17.86%) patients who received a pedometer lost it during the study. 
Three other participants also felt that the step count was under-estimating the amount 
of physical activity which they were doing, with a further one participant 
discontinuing their pedometer use due to waist line irritation and another patient could 
not use it as they were in a wheelchair. Although pedometers have been reported to be 
feasible for use in stroke patients, their accuracy at slow walking speeds has been 
questioned (90)(91) and this appeared a particular issue with the more frail 
participants. Despite this, positive experiences with using pedometers were reported in 
the feasibility study (272) and in previous community-based physical activity research 
that I have been involved in (209). For the next stage in the development of the 
intervention, I will therefore explore alternatives to pedometers, such as a wrist-worn 
physical activity device, testing this out within a further internal pilot study.  
The intervention found a statistically significant reduction in systolic blood pressure in 
Group 2 (137.9 (SD 16.36) at baseline to 127.6 (SD 9.95) at follow-up). Although this 
is a pilot study, these results indicate the potentially positive impact that this 
intervention can have on reducing systolic blood pressure and other cardiovascular 
risk factors. Indeed a recent systematic review assessing the effect of lifestyle 
interventions following a TIA or ischaemic stroke (147) found a 3.6mmHg reduction 
in systolic blood pressure. Systolic blood pressure is one of the most important risk 
factors for stroke (34) and a 10 mmHg reduction in systolic blood pressure has been 
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shown to reduce the risk of future strokes by a third (206), with bigger reductions in 
blood pressure showing greater reductions in stroke risk.  
The intervention promotes adherence to the physical activity guidelines, including the 
endurance, strengthening and balance components. Indeed the self-reported physical 
activity questionnaire data and the TUGT and 2MWT performances in Groups 2 and 
3, as well as the accelerometer data in Group 2, show that participants increased their 
general physical activity levels. This is an important finding as a Cochrane Systematic 
Review which was updated in 2016 (273), has shown that cardiorespiratory and mixed 
exercise training were effective in reducing disability in stroke survivors. Promotion of 
walking was also found to be particularly effective at increasing mobility in the stroke 
survivors and the authors (273) found that a variety of forms of physical fitness 
training were safe for the stroke survivors to do, in-keeping with the safety findings in 
the present study.  
The positive effects of cardiac rehabilitation on cardiovascular risk factors have been 
well reported by other authors. Indeed Dalal et al (161), in a review article focused on 
myocardial infarction, cardiac revascularisation and heart failure patients, reported that 
cardiac rehabilitation reduces overall mortality (relative risk 0.87 (95% CI 0.75 – 
0.99)), cardiovascular mortality (relative risk 0.74 (95% CI 0.63 – 0.87)) and hospital 
admissions (from 30.7% to 26.1%) with improvements in depression, anxiety and 
hostility scores. They also reported improvements in systolic blood pressure, serum 
cholesterol, weight and quality of life measures (161) and these findings have now 
been supported by my pilot study findings in TIA and ‘minor’ stroke patients.  
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Participants in the focus group suggested including an assessment of cognitive 
function within the research programme. Previous authors have reported that in 
patients aged 45-65 years of age, over one third will have impairment in one cognitive 
domain 3 months following a TIA (274). A recent systematic review has also shown 
that exercise can improve cognitive functioning in the over 50s, regardless of baseline 
cognitive functioning (275) and a small intervention study has shown that aerobic 
exercise in those with mild cognitive impairment can improve executive functioning 
(276). To assess cognition, I would therefore propose to use the Montreal Cognitive 
Assessment (277) tool, which has been previously used in TIA and ‘minor’ stroke 
research (278).  
The focus group feedback also suggested the addition of a food diary to the manual. 
Indeed previous work (279) has reported the telephone use of a food diary, with 
important reductions in cardiovascular risk factors. Higher adherence to a 
Mediterranean diet is associated with lower ischaemic stroke risk (280) and food 
diaries improve adherence to the Mediterranean diet (281).  
 
 Accelerometer and Physical Activity Measures  
Accelerometry is an objective measure of physical activity. Doherty et al (252) 
showed that wrist-worn accelerometer was acceptable to patients with a high rate of 
compliance and this is supported within this current study by the high rate of 
completion of accelerometry assessments. Sedentary time is an important predictor of 
mortality (282)(283) and inversely associated with healthy ageing (284) and mortality 
(285). It is therefore important, particularly amongst TIA and minor stroke patients 
who are at high future cardiovascular risk, to not only educate patients about doing 
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more physical activity and exercise but also to spend less time sitting. Sedentary time, 
as objectively measured by accelerometry, reduced in Group 2 at follow-up and this is 
an important health measure that should be promoted to these patients. Moreover 
Keadle et al (286) did an analysis on over 100,000 older adults aged 50 – 71 years of 
age who were part of an NIH cohort study. They found that those adults who watched 
5 or more hours/day of TV had a 28% higher risk of death over 6.6 years of follow-up 
than those who watched less than 3 hours/day. The current intervention appeared to 
reduce sitting time, as measured by the IPAQ, with fewer adults spending 5 or more 
hours sitting per day at follow-up compared to baseline, albeit that this was a self-
reported measure.  
Group 2 improved their objectively measured moderate and moderate-vigorous 
physical activity at follow-up as measured by the accelerometer. The American Heart 
and Stroke Associations have produced physical activity and exercise 
recommendations for stroke patients (109). In keeping with the guideline 
recommendations, ‘The Healthy Brain Rehabilitation Manual’, supports the use of 
tailored physical activity goals and exercise prescription, which should help promote 
long-term adherence (109).  
Bohannon et al (287) report that the mean 2MWT performance for adult men is 
189.4m and for adult females it is 176m. The results for the current study participants 
are below this. Thus although the intervention improved 2MWT performance at 
follow-up compared to baseline, further improvement could be achieved and a longer 
term intervention with an appropriate exercise prescription is planned for the next 
stage of the research process. The authors (287) also reported that the test-retest 
intraclass correlation coefficient of the 2MWT was 0.82, thus helping to ensure that 
the present results are reliable when comparing baseline to post-intervention values.   
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At follow-up the mean increase from baseline in steps/day in Group 2 was 1,164 and 
1,885 in Group 3 and this was similar to the increase in steps/day found in the 
feasibility study (272). Cupples et al (243) used a pedometer in 45 patients finishing a 
supervised 8-week, hospital-based cardiac rehabilitation programme to try to maintain 
physical activity levels. After 6 weeks of follow-up in the pedometer/intervention arm, 
they found a mean increase in steps/day of 2,742 from baseline. Their mean steps/day 
was 6,132 at baseline and 8,352 at the 6 weeks of follow-up, which is comparable to 
the baseline and follow-up results for Group 3. Participants in their study enjoyed 
having a step-count goal/target to achieve, a finding supported within our qualitative 
findings as well as national guidelines (136). Also in accordance with my findings, 5 
of their participants felt it was under-recording and 2 had issues positioning the device 
on their clothes, although none reported losing it. However the pedometer step counts 
for Groups 2 and 3 in the present study do not seem to correlate with the 
accelerometry data, with only Group 2 improving their moderate-vigorous physical 
activity levels at follow-up. This finding may be partially explained by the pedometer 
dropouts, with the included pedometer values perhaps inflating the true response in 
Group 3.  
Previous authors (288) have compared self-reported sedentary time to objectively 
measured sedentary time and found that self-reported tools generally underestimated 
sedentary time. This is generally comparable to my findings. However I advised my 
study participants to wear the accelerometer throughout the day and sedentary time 




Stroke risk post-TIA  
In this study of 40 patients with 12 weeks of follow-up after a TIA or minor stroke, 
only 1 patient, who was in the control group, had a further event. This event was 
diagnosed as an ischaemic stroke. Coull et al (9) in their Oxford, United Kingdom, 
primary care based study estimated the risk of stroke after a TIA in the first 90 days as 
17.3% (95% confidence interval 9.3 – 25.3%) and the risk of stroke following a minor 
stroke as 18.3% (95% confidence interval 10.3 – 26.7%). Although this is a pilot 
study, the reduction in cardiovascular events reported in this study suggests that, ‘The 
Healthy Brain Rehabilitation Manual’, is an effective form of secondary prevention to 
use in the acute period following a TIA and/or minor stroke. The safety of this 
approach is supported by the evidence from the systematic review in Chapter 2 (179), 
which found no excess deaths in those undergoing rehabilitation compared to controls, 
in keeping with the findings in the feasibility study described in Chapter 5 (272).  
  
Chronic symptoms following a TIA and/or ‘minor’ stroke  
Despite TIAs being described as ‘transient’, previous work (186) has shown that post-
TIA patients experience prolonged symptoms, for example fatigue and mental health 
issues as well as ongoing focal neurological symptoms. The authors (186) also report 
that the TIA patients were keen to learn further information about their condition and 
appropriate treatments but were left frustrated by the lack of information in this area. 
My qualitative findings from the patient focus group support the ongoing nature of 
symptoms following a TIA and/or ‘minor’ stroke, with fatigue, anxiety, stress, 
hoarseness, word finding difficulties and cognitive slowing all being reported. This 
intervention, ‘The Healthy Brain Rehabilitation Manual’, with follow-up from a health 
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professional (GP or stroke nurse) gives people information about these symptoms and 
gives them suggestions for treatment, helping to fill this current knowledge void.   
 
Protocol components 
As can be seen from the above presented qualitative and quantitative results, the 
protocol worked well although some improvements have been suggested for the next 
stage of the trial and these have been included within the implications for future work 
section (see below). Indeed Greaves et al (289) undertook a systematic review of 
reviews to identify the effective components of programmes that are associated with 
the greatest change in physical activity levels and dietary improvement in those 
patients at risk of type II diabetes mellitus. Similar to this current work, they found 
that effectiveness was improved by facilitating social/family support (which is actively 
encouraged within our manual), targeting both diet and physical activity promotion 
together, increased review contacts and using appropriate behaviour change techniques 
(as described in Chapter 5 for our intervention), such as goal setting, feedback, 
reviewing goals and self-monitoring. Adding social/family support also appeared to 
promote a longer term (12 months in this review) improvement in results. Moreover a 
recent systematic review and meta-analysis reviewing the effect of lifestyle 
interventions post-TIA and/or stroke (147) suggested that future randomised 
controlled trials investigating the effect of lifestyle interventions on preventing cardio- 
and cerebro-vascular events, mortality and cardiovascular risk factors should meet 5 
criteria: 
a) complete description of the intervention; 
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b) the intervention should have more than 8 contact moments over more than 4 
months; 
c) the intervention should use greater than 3 behaviour change techniques; 
d) the intervention should focus on physical activity and exercise promotion as 
well as managing the other modifiable cardiovascular risk factors; 
e) a theoretical framework should be used in developing the intervention.  
 
‘The Healthy Brain Rehabilitation Manual’ currently meets 4 out of these 5 criteria 
and for the next stage of the intervention development, the plan is to increase the 
duration of follow-up beyond 3 months, allowing more than 8 contact moments, 
therefore ensuring all 5 criteria are met. Thus the intervention and research methods 
are in keeping with the current evidence base for secondary cardiovascular prevention 
in this patient cohort.  
 
Implications for future work 
The proposed intervention has the potential to reduce future cardiovascular risk in 
those patients experiencing a TIA and/or ‘minor’ stroke. There is a high level of 
interest currently amongst stroke health professionals and commissioners about how to 
effectively implement non-pharmacological secondary prevention post-TIA and/or 
‘minor’ stroke (14). If strong evidence of the effectiveness of such interventions can 
be found within a randomised controlled trial, then they should be implemented for 
this patient population throughout the UK.  
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For the next stage in the development of the intervention, I am planning to: 
 Add SF-36 (269) and the Montreal Cognitive Assessment (277) tool to the 
study measurements.  
 I am also hoping to recruit directly from the TIA and ‘minor’ stroke clinics so 
that patients do not have to return on a different occasion to get enrolled in the 
research.  
 Follow-up will be extended to 6 months with monthly follow-up calls and the 
2 intervention arms will reduce to 1, with only stroke nurse telephone follow-up. 
Further training is planned for the stroke nurses on the use of physical activity 
monitors during follow-up.  
 I will add a section at the start of the manual asking patients, “What matters 
to you?” (290) to help encourage a more open approach at the health 
professional contacts and develop an electronic version of the manual following 
patient feedback, as well as trialling alternatives to pedometers and including a 
food diary for use in the manual.  
 There will also be further space within the manual to write questions to ask 
health professionals and a section added to the physical activity chapter on how 
to exercise during the winter months and periods of bad weather.  
 I will also apply for ethical approval to have access to the participants’ 
electronic healthcare record for the next study.  
  
Strength and Limitations 
The main strength of this study is the use of rigorous research methods in piloting the 
intervention and assessing the feasibility of conducting a full-scale randomised 
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controlled trial (246). Physical activity was assessed objectively using accelerometry 
and blood pressure was measured using BpTru, which is equivalent to 24 hour blood 
pressure monitoring (218), the current national UK standard for diagnosing 
hypertension (291). I also recruited patients from across a broad range of socio-
economic deprivation levels, as well as from across educational attainment levels, with 
most recruits only being educated up to secondary/high school level. This pilot study 
also recruited from across NI, with only the Western Trust not recruiting, therefore 
allowing me to test if this is a feasible intervention to deploy throughout the region. 
The recruitment rates were very favourable for a pilot study and could have improved 
if a further 3 eligible patients had been given an invite into the study. Recruitment 
could also have been improved by having a dedicated Research Stroke nurse in all 
sites. Another strength is the low study drop-out rate. Due to the randomisation 
process the study groups were well-balanced in terms of their baseline measurements 
and the nurse doing the follow-up assessments was blinded to study group allocation 
as well as the statistician being blinded to group allocation.  
 
Only white, English speaking people were included in the study. Therefore to help 
improve the generalisability of the study findings, I would hope to recruit from across 
ethnic population groups. I would plan to achieve this by recruiting across NI and 
holding regular ‘cardiovascular prevention’ clinics in every hospital to capture suitable 
patients. The study measurements were not adapted for a study participant in a 
wheelchair and for the next stage in the intervention’s development, I therefore plan to 
include measurements, which could be undertaken for disabled participants. From 
reviewing the baseline data there was a preponderance of TIA patients in Group 2. I 
plan to ensure an even spread of TIA and ‘minor’ stroke patients across the control and 
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intervention arms by using stratified randomisation. Finally, to improve the qualitative 
review of the intervention, I would hope to ask about the views of those not entering 
the study regarding recruitment and I will apply for appropriate ethical approval to do 
this.     
 
Conclusion 
This pilot study of an innovative secondary prevention intervention, ‘The Healthy 
Brain Rehabilitation Manual’, utilising core components of home-based cardiac 
rehabilitation in those suffering a first TIA or minor stroke within the preceding 
month, has shown that a randomised controlled trial to test its effectiveness is 
practical, that high recruitment and retention rates are possible, and that the 
intervention and trial is acceptable to patients. ‘The Healthy Brain Rehabilitation 
Manual’ is a patient-centred rehabilitation programme and has shown potential in 
reducing important cardiovascular risk factors in a patient cohort who are at high 
cardiovascular risk. Subject to some minor changes to the intervention, the addition of 
new outcome measures and longer-term follow-up, the intervention is now ready for 
evaluation in a full-scale randomised controlled trial. If this trial demonstrates 
statistically significant results, then implementation of this intervention into clinical 
practice would ensure that UK health trusts achieve the recently published national 
guidelines for TIA and stroke management (14). Indeed the intervention provides an 
appropriate rehabilitation and secondary prevention programme for TIA and ‘minor’ 
stroke patients, as well as appropriate guidance for patients regarding return to work, a 
supportive early discharge model, better management of systolic blood pressure (to 
aim for less than 130mmHg) and the promotion of ‘life after stroke’. Thus this 
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intervention has the potential to significantly improve the management of TIAs and 





















Personal Reflection and Implications for Future 
Practice 
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 Personal reflection 
Through my PhD I have gained lots of invaluable skills. Firstly, going through the 
process of obtaining external NIHR PhD funding was taxing but has equipped me with 
the necessary skills I hope for a future clinical-academic career – in particular, how to 
persevere and change an unsuccessful funding bid into a successful one. I have 
enjoyed the teamwork and leadership skills required to undertake a successful research 
programme and would hope to further develop these skills through further research 
work. In particular, I am looking forward to utilising technology to help improve the 
efficiency and user experience of my research project.   
There was a considerable amount of time and effort required to obtain all the 
necessary ethical and clinical governance approval for the studies, particularly as I was 
working across 4 trusts. The ethical and clinical governance approval processes should 
ideally be streamlined with a view to avoiding duplication of work across Trusts.  
Through the PhD I have successfully developed a complex health service intervention 
following appropriate guidelines and putting the patient experience and views at the 
heart of this. As well as developing this intervention further, I would hope to utilise 
these skills in developing complex health service interventions in other medical fields, 




Implications for practice/future research 
I would like to complete the steps in developing a complex health service intervention, 
by applying for funding to do a randomised controlled trial, to test the effectiveness of 
the ‘The Healthy Brain Rehabilitation Manual’, powered to detect reductions in 
systolic blood pressure. I would also like to offer a regular secondary cardiovascular 
prevention service to those patients experiencing recent cerebrovascular events as well 
as other high risk vascular patients (‘panvascular rehabilitation programme’). To 
enable me to do this I would like to develop the manual into an app to be downloaded 
onto a smartphone. I could then offer patients the option of having the paper copy of 
the manual or the electronic app version. I would also be keen to expand the different 
options available to patients to improve their cardiovascular risk, particularly in terms 
of alternatives to pedometers. Moreover, I would be keen to work with community-
based organisations to ensure my rehabilitation programme fits the needs of service 
users and what they as organisations can offer patients. Indeed some patients may wish 
to benefit from running/jogging classes whilst others may wish to attend cooking 
classes to teach them about the Mediterranean diet and how to prepare appropriate 
meals, for example. These may be interventions that could be offered by local 
charities, for example NI Chest Heart and Stroke, and could complement ‘The Healthy 
Brain Rehabilitation Manual’. Seasonality also affects adherence to physical activity 
and exercise prescription and one way to account for this would be report weekly 
average rain fall in the area in which the research participant lives when conducting 
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Figure 1 – Flow diagram of reviewed and included papers for Systematic Review 
1 (Rehabilitation Programmes with Secondary Prevention Lifestyle Interventions 


















1. TIA/minor stroke not 
identified - 20 
2. No appropriate outcome 
measure - 2 










Figure 2 – Resting systolic blood pressure (mmHg) in the experimental compared 
to the control groups post-intervention for Systematic Review 1 (Rehabilitation 
Programmes with Secondary Prevention Lifestyle Interventions Initiated within 




Figure 3 – Six minute walking test performance (metres walked) in the 
experimental compared to the control groups post-intervention for Systematic 
Review 1 (Rehabilitation Programmes with Secondary Prevention Lifestyle 
Interventions Initiated within 90 days following a TIA or ‘minor’ stroke: 




Figure 4 – exercise testing result (METs) in the experimental compared to the 
control groups post-intervention for Systematic Review 1 (Rehabilitation 
Programmes with Secondary Prevention Lifestyle Interventions Initiated within 










Figure 5 – Flow diagram of reviewed and included papers in Systematic Review 2 
(Behaviour change techniques in home-based cardiac rehabilitation programmes 



















1. No randomisation - 10 
2. No appropriate outcome measure - 2 
3. Not assessing a home-based cardiac 









Funnel plot for the variable systolic blood pressure in Systematic Review 2 
(Behaviour change techniques in home-based cardiac rehabilitation programmes 
for patients with cardiovascular disease: systematic review): 
  
  Mean difference in systolic blood pressure (mmHg) 
Standard 









Funnel plot for the variable diastolic blood pressure in Systematic Review 2 
(Behaviour change techniques in home-based cardiac rehabilitation programmes 
for patients with cardiovascular disease: systematic review): 
 
 











Meta-analysis of resting systolic blood pressure (mmHg) in Systematic Review 2 
(Behaviour change techniques in home-based cardiac rehabilitation programmes 




Meta-analysis of total cholesterol (mmol/l) in Systematic Review 2 (Behaviour 
change techniques in home-based cardiac rehabilitation programmes for patients 




Meta-analysis for the anxiety section of the HADs questionnaire in Systematic 
Review 2 (Behaviour change techniques in home-based cardiac rehabilitation 
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External factors: Distance to travel to research centre for baseline/follow-up 
assessments; competing demands on time, e.g. hospital follow-up visits; family support 
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Table 1 – Information on included studies, Risk of Bias and PEDrO Score 
Study Sample size Dropouts Intervention design Follow-
up 
duration 
Control Risk of 
bias 
Allen et al.
2009.  (142)  
Intervention 
(I) 190;  
Control  
(C) 190  
I: 25  
C: 36 
Comprehensive post-discharge care management 
intervention; assessment by nurse in participants’ 
home; reviewed by the treating medical team.  
Patient care plans developed. Periodic telephone 
calls to assess change.   








I: 43 C: 9   I: 2, C: 2 Education on vascular risk, physical exercise and 
healthy lifestyle; supervised exercise program, 
twice/week for 3 months (15 mins warm-up, 45 mins 
on treadmill, stair machine and bicycle at 60-70% of 
maximal heart rate); prescribed by physiologist; 
supervised by physical therapist and cardiac 
rehabilitation staff.  Exercise prescription adjusted if 
capacity improved.   
3 months Usual 
post-
TIA/stroke 









I:14, C: 14   I: 1, C: 0. Exercise group enrolled in 6-week supervised 
exercise program - 3 hours weekly: 2 sessions of 35-
55 mins on treadmill, hand-bike and bicycle, 
supervised by physical therapy and cardiac 
rehabilitation staff: 8 progressive stages; also, 45-55 
mins group practice for strength, flexibility and 
coordination.  Exercise prescription adjusted if 















care.   
Boysen et al.
(144) 
I: 157, C: 157   I: 24, C: 14 Repeated encouragement and verbal instruction on 
being physically active given by a physiotherapist or 
neurologist. 








Table 2 – BCTs used by the included studies 














“… exercise at “60-70% of maximal heart rate, as prescribed by 
a physiologist” (145) 





“.. twice weekly session of 35-55 minutes on a treadmill, a hand-
bike machine and a bicycle.  …....  A pulse rate target of 50-70% 
of maximal heart rate…” (143) 





“The experimental intervention consisted of repeated 
encouragement and verbal instruction on being physically active 
given by a physiotherapist….” (144) 




















“…instructor and participants would fill in a standard agreement 







“... received a personalized health record to help them self-
manage their risk factors.” (142) 
1; (142) 
Social support Social support “Considerable effort was taken to motivate the participants.” 1; (144) 
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(unspecified)  (144) 
Social support 
(practical) 
Social support “…ensure that needed social services (e.g. Meals on Wheels….) 




Social support “…intervention to reduce common post stroke complications 







“ educated on vascular risk factors and the importance of 







“…group practice for inducing strength, flexibility and 
coordination performances” (143) 
1; (143) 








“…group practice for inducing strength, flexibility and 
coordination performances was performed once a week…” (143) 
1; (143) 
Pharmacologic
al support  
Regulation ‘..medication reconciliation and pill organizers to optimize stroke 









Table 3 – Information on included studies, Risk of Bias and PEDrO Score 
Study Sample (n) Drop-outs Population Setting Intervention 
design 




Jolly et al, 
(114) 
525 Home programme 
6 month data n = 
246 (11 DNA, 3 
died, 3 withdrew); 
at 12 months n = 




month data n = 
239 (18 DNA, 2 
died, 3 withdrew); 
at 12 months n = 
236 (20 DNA, 1 
died). 










12 months.  Hospital-

















Dalal et al, 
(166) 
230 – 104 
into 
randomised 













acute MI.  
UK ‘Heart Manual’ for 
6 weeks. Cardiac 
rehab nurse made 
one home visit in 1st 
week after 
discharge followed 
up by telephone 
calls over 6 weeks 
(typically one call 















Zutz et al, 
(169) 
15 – 7 for 
usual care 
and 8 for the 
2 dropouts by the 
end of the study 
for the usual care 















group. living within 
60km of site.  
email 
communication 




and entry of health 














324 – 163 in 
intervention 
and 161 in 
control 
groups.  
134/163 (82%) in 
intervention 
group; 133/161 
(82.6%) in the 
control group.   
Discharged 
from hospital 
with acute MI 
and aged greater 
than or equal to 
65 years old 
UK At least 2 home 
visits from trained 





advice on stress, 
exercise, smoking 




and manual.  





















based CR.  
8 
Lie et al, 
2009 (174) 
 203 93/101 (92%) in 
intervention 
group; 92/102 





























patients in the 
intervention group 
received 2 1hr 
home visits at 2 and 
4 weeks after 
surgery. 
the nurse-




daily living.  
Wang et al, 
2012 (165) 
160 In the intervention 
group at 6/12 n = 
68/80 (85%); for 
the control group 




China. A home-based 
cardiac 
rehabilitation 
programme using a 
self-help manual, 
the Heart Manual, 
developed by the 
researchers. 
Patients had a one 
hour introduction to 
the manual and 
telephone follow-up 
at 3 weeks.   



















Lee et al, 
2006 (167) 





n patients.  
UK The home-based 
programme is nurse 
facilitated (with 
home visits and 
telephone contact), 
using the Heart 
Manual. 




















et al, 2010 





Poland.  Home-based 
telemonitored 
rehabilitation based 








(170) 56/75 (75%) for 
the control.  
on continuous 
walking training on 
level ground; 
ECHO3 device and 


































75 patients 30/36 (83%) for 
home-based 
intervention; 
34/39 87%) for 
the control.  




Denmark For home-based 
programme, a 
physio visited twice 
within a 6 week 
interval to develop 
a training 
programme that 
could be performed 
at home and in the 
surrounding 




from a cardiologist 
at baseline and after 
3, 6 and 12 months. 
12 months The centre-
based CR 
consisted 

































120 patients For intervention n 
= 46/60 (77%); 




Australia CR delivered at 







consultations for 6 
weeks, via 
telephone (approx. 
15 mins each)  
6 months Traditional 
hospital-
based CR 







6 wks at 























40 patients 19/19 (100%) for 
the home-based 
intervention; 
17/21 (81%) for 
the control.  

















baseline, 3, 6, 12 
mths. 
12 months of follow-
up and mortality data 





















*PEDrO score maximum =11
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Table 4 – BCTs used by the included studies 
BCT Label BCT 
group 






“…motivational and educational materials to participants 

















Regulation “…relaxation and stress management techniques….” (167) 7 (174)(165)(168)(114) (166) 
(173)(167) 
4.1 Instruction 





“Patients were carefully instructed in the training 





















“Participants were asked to wear their heart rate monitors.. 
and upload their exercise data at least twice per week onto 










“Each participant was equipped with a smartphone ... with 
health diary and activity monitoring applications; blood 





“….monthly ask-an-expert group chat sessions.” (169) 6 (170)(169) 
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Regulation “…….nurse counselled patients ……, giving information 










“… simple explanations about coronary heart disease…” 
(166) 









“Regarding risk factor intervention and medical 
adjustment, the patients consulted a cardiologist at baseline 
and after 3, 6 and 12 months.” (172) 






“…technical phone support during the trial if required.” 
(168) 
3 (168) (173) (167) 
12.5 Adding 




“Each participant was equipped with a smartphone…” 
(168) 





“…self-help treatments for psychological problems 
commonly experienced by patients with myocardial 
infarction…” (167) 






“Mentors reviewed participants’ updated data prior to 
weekly consultations …. to provide informed, personalised 







“Before beginning a training session, patients … used the 
mobile phone to answer a series of questions regarding 
their present condition, including fatigue, dyspnoea, blood 
pressure, body mass and medication taken. Patients then 
transmitted resting ECG data to the monitoring centre. If 
no contra-indications to training were identified, patients 
2 (170)(168) 
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“…specific self-help treatments for psychological 
problems commonly experienced by patients with 
myocardial infarction…..” (167) 








“A physiotherapist made home visits … in order to 
develop a training programme that could be performed at 









“In order to prescribe adequate exercise programmes, a 6 
min walk test and a maximal symptom-limited exercise 
capacity test on bicycle ergometer … was conducted. The 
main types of exercise recommended were self-paced brisk 














Table 5a – Baseline characteristics of 
feasibility study participants 
Variable  Group 1 
(Control) 
(SD) (n = 5) 
Group 2 
(Manual) 
(SD) (n = 5) 
Group 3 (manual 
+ pedometer) 
(SD) (n = 5) 
Sex (M – male, F – 
female) 
4 M 1F 4M 1F 2M 3F 
Diagnosis 
- TIA 










Mean age (years) 76.2 67.8 63 
Mean time (days) -event 
to enrolment 
19.8 (7.09) 22.2 (9.18) 19.6 (3.58) 
Level of education 



































784 (51 – 863) 
 
413 (250 – 726) 
 
681 (333 – 825) 
Family history of 
cardiovascular disease 
(<55 years for males, 
<65 years old for 
females) 



















- Minimally active 
- Health-enhancing 
























870.4 (948.22) 1531.2 (902.5) 
IPAQ number of hours 
sitting/day, mean 
6.20 (4.09) 4.80 (1.48) 5.00 (1.00) 
Average steps/day in 1st 
week 
  8356 
Mediterranean diet 











(1.14) (1.79) (1.22) 
*Number of participants (n); standard deviation (SD); multiple 
deprivation measure (MDM) is calculated from the subject’s postcode 
and is a marker of spatial deprivation.  
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Table 5b – Baseline characteristics of 
feasibility study participants 
Variable  
Group 1 (Control) 
(SD) (n = 5) 
Group 2 
(Manual)(SD) 
(n = 5) 
Group 3 (manual 
+ pedometer) 
(SD) (n = 5) 
Mean number of 


































Mean resting heart 




























 -  Non-smoker 
-  Ex – smoker 

































*Number of participants (n); standard deviation (SD); multiple 
deprivation measure (MDM) is calculated from the subject’s postcode 
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and is a marker of spatial deprivation; Hospital Anxiety and 
Depression questionnaire score (HADs). 
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Table 5c – Baseline characteristics of feasibility 
study participants 
Variable  
Group 1 (Control) 
(SD) (n = 5) 
Group 2 
(Manual)(SD) 
(n = 5) 
Group 3 (manual 
+ pedometer) (SD) 


































































































































*Number of participants (n); standard deviation (SD); multiple 
deprivation measure (MDM) is calculated from the subject’s postcode 
and is a marker of spatial deprivation; Hospital Anxiety and 
Depression questionnaire score (HADs). 
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Table 6 – Post-intervention results for 
feasibility study participants 




Group 3 (manual 
+ pedometer) 
(SD) 
Number of patients in arm 5 5 5 
IPAQ continuous score 1093.8 (851.1) 4366.2 (3140.75) 5335.8 (3133.60) 
IPAQ number of hours 
sitting/day 
6.3 (3.99) 3.2 (1.30) 3.8 (1.30) 
IPAQ category 
- Inactive 
- Minimally active 
- Health-enhancing 













Average steps/day in 6th 
week 
  9762.8 (3473.45) 
Mediterranean diet total 
score, mean 
5.8 (2.49) 8.4 (2.30) 8.0 (1.41) 
Mean number of pieces of 
vegetables/day 
1.8 (1.48) 2.4 (0.55) 2.8 (0.84) 
Mean number of pieces of 
fruit/day 
2.6 (1.52) 2.8 (1.3) 4.0 (1.41) 
Average systolic blood 
pressure (mmHg) 
135.8 (24.83) 128.0 (2.00) 131.0 (12.88) 
Average diastolic blood 
pressure (mmHg) 
76.8 (10.01) 74.8 (3.96) 80.4 (11.24) 
Average resting heart rate 
(bpm) 
71.6 (8.35) 61.6 (3.36) 73.8 (10.78) 
Average 2 minute walk 
test performance (metres 
walked) 
118.2 (28.15) 149.75 (28.69) 163.38 (23.36) 
Mean weekly alcohol 
intake (units/week) 
5.6 (8.41) 1.6 (2.61) 2.4 (2.61) 
Average HADs total score 11.0 (5.15) 7.4 (5.50) 3.8 (2.68) 
Average HADs Anxiety 
score 
6.2 (3.63) 4.2 (3.49) 3.00 (2.00) 
Average HADs Depression 
score 
4.8 (2.39) 3.2 (2.39) 0.8 (1.30) 
Mean EQ5D5L overall 
index score 
0.70 (0.37) 0.86 (0.13) 0.96 (0.06) 
Mean EQ5D5L VAS score 53.0 (29.71) 86.0 (6.52) 85.8 (17.63) 
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Mean weight (kg) 80.32 (10.89) 80.06 (8.21) 79.4 (16.45) 
Mean BMI (kg/m2) 27.16 (2.45) 29.49 (3.35) 28.14 (2.18) 
Mean waist circumference 
(cm) 
97.7 (5.74) 98.7 (6.53) 100.4 (11.08) 
*Number of participants (n); standard deviation (SD); multiple 
deprivation measure (MDM) is calculated from the subject’s postcode 
and is a marker of spatial deprivation; Hospital Anxiety and 
Depression questionnaire score (HADs). 
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Table 7 – Study Group Baseline and Post-Intervention Measurements (Mean 
(Standard Deviation (SD)) and categorical values) for the Feasibility Study 
Variable  Group 1 
(Control) – 
baseline 












































IPAQ continuous score 
(Mean (SD)) 






IPAQ number of hours 
sitting/day 
6.20 (4.10) 6.3 (4.0) 4.80 (1.5) 3.2 (1.3) 5.00 (1.0) 3.8 (1.3) 
Steps/day     8356 9762.8 
(3473.5) 

















































Mediterranean diet total 
score 
5.6 (3.1) 5.8 (2.5) 6.2 (3.3) 8.4 (2.3) 6.0 (2.2) 8.0 (1.4) 
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Number of pieces of 
vegetables/day 
1.6 (1.1) 1.8 (1.5) 2.2 (1.8) 2.4 (0.6) 2.0 (1.2) 2.8 (0.8) 
Number of pieces of fruit/day 2.2 (1.9) 2.6 (1.5) 2.2 (1.3) 2.8 (1.3) 3.4 (0.9) 4.0 (1.4) 
Systolic blood pressure 
(mmHg) 
135.8 (8.4) 135.8 (24.8) 136.2 (15.2) 128 (2.0) 129.4 (15.2) 131.0 (12.9) 
Diastolic blood pressure 
(mmHg) 
76.4 (10.8) 76.8 (10.0) 82.8 (13.9) 74.8 (4.0) 77.2 (8.1) 80.4 (11.2) 
Resting heart rate (beats per 
minute) 
66.2 (3.0) 71.6 (8.4) 65.6 (0.9) 74.8 (4.0) 75.0 (9.4) 73.8 (10.8) 
2 minute walk test 
performance (metres walked) 
109.5 (46.3) 118.2 (28.2) 128.8 (29.1) 149.8 (28.7) 136.5 (41.5) 163.4 (23.4) 
Weekly alcohol intake 
(units/week) 
6.4 (12.1) 5.6 (8.4) 5.6 (10.4) 1.6 (2.6) 2.8 (3.0) 2.4 (2.6) 
HADs total score 10.6 (6.5) 11.0 (5.2) 10.4 (4.7) 7.4 (5.5) 7.00 (4.2) 3.8 (2.7) 
HADs Anxiety score 6.0 (4.1) 6.2 (3.6) 6.0 (2.1) 4.2 (3.5) 5.2 (2.8) 3.0 (2.0) 
HADs Depression score 4.6 (3.2) 4.8 (2.4) 4.4 (3.1) 3.2 (2.4) 1.8 (1.9) 0.8 (0.1) 
EQ5D5L overall score 0.7 (0.4) 0.7 (0.4) 0.9 (0.1) 1.0 (0.1) 1.0 (0.0) 1.0 (0.1) 
EQ5D5L VAS score 66.0 (32.1) 53 (29.7) 72.0 (17.5) 86 (6.5) 83.0 (18.2) 85.8 (17.6) 
Weight (kg) 80.6 (10.9) 80.3 (10.9) 80.7 (8.1) 80.1 (8.2) 79.6 (15.6) 79.4 (16.5) 
BMI (kg/m2) 27.3 (2.5) 27.2 (2.5) 29.7 (3.2) 29.5 (3.4) 28.2 (2.2) 28.1 (2.2) 
Waist circumference (cm) 97.7 (5.7) 97.7 (5.7) 99.9 (6.1) 98.7 (6.5) 101.2 (11.3) 100.4 (11.1) 
*Number of participants (n); standard deviation (SD); multiple deprivation measure (MDM) is calculated from the 
subject’s postcode and is a marker of spatial deprivation; Hospital Anxiety and Depression questionnaire score (HADs). 
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Table 8 – Recruitment for Pilot Study 
 






















16 12 (75%) 12 
(100%) 





Table 9 (a)  Baseline Characteristics of Participants in Pilot Study 
Variable Group 1(n=12) (Control) Group 2 (GP)  (n = 14) Group 3 (SN) (n = 14) 
Mean age (years) 69.67 (14.71) 65.71 (12.99) 63.29 (9.60) 
Sex (M – male, F – female) 8 M 4 F 9 M 5 F 6 M 8 F 
Diagnosis  6 TIA  
 6 Minor stroke 
 12 TIA  
 2 Minor stroke 
 9 TIA  
 5 Minor stroke 
Mean (SD)  ABCD2 score  3.29 (0.95) 3.67 (1.30) 3.63 (1.12) 
No. with ABCD2 score     ≥4                      3 8 6 
No. with NIH score for minor strokes 0
                                                             1 










Mean (SD) days: event to study entry  19.25 (8.85) 15.23 (7.76) 16.87 (7.25) 
No. (%) living in 50% most SED areas        7 (58.3)        7 (50)        9 (64.3) 
Education -       High school 
       Apprenticeship 
       College 
       Undergraduate degree 
















Employment –      Employed 
           Unemployed 










Marital status  -      Single 








            Divorced 
            Widowed 










Smoking status  -        Never 
                  Current smoker 
                  Ex-smoker 









Mean (SD) units of alcohol per week  6.58 (14.16) 6.50 (10.78) 5.93 (8.78) 
Mean IPAQ score (SD) 
(MET/mins/wk) 
1287 (1738) 1104 (1883) 1276 (1397) 
IPAQ category  - Inactive 
                          - Minimally inactive 










Mean IPAQ sitting time/day (SD) 
(mins)  
452.5 (229.4) 533.6 (247.0) 520.0 (351.5) 
No. sitting for ≥5 hours daily 8 11 10 
Mean (SD) steps/day in 1st week   5546 (4127) 6538 (3993) 
Mean (SD) steps/day in 4th week   5965 (4217) 7807 (2927) 
Mean (SD) steps/day in 9th week   6582 (5035) 6305 (4406) 
*n = number of participants; multiple deprivation measure (MDM), calculated from postcode indicates socio-economic status;  
Abbreviations: SN=Stroke Nurse; SED=socio-economically disadvantaged; SD=standard deviation; FH=Family History.  
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Table 9 (b) Baseline Characteristics of Participants in Pilot Study 
Variable Group 1(n=12) 
(Control)
Group 2 (GP)  (n 
= 14)
Group 3 (SN) (n = 
14)
Mean (SD) sedentary mins/day (accel) 1266 (72.18) 1240 (73.83) 1230 (108.1) 
Mean (SD) light PA mins/day  36.11 (12.39) 36.75 (14.83) 32.80 (9.68) 
Mean (SD) MPA mins/day   137.2 (65.93) 162. 9 (68.76) 176.6 (100.6) 
Mean (SD) VPA mins/day 0.39 (0.67) 0.70 (1.56) 0.31 (0.55) 
Mean (SD) MVPA mins/day 137.6 (66.21) 163.6 (68.75) 176.9 (100.8) 
No. having a home assessment 1 1 0 
Mean SBP (SD) mmHg  140.4 (23.67) 137.9 (16.36) 129.4 (19.75) 
Mean DBP (SD) mmHg 140.4 (23.67) 88.9 (11.74) 81.00 (14.53) 
Mean (SD) resting heart rate 
(beats/min) 
74.25 (14.4) 68.07 (9.64) 75.0 (7.57) 
No. with SBP <130 mmHg 4 3 7 
Mean (SD) HADs total score  7.50 (3.06) 9.357 (6.77) 13.21 (10.93) 
Mean (SD) HADs depression score  3.08 (1.93) 3.21 (2.99) 5.71 (5.31) 
Mean (SD) HADs anxiety score  4.42 (2.84) 6.14 (4.52) 7.50 (6.31) 
Mean (SD) weight kg  85.19 (20.52) 88.05 (21.43) 76.78 (12.63) 
Mean BMI (SD) kg/m2  28.98 (3.89) 29.75 (6.68) 28.02 (2.95) 
No. with BMI   ≥30 kg/m2  5 5 4 
Mean waist circumference (SD) cms  99.83 (10.56) 104.3 (15.38) 93.92 (10.16) 
Mean 2 minute walk test (SD) metres  127.5 (33.09) 143.5 (53.76) 142.2 (38.59) 
Mean TUG test (SD) seconds  13.33 (6.45) 12.90 (7.04) 10.50 (5.96) 
Mean EQ5D-5L index score (SD) 0.84 (0.12) 0.79 (0.17) 0.67 (0.30) 
Mean (SD) Mediterranean diet score  3.08 (1.56) 4.50 (1.79) 3.57 (2.59) 
Mean EQ5D-5L VAS score (SD)  65.83 (13.29) 62.86 (21.90) 69.64 (15.99) 
Modified Rankin scale -  0 3 8 8 
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                                         1 
                                         2 
                                         3 
                                         4 
















No. prescribed:  - Aspirin 
                           - Clopidogrel 
                           - Statin  
                           - ACE-Inhibitor  
















Stages of change (No.) -           1 
                                                  2 
                                                  3 
                                                  4 
















*Multiple deprivation measure (MDM), calculated from postcode indicates socio-economic status 
** Family history of CVD (1st degree relatives, males aged <55 years; females <65 years) 
Abbreviations: SN=Stroke Nurse; SD=standard deviation; SBP=systolic blood pressure; DBP= diastolic blood pressure; mins=minutes; 
TUG=Timed Up and Go test; accel = accelerometer; PA=physical activity; MPA=moderate PA; VPA= vigorous PA; MVPA=moderate 
and vigorous PA.  
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Table 10a  – Study Group Baseline and Post-Intervention Measurements (Mean 
(Standard Deviation (SD)) and categorical values) for Pilot Study 
Variables  Group 1 
(Control) – 
baseline (SD – 
standard 
deviation) (n = 
12) 





deviation) (n = 
12) 
















baseline (SD – 
standard 
deviation) (n = 
14) 





deviation) (n = 
13) 
Sex (M – male, F 
– female) 
 8M 4F  8M 4F 9M 5F 9M 5F 7M 7F 7M 6F 
Smoking status 
- Never  


































84.17 (12.27) 83.58 (16.59) 88.9 (11.74) 80.50 (8.22) 81.00 (14.53) 82.31 (7.50) 
Mean resting 
heart rate, bpm  
74.25 (14.4) 76.92 (16.62) 68.07 (9.64) 68.86 (11.17) 75.0 (7.57) 74.85 (9.00) 
Number of 


















minute walk test 
performance, 
metres 
127.5 (33.09) 126.6 (45.84) 143.5 (53.76) 159.0 (50.27) 142.2 (38.59) 160.4 (37.79) 
Average timed 
up and go test, 
seconds  
13.33 (6.50) 12.19 (7.63) 12.9 (7.04) 9.34 (5.80) 10.50 (5.96) 8.15 (2.79) 
Mean HADs total 
score  
7.50 (3.06) 6.67 (5.30) 9.36(6.77) 5.64 (5.93) 13.21 (10.93) 8.77 (9.51) 
Mean HADs 
depression score  
3.08 (1.93) 3.75 (2.70) 3.21 (2.99) 2.29 (3.32) 5.71 (5.31) 3.31 (4.07) 
Mean HADs 
anxiety score  
4.42 (2.84) 2.92 (3.03) 6.14 (4.52) 3.36 (3.15) 7.50 (6.31) 5.46 (5.74) 
Mean EQ5D-5L 
index score  
0.84 (0.12) 0.84 (0.21) 0.79 (0.17) 0.85 (0.24) 0.67 (0.30) 0.86 (0.15) 
Mean VAS score 
from EQ5D-5L  
65.83 (13.29) 66.25 (11.70) 62.86 (21.90) 71.79 (14.76) 69.64 (15.99) 76.92 (17.50) 
Mean units of 
alcohol per week  
6.58 (14.16) 12.75 (34.07) 6.50 (10.78) 4.29 (6.70) 5.93 (8.78) 6.39 (9.45) 
Mean weight, kg  85.19 (20.52) 85.83 (21.12) 88.05 (21.43) 86.45 (20.43) 76.78 (12.63) 75.73 (13.26) 
Mean BMI, 
kg/m2  




99.83 (10.56) 102.8 (11.43) 104.3 (15.38) 102.8 (13.98) 93.92 (10.16) 93.63 (10.52) 














































Table 10b  – Study Group Baseline and Post-Intervention Measurements (Mean 
(Standard Deviation (SD)) and categorical values) for Pilot Study 













Group 2 (GP 
Follow-up) – 
baseline (SD – 
standard 
deviation) (n = 
14) 
Group 2 – post-
intervention (SD 
– standard 
deviation) (n = 
14) 
Group 3 (Stroke 
nurse follow-up) – 
baseline (SD – 
standard 
deviation) (n = 14) 
Group 3 – post-
intervention (SD – 
standard deviation) 
(n = 13) 





































Mean IPAQ score 
(MET/minutes/wee
k)  






























IPAQ Mean sitting 
time per day 
(minutes)  
452.5 (229.4) 390.0 (223.8) 533.6 (247.0) 312.9 (156.4) 520.0 (351.5) 378.5 (347.6) 
Number of       
		 239
participants sitting 
for 5 or more 
hours 
8 8 11 8 10 7 
Average steps/day 
at 12 wks  





1266 (72.18) 1266 (90.02) 1240 (73.83) 1210 (110.6) 1230 (108.1) 1236 (98.50) 



















3.08 (1.56) 3.46 (1.70) 4.50 (1.79) 7.64 (2.06) 3.57 (2.59) 6.92 (2.78) 











































Number of times 
attended the 
 - GP  
- Practice nurse  
- Hospital 
outpatient appts  
- A&E dept  

























Total number of 






38   35   31  
Mean number of 
health contacts 
over the study  
 2.67 (1.78)  2.07 (1.39)  2.39 (2.10) 
** Family history of CVD (1st degree relatives, males aged <55 years; females <65 years) 
Abbreviations: SN=Stroke Nurse; SD=standard deviation; SBP=systolic blood pressure; DBP= diastolic blood pressure; 
mins=minutes; TUG=Timed Up and Go test; accel = accelerometer; PA=physical activity; MPA=moderate PA; VPA= vigorous 




Table 11a  – Study Group Baseline and Post-Intervention Measurements (Mean 
(Standard Deviation (SD)) and categorical values) with ANCOVA analysis for 
Pilot Study (statistical significance p<0.05) 
Variable Group Baseline mean (SD 
– standard 
deviation) 
Post intervention mean 
(SD – standard 
deviation) 









 140.4 (23.67)  140.8 (8.03) Reference category  
 GP (Group 
2) 
137.9 (16.36)  127.6 (9.95) -12.63 (-21.28, -3.98) 0.005 
 Nurse 
(Group 3) 




Group 1 84.17 (12.27) 83.58 (16.59) Reference category  
 Group 2 88.9 (11.74) 80.50 (8.22) -5.03 (-12.79, 2.721) 0.196 
 Group 3 81.00 (14.53) 82.31 (7.50) -0.29 (-8.12, 7.55) 0.941 
Average 2 
minute walk test 
Group 1 127.5 (33.09) 126.6 (45.84) Reference category  
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(metres walked) 
 Group 2 143.5 (53.76) 159.0 (50.27) 18.16 (-0.09, 36.41) 0.051 
 Group 3 142.2 (38.59) 160.4 (37.79) 21.27 (2.40, 40.14) 0.028 
Timed up and go 
test (TUGT) 
(seconds) 
Group 1 13.33 (6.50) 12.19 (7.63) Reference category  
 Group 2 12.9 (7.04) 9.34 (5.80) -2.54 (-5.17, 0.10) 0.059 
 Group 3 10.50 (5.96) 8.15 (2.79) -2.11 (-4.84, 0.67) 0.132 
HADs total score Group 1 7.50 (3.06) 6.67 (5.30) Reference category  
 Group 2 9.36(6.77) 5.64 (5.93) -2.51 (-5.55, 0.54) 0.104 
 Group 3 13.21 (10.93) 8.77 (9.51) -3.15 (-6.42, 0.13) 0.059 
EQ5D-5L VAS 
score  
Group 1 65.83 (13.29) 66.25 (11.70) Reference category  
 Group 2 62.86 (21.90) 71.79 (14.76) 6.39 (-4.99, 17.77) 0.262 
 Group 3 69.64 (15.99) 76.92 (17.50) 9.81 (-1.78, 21.39) 0.094 
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Weight (kg) Group 1 85.19 (20.52) 85.83 (21.12) Reference category  
 Group 2 88.05 (21.43) 86.45 (20.43) -2.20 (-4.02, -0.38) 0.019 
 Group 3 76.78 (12.63) 75.73 (13.26) -1.22 (-3.14, 0.71) 0.207 
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Table 11b  – Study Group Baseline and Post-Intervention Measurements (Mean 
(Standard Deviation (SD)) and categorical values) with ANCOVA analysis for 
Pilot Study (statistical significance p<0.05) 




Post intervention mean 
(SD – standard 
deviation) 
Mean difference at 






Group 1 99.83 (10.56) 102.8 (11.43) Reference category  
 Group 2 104.3 (15.38) 102.8 (13.98) -4.20 (-7.00, -1.41) 0.004 
 Group 3 93.92 (10.16) 93.63 (10.52) -2.82 (-5.76, 0.11) 0.059 
IPAQ score 
(MET/minutes/week) 
Group 1 1287 (1738) 2534 (4055) Reference category  
 Group 2 1104 (1883) 4060 (4865) 1831 (-4565, 8226) 0.565 
 Group 3 1276 (1397) 6787 (13047) 4346 (-2156, 10848) 0.184 
IPAQ mean sitting 
time/day (mins/day) 
Group 1 452.5 (229.4) 390.0 (223.8) Reference value   
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 Group 2 533.6 (247.0) 312.9 (156.4) -125.8 (-282.1, 30.50) 0.111 
 Group 3 520.0 (351.5) 378.5 (347.6) -59.45 (-218.4, 99.53) 0.453 
Mediterranean Diet 
Questionnaire score 
Group 1 3.08 (1.56) 3.46 (1.70) Reference category  
 Group 2 4.50 (1.79) 7.64 (2.06) 3.56 (1.90, 5.22) 0.000 
 Group 3 3.57 (2.59) 6.92 (2.78) 3.37 (1.73, 5.02) 0.000 
Resting heart rate 
(bpm) 
Group 1 74.25 (14.4) 76.92 (16.62) Reference category  
 Group 2 68.07 (9.64) 68.86 (11.17) -1.83 (-7.30, 3.64) 0.501 
 Group 3 75.0 (7.57) 74.85 (9.00) -1.74 (-7.15, 3.66) 0.517 
Average sedentary 
time/day (mins/day) 
from accelerometer  
Group 1 1266 (72.18) 1266 (90.02) Reference category  
 Group 2 1240 (73.83) 1210 (110.6) -32.51 (-83.20, 18.17) 0.201 
 Group 3 1230 (108.1) 1236 (98.50) 7.55 (-46.76, 61.86) 0.779 
Average light PA 
time/day (mins/day) 
Group 1 36.11 (12.39) 36.57 (14.22) Reference category  
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from accelerometer 
 Group 2 36.75 (14.83) 40.01 (17.30) 2.89 (-4.52, 10.30) 0.433 




Group 1 137.2 (65.93) 136.8 (79.03) Reference category  
 Group 2 162. 9 (68.76) 189.5 (103.8) 29.52 (-16.94, 75.98) 0.205 




Group 1 0.39 (0.67) 0.31 (0.64) Reference category  
 Group 2 0.70 (1.56) 0.63 (1.51) 0.08 (-0.38, 0.53) 0.735 




Group 1 137.6 (66.21) 137.1 (79.14) Reference category  
 Group 2 163.6 (68.75) 190.2 (103.9) 29.57 (-16.93, 76.08) 0.205 
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 Group 3 176.9 (100.8) 170.5 (93.29) -6.07 (-56.10, 43.97) 0.807 





Database(s): Ovid MEDLINE(R) 1946 to October Week 5 2014 
1) Ischemic Attack, Transient 
2) TIA*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier] 
 3) "transient isch?emic attack*".mp. [mp=title, abstract, original title, name of 
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cerebral artery/ or infarction, posterior cerebral artery/ or stroke, lacunar/ 
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 5) (minor adj5 stroke*).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier] 
 6) 1 or 2 or 3 or 4 or 5 
 7) rehabilitation/ or "activities of daily living"/ or animal assisted therapy/ or art 
therapy/ or bibliotherapy/ or "correction of hearing impairment"/ or dance therapy/ or 
early ambulation/ or exercise therapy/ or music therapy/ or myofunctional therapy/ or 
occupational therapy/ or recreation therapy/ or "rehabilitation of speech and language 
disorders"/ or rehabilitation, vocational/ 
 8) rehabilitat*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier] 
 9) 7 or 8  
10) 6 and 9 
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 11) exp Community Health Services 
 12) ("community based" or "in the community").mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] 
 13) home care services/ or home health nursing/ or home nursing/ 
 14) "home based".mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier 
15) 11 or 12 or 13 or 14 
 16) 10 and 15 
 17) ("within 90 days" or "within ninety days" or early).mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading word, 
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protocol supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
18) 16 and 17 
For studies assessing just cardiac rehabilitation following an initial TIA or 
‘minor’ stroke:  
19) exp Rehabilitation/ 
 20) exp Cardiology/ 
 21) 19 and 20 
 22) 21 and "cardiac rehabilitat*".mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] 
23) 18 and 22   24) 6 and 23  25) 6 and 22
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Appendix II 
Author, title  




Risk of bias  
Random sequence generation (selection bias)  
Allocation concealment (selection bias)  
Blinding of participants and personnel (performance bias)  
Blinding of outcome assessment (detection bias)  
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Incomplete outcome data (attrition bias)  




Database(s): Ovid MEDLINE(R) 1946 to June 2015 
1) Myocardial infarction, ‘heart attack’ 
2) Angina 
3) Angioplasty 
4) Heart failure 
5) Cardiac rehabilitation/rehab 
6) 1 or 2 or 3 or 4 or 5 
 7) rehabilitation/ or "activities of daily living"/ or animal assisted therapy/ or art 
therapy/ or bibliotherapy/ or "correction of hearing impairment"/ or dance therapy/ or 
early ambulation/ or exercise therapy/ or music therapy/ or myofunctional therapy/ or 
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occupational therapy/ or recreation therapy/ or "rehabilitation of speech and language 
disorders"/ or rehabilitation, vocational/ 
 8) rehabilitat*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier] 
 9) 7 or 8  
10) 6 and 9 
 11) exp Community Health Services 
 12) ("community based" or "in the community").mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] 
 13) home care services/ or home health nursing/ or home nursing/ 
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 14) "home based".mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier 
15) 11 or 12 or 13 or 14 
 16) 10 and 15 








Appendix V - General questions for patients/health professionals: 
1) What do you think about the general level of information included within the booklet 
– too much/too little? 
2) What do you think of the exercise programme? Would you be able to do this within 
your own home? Is it hard enough? 
3) Is there anything in particular which would worry you about exercising or asking 
people to exercise after a TIA/stroke? 
4) What do you think of the length of the booklet? Is it too short? Is it too long? 
5) What do you think of the layout of the booklet? Does it need more colour, pictures, 
different font size, etc? 
6) Would you like a patient story within the book – detailing their thoughts/emotions 
after being diagnosed with a TIA/minor stroke? 
7) Are there any risk factors which haven’t been covered, which you would like 
included? Are there any risk factors which you would like more information on – or less 
to be given? 
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Appendix VI 
Focus group topic guide: 
Impact of the diagnosis/illness on the patient: 
1) After the diagnosis, what was your biggest problem, e.g. fatigue? 
2) How did the diagnosis affect your life? 
 
Views on the manual: 
3) What do you think of the manual? 
4) What do you think about the general level of information included within the booklet – too much/too 
little? 
5) What do you think of the length of the booklet? Is it too short? Is it too long? 
6) What do you think of the layout of the booklet? Does it need more colour, pictures, different font size, 
etc? 
7) Would you like a patient story within the book – detailing their thoughts/emotions after being diagnosed 
with a TIA/minor stroke? 
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8) Are there any risk factors which haven’t been covered, which you would like included? Are there any 
risk factors on which you would like more information to be given – or less? 
9) Did family members read the manual? What did they think? Anything which you particularly enjoyed 
about the manual? 
10) Anything you would improve about the manual? 
 
Exercise programme within the manual: 
11) Is there anything in particular which would worry you about exercising or asking people to exercise 
after a TIA/stroke? 
12) What do you think of the exercise programme? Would you be able to do this within your own home? Is 
it hard enough? 
 
Study duration and future goals: 
13) What goals/aims are important to you now that you have been diagnosed and are on the path to 
recovery? 
14) What did you think about the duration of the study follow-up? Longer/shorter? 
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Review of FitBit v pedometer: 
15) What are your views on the pedometer? 
16) How did people find using the FitBit compared to the pedometer? What did you prefer/ why? 
17) What made you stop using the FitBit? 
 
Research assessments and exercise treadmill test: 
18) What did people think about how they were invited and then recruited into the research study? 
19) What did people think about the research assessments? 
20) What did people think about the amount of time involved in the research assessments? 






Study: SPRITE – A Pilot Study 
Patient research code: 
First name: 
Patient telephone contact number: 
Telephone follow-up review at end of week 1: 
Date and time of call: 
Duration of call (minutes and seconds):  
Throughout the telephone calls, adopt a motivational interviewing approach. Try to avoid conflict 
with the participants – the participants will decide if they wish to tackle a particular issue. Your role is 
to gently challenge the participant and provide appropriate health advice to your level of training.   
Welcome the patient and thank them for taking part in the research study.  
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At each telephone conversation, ask the patient: 
1) Are there any particular questions which they would like answered? 
 
2) Every patient has a pedometer, review their average step counts for the previous week and 
write down the daily step counts and average achieved for the last week. Encourage participants to 
keep a daily diary of their step-counts.   
 
3) What are their goals which they wrote down at the start of the manual/programme? Are they 
achieving them? If not, why not? What can they do differently to achieve them? Is there anything which 
health professionals can do to help them? Signpost them to appropriate support, e.g. smoking cessation 
clinics, local pharmacy, GP surgery, local charities, etc depending on the patient needs.  
 
If they are achieving their goals, are there any new goals which they would like to achieve? Get them to 
write these down as well as an action plan on how to achieve them. Action plan examples are included 
in the Introduction of the manual.   
 
4) Finish the conversation by reviewing the next section of the manual with them. 
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5) Any other questions which they would like answered? 
 
If you have any questions about this or anything which you are not sure about, please contact Dr Heron 
on the above number (07808774292) to clarify this.  
Telephone follow-up review at end of week 4: 
Date and time of call: 
Duration of call (minutes and seconds):  
 
1) Are there any particular questions which they would like answered? 
 
2) Every patient has a pedometer, review their average step counts for the previous week and 
write down the daily step counts and average achieved for the last week. Encourage participants to 
keep a daily diary of their step-counts.   
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3) What are their goals which they wrote down at the start of the manual/programme? Are they 
achieving them? If not, why not? What can they do differently to achieve them? Is there anything which 
health professionals can do to help them? Sign post them to appropriate support, e.g. smoking cessation 
clinics, local pharmacy, GP surgery, local charities, etc depending on the patient’s needs.  
 
If they are achieving their goals, are there any new goals which they would like to achieve? Get them to 
write these down as well as an action plan on how to achieve them. Action plan examples are included 
in the Introduction of the manual.   
4) Finish the conversation by reviewing the next section of the manual with them. 
 
5) Any other questions which they would like answered? 
 
At the end of the first 6 weeks, encourage the person to continue to read the manual intermittently for 
the rest of the study duration (12 weeks) and to continue to set themselves step-count targets to achieve 
each week. Again, encourage the use of a step-diary or physical activity diary.   
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If you have any questions about this or anything which you are not sure about, please contact Dr Neil 
Heron on the above number (07808774292) to clarify this.  
Telephone follow-up review at end of week 9: 
Date and time of call: 
Duration of call (minutes and seconds):  
1) Are there any particular questions which they would like answered? 
 
2) Every patient has a pedometer, review their average step counts for the previous week and 
write down the daily step counts and average achieved for the last week. Encourage participants to 
keep a daily diary of their step-counts.   
3) What are their goals which they wrote down at the start of the manual/programme? Are they 
achieving them? If not, why not? What can they do differently to achieve them? Is there anything which 
health professionals can do to help them? Sign post them to appropriate support, e.g. smoking cessation 




If they are achieving their goals, are there any new goals which they would like to achieve? Get them to 
write these down as well as an action plan about how to achieve them.  
4) Finish the conversation by reviewing the next section of the manual with them. 
5) Any other questions which they would like answered? 
 
If you have any questions about this or anything which you are not sure about, please contact Dr Neil 
Heron on the above number (07808774292) to clarify this.  
NB - At the end of the 9 week telephone conversation, please contact Dr Neil Heron on 07808774292 to 
arrange their final assessment (at 12 weeks). Please advise the patient that Dr Heron will be in contact 
with them to arrange this final assessment which will take place in the Northern Ireland Clinical 




End of pilot study questions for patients and stroke nurses, focus group February 
2018: 
Recruitment: 
I’m interested in knowing your views about the recruitment process to the study  
‐ How did you feel about being given information at the TIA clinic and being asked if someone could 
contact you by phone? 
‐ How did you feel about being contacted by someone you’d not met? 
‐ How did you feel about being asked to come to the research unit in Belfast to take part in the study? 
‐ Would it have made a difference to your response if you could have been seen anywhere else – (eg 
GP surgery/ local hospital/home?) 
‐ Do you think people might have preferred other ways of being invited to take part, or meeting the 
researcher?  
 
Views on the manual: 
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‐ What do you think of the manual? How often did you use or refer to it? Was there anything you found 
hard to understand or would want more information on? 
‐ What do you think about the general level of information included within the manual – too much/too 
little? 
‐ What do you think of the length of the booklet? (short/ long)? 
‐ What do you think of the layout of the booklet? (colour, pictures, font size)? 
‐ What did you think of the patient story? 
‐ Did family members/ friends read the manual? What did they think?  
‐ Anything which you particularly enjoyed or disliked about the manual? Anything you would change 
in it? 
‐ If an app version of the manual was available, would people use it?  
 
Exercise programme within the manual: 
‐ How do you feel about exercise after having had a TIA/stroke? 
‐ What do you think of the exercise programme in the manual? Could you do this in your own home? Is 
it challenging?  
 
Use of pedometer: 
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‐ What are your views on using the pedometer/ step-count goals with the manual? 




‐ What were your views on the telephone contacts during the study? (number/ frequency/ content 
(topics covered/ feedback given)/ GP/ nurse?) 
‐ About how much time did each telephone call take up for you?  




‐ What did you think about the tests and measurements that were done as assessments? (comments 
about the examination/ questionnaires?) 
‐ What did you think about the time involved in the assessments?  
‐ Are there any tests which you would have preferred not to do or would like to see included?  
‐ What do you think would incentivise more people to take part in studies like this? 
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Dissemination of research findings:  
‐ Who do you think should be told about our study’s findings? 
‐ What do you think is the best way to tell people about our findings?  
 
Study duration and future goals: 
‐ What goals/aims are important to you now that you have been diagnosed and are on the path to 
recovery? 
‐ What did you think about the 12-week study follow-up? Longer/shorter? 
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Supplementary File 1 – BCTs utilised within the Manual Preface 







“Please remember to visit them 
(GP/practice nurses) regularly for health 






“This manual can also be shared with 
your family and friends…as well as with 







“The facilitator, who will contact you by 
telephone, will help you go through the 
book.” 
5.3 Information 




“….giving you information about TIAs, 
minor strokes, your brain and the impact 










“Your facilitator, GP and practice nurse 




13. Identity “This manual contains information 
about ways you can help yourself to feel 
good now and remain healthy in the 
future.” 
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Supplementary File 2 – BCTs utilised within the Manual Introduction 
BCT Label BCT group Example of how the BCT was used  
1.1 Goal setting 
(behaviour) 
1. Goals and 
planning 
“Have realistic goals.” 
 
Patient encouraged to keep a goal and 
action plans diary and write this down 
within the manual.  
1.3 Goal setting 
(outcome) 
1. Goals and 
planning 
“Goal – stress (reduction). Plan – I will 
join a yoga class. I will find out about 
where there are yoga classes happening 
and I will sign up to attend a class once 
a week starting from next week.” 
1.4 Action 
planning 
1. Goals and 
planning 
“Make an action plan.” 
 
Patient encouraged to keep a goal and 
action plans diary and write this down 
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within the manual. 
1.7 Review 
outcome goal(s) 
1. Goals and 
planning 
“Write a few goals and action plans 
down for you to try to achieve over the 
next few weeks. You can discuss how to 
achieve these with your facilitator or 
other health professional.” 
1.8 Behavioural 
contract 
1. Goals and 
planning 
The goals and action plans diary is 






Advice provided about what to do if 
they suspect they are having another 






“….try to contact someone who could 
come and be with you while you are 






“The fact that you have had a TIA or 
minor stroke doesn’t mean that your 
brain is worn out or that you are 
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‘finished’ but should serve as a warning 
to you that you need to improve your 
health.” 
 
“Changing the way you live, such as 
making small changes to your diet or 
getting more exercise, can reduce your 
risk of having another transient 






“These changes can also make you feel 




11. Regulation “After a TIA or stroke it is common to 
notice unusual feelings in your body 
much more than you did before. It is 
important not to get too worried about 
this. Worrying and thinking about these 
		 278




13. Identity “The good news is that it’s well on the 




15. Self-belief “Things to remember: 
- The brain has miraculous powers of 
recovery. 
- It is one of the strongest and most 
adaptable organs in your body. 
- It is also capable of doing much more 
work than most of us ever need.” 
 
“People who have realistic goals and 
plan changes have greater success in 
changing the way they live.” 
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Supplementary File 3 – BCTs utilised within Section 1 - Smoking 
BCT Label BCT group Example of how the BCT was used  
1.1 Goal setting 
(behaviour) 
1. Goals and 
planning 
“Weigh these up for yourself and decide 
whether you are ready to quit.” 
1.2 Problem 
solving 
1. Goals and 
planning 
“Identify situations that will be difficult 
and plan how you’ll cope…” 
1.4 Action 
planning 
1. Goals and 
planning 
“Try taking chewing gum or something 
healthy rather than a cigarette.” 
 
“Some people say that smoking is good 
for them because it helps them to relax. 
If this is the case for you, think of other 
ways to relax. Perhaps going for a walk, 
instead of having a cigarette, might 
make you feel good?” 




support family wants to stop too?” 
 
“For those experiencing specific 
difficulties and challenges, there is 
specific help available in the community 
and your facilitator can help identify 
this.” 
4.1 Instruction 





“If you enjoy a cigarette after a meal, 






“Stick with it….. 
- even though you may have withdrawal 
symptoms once you stop smoking. 
These should disappear within a week or 
two.  
- Don’t give in to cravings – these 
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“It is never too late to stop smoking and 
the benefits begin as soon as you give 
up: 
- Within days, your blood is less likely 
to clot. 
- Within 5 years, the risk of a heart 
attack falls to half that of a smoker. 
Within 10 years, you will have about the 
same risk of heart and brain disease as 






“If you normally have a cigarette first 






“If you like a cigarette with tea or 
coffee, try changing your drink to water 
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substitution or a fruit juice.” 




“First, think about the reasons you like 
smoking and the reasons you would like 












“Be nice to yourself: 
- Reward yourself for staying off 
cigarettes, even for one day. 
- Save the money you are not spending 





11. Regulation “There are treatments available that can 
at least double your chances of 
quitting…” 







Antecedents the phone, move the ashtray.” 
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Supplementary File 4 – BCTs utilised within Section 2 – Physical Activity 
BCT Label BCT group Example of how the BCT was used  
1.1 Goal setting 
(behaviour) 
1. Goals and 
planning 
“Your aim is to build up to 30 minutes 
of moderate activity every day and 
reduce the amount of time you spend 
being inactive.” 
 
“To help guide the intensity of your 
physical activity/exercise: moderate 
intensity activity is when you’re 
working hard enough to raise your heart 




1. Goals and 
planning 
“Finding a way of being active can 
sometimes be hard, so here are some 
tips on how to make it easier for 
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yourself: 
- Choose an activity you enjoy! 
- Listen to music whilst you exercise. 
- Try and find activities that fit in with 
your lifestyle and that you can do on 
most days of the week.” 
 
“Give the car a rest – walk or cycle to 






“A general target to aim for is about 
7,500 steps/day although some people 
will manage more than this…” 
 
“You will be able to talk but unable to 




“Physical activity and exercise record”.  
 
“Please continue writing at the end of 
the manual, use a separate diary or an 








“….set your own personal target after 
talking to the facilitator.” 
 






“Chest Heart and Stroke (NI) organise 
exercise classes (called Post Rehab 
Exercise Programme – PREP) for 
patients and can be accessed directly 
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“Having company can make exercising 
more enjoyable.” 
 
“Discuss the problem with your partner 
so that they know that they aren’t 
putting you off.” 
4.1 Instruction 





Written explanation of 5 exercises to try 
at home.  
6.1 
Demonstration 
of the behaviour 
6. Comparison 
of behaviour 
The home exercise programme is 
illustrated to the reader through 
appropriate diagrams.  
7.1 
Prompts/cues 
7. Associations For being physically active: 
“- Keep your walking shoes near the 
door. 
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- Keep your golf clubs or swim suit in 







“Add activity to your daily routine – 
begin with three 10-minute walks spread 





“Some GPs can also refer you to your 
local council gyms through local 




11. Regulation “This often leads to avoiding sex or not 
enjoying it when it does happen. In fact, 
it seems to be very rare for a person to 
have a TIA or stroke after having sex.” 
12.5 Adding 







13. Identity “It is important to realise that sex is no 




exercise. It does not put a special kind of 
strain on your brain.” 
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Supplementary File 5 – BCTs utilised within Section 3 – Healthy Eating and 
Alcohol 
BCT Label BCT group Example of how the BCT was used  
1.1 Goal setting 
(behaviours) 
1. Goals and 
planning 
“Safe limits of alcohol intake: 
1) 14 units per week for both men 
and women; 
2) spread your alcohol intake 
evenly throughout the week; 
3) maximum of 2-3 units per 
day.” 
 
- “ I will use only semi-skimmed milk. 
- I won’t have second helping. 
- I will eat a healthy breakfast every 





1.3 Goal setting 
(outcome) 
1. Goals and 
planning 
“Aim to lose weight slowly. Short-term 
or quick-fix diets are not good – you 




1. Goal and 
planning 
“Recommendations to adopt a 
Mediterranean-style diet:….” 
 
“Make out a shopiing list with all the 
healthy foods you plan to buy, then take 
it with you to the shop.” 
 




planning surprised to see what your Food Diary 
looks like after one week! Try writing 







“Set Targets for Yourself…” 
4.1 Instruction 





“There are four main messages when 
eating for a healthy brain and heart: 
- Eat less fat – especially saturated fat. 
- Eat more fibre – fruits, vegetables, 
cereals. 
- Eat less salt. 
- Eat less sugar.” 
 
“Here are some helpful tips to make it 
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easier for you to switch to healthier 







“A healthy Mediterranean diet can help 
prevent further brain disease, as well as 
other diseases such as heart attacks, by: 
1. Lowering cholesterol in the 
blood vessels around your heart. 
2. Controlling your weight, which 
affects your blood pressure. 
Supplying you with vitamins and 
antioxidants, which help to keep your 






“After a few weeks you may find that 
you can enjoy yourself just as much on a 






“A Patient’s Story” 
 
A patient details their experience of 







“Eat more fruit and vegetables – aim for 







“Switch to olive oil and rapeseed oil 
instead of lard or other vegetable oils 
- Switch to olive oil spreads instead of 
butter or margarine”.  
 











“A Patient’s Story” 
 
A patient details their experience of 





“Enjoy a treat once a week as a reward.” 
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Supplementary File 6 – BCTs utilised within Section 4 – Stress and Fatigue 
BCT Label BCT group Example of how the BCT was used  




“- Keep active – a healthy body helps 
keep a healthy mind.” 
 




1. Goals and 
planning 
“The way we think about a situation is 
part of what makes it stressful. It’s not 
always the situation itself that matters 
most, but our response to it.” 
 






“…keeping a diary of your activities can 








“If you are finding it difficult to sleep, 







“Speak with your GP or healthcare 
professional who can suggest some 







“Speak with your GP or healthcare 
professional who can suggest some 






“two people might experience the same 
stressful situation in two different ways: 
One might say it makes them feel 
helpless against an impossible barrier, as 
in a nightmare or a trap, with pressure 
from both sides – like being the meat in 
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a sandwich. 
Another person might view the same 
situation as an obstacle which can be 
overcome – an exciting opportunity or a 







“Long periods of stress can lead to: 
- High blood pressure 
- Muscle tension and backache…” 
5.3 Information 





“Without stress and adrenaline, we 






“Long periods of stress can lead to: 
- Frustration, irritability and anxiety…” 








11. Regulation “Try not to be a perfectionist in 
everything.” 
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Supplementary File 7 – BCTs utilised within Section 5 - Medication 
BCT Label BCT group Example of how the BCT was used  
1.2 Problem 
solving 
1. Goals and 
planning 
“You may find it useful to make a list of 
all the medicine you have to take, at 
which time and connect it with something 
you usually do at that time – like your 
morning wash, eating lunch, getting 
changed after work or going to bed.” 
1.4 Action 
planning 
1. Goals and 
planning 
“You may find it useful to make a list of 
all the medicine you have to take, at 
which time and connect it with something 
you usually do at that time – like your 
morning wash, eating lunch, getting 
changed after work or going to bed.” 
7.1 Prompts/cues 7. Associations “You may find it useful to make a list of 
all the medicine you have to take, at 
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which time and connect it with something 
you usually do at that time – like your 
morning wash, eating lunch, getting 







“If you always take them at these times it 
will soon become a habit and you are less 






“If you always take them at these times it 
will soon become a habit and you are less 









11. Regulation “Medication to Help your Brain”.  
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Supplementary File 8 – BCTs utilised within Section 6 – Community Support 
 
  






“A friend or family member may join 
you, for example, in starting an exercise 






“Your facilitator, doctor or practice 
nurse will help you to identify 
organisations and services in your area 
that can help you in whatever positive 
lifestyle changes you choose to make.” 
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